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 mRNA Display is an increasingly popular technique in pharmaceutical sciences to make 
highly diverse peptide libraries to pan for protein inhibitors. The current state of the art applies 
Flexizyme codon reprogramming with mRNA display to introduce unnatural amino acids for 
peptide cyclization and to further increase library diversity. Interestingly, ribosomally synthesized 
and post-translationally modified peptides (RiPP) are a unique class of natural products that 
transform linear peptides into highly modified and structurally complex metabolites. By 
combining RiPP biosynthesis with mRNA display, libraries of increasingly greater diversity can 
be achieved, and impending selected inhibitors will have natural product-like qualities, which we 
expect will allow these compounds to have better drug-like properties. Herein, we have developed 
a platform to measure RiPP enzyme modification of mRNA display libraries to show for the first 
time that RiPP enzymes can modify RNA linked peptide substrates. The platform may be 
extrapolated to many different RiPP enzymes and provides useful measurements to determine if a 
RiPP enzyme is promiscuous and effective to produce highly diversified peptides. Thiopeptides 
are a specific class of RiPP that we would like to apply to mRNA display, because they have broad 
activities. Additionally, the structure of thiopeptides is primed for mRNA display protocols, 




mRNA tag. We present a redesigned chemoenzymatic strategy to make thiopeptides using cell free 
protein synthesis that is promiscuous, can synthesize different thiopeptide classes, and is mRNA  
display ready. Finally, bioinformatic analysis of publicly available thiopeptide gene clusters shows 
that many unknown thiopeptides still exist. We have organized a set of 14 new clusters for which 
we can apply our chemoenzymatic strategy and characterize these unknown compounds, with the 
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CHAPTER 1: INTRODUCTION 
1.1 Modification of Genetically Encoded Peptide Libraries and Drug Discovery 
 In recent years, we have seen an explosion of peptide display technologies for the discovery 
of protein binding peptides.1 Genetically encoded libraries, in particular, are useful because very 
large and diverse libraries can be made quickly, and amplification by PCR or organism replication 
enables several rounds of enrichment to be conducted to reveal unambiguous, high affinity binders 
illuminated by next generation sequencing.2 It is becoming increasingly clear that modified 
peptides perform much better as drugs than unmodified peptides.3–5 Altering a peptide inhibitor 
post selection often lowers the target binding affinity, and only sometimes can careful SAR studies 
lead to modified peptides which retain binding and become more bioavailable.6,7 But, to avoid 
such arduous SAR studies, it may be prudent to modify peptide libraries before they are triaged 
for a specific activity. In this manner, greater diversity can be achieved leading to better target 
binding affinity, and hits can be preemptively biased for better drug-like properties.  Indeed, much 
effort and vigor are being put into developing peptide display chemistries and enzymatic reactions 
to achieve this goal,8–17 especially from those in the pharmaceutical industry.  
1.2 mRNA Display Has Specific Advantages Over Other Display Technologies 
 Some of the most popular genetically encoded peptide panning technologies are mRNA, 
ribosomal, yeast, phage, and bacterial display. Each of these techniques can display a peptide for 
selection coupled to a genetic tag for identification. Furthermore, they have an advantage over 
DNA-encoded libraries because hits can be amplified and subjected to multiple rounds of 





Figure 1.1. mRNA display of modified peptide libraries. (1) An mRNA library is translated to 
peptides by the ribosome. Each peptide is covalently linked to its cognate mRNA via puromycin 
(P). (2-3) Chemistry or enzymes can be used to modify peptides libraries. (4) Using an 
immobilized protein target, binders can be pulled out. (5) After multiple rounds, the mRNA library 
can be sequenced to reveal protein binders. 
 
which immediately places a limit on library diversity due to transformation efficiency18 (~109), 
and selections can be slow because organisms need time to replicate and grow. Additionally, very 
careful design is needed to make sure that the peptides are displayed in a manner that is available 
for panning and does not affect the livelihood of the organism, i.e. choosing the right protein within 
the viral coat to conjugate a peptide library to.  Ribosomal display and mRNA display are valuable 
because they do not rely on a living organism for amplification, leading to a larger library diversity 
(~1013). But with regards to displaying small peptides, mRNA display is the best, because a 
covalent bond is formed between the peptide and RNA.19 Additionally, of all the genetically 
encoded display techniques, mRNA display has the smallest tag placed on the peptide, leading to 






1.3 RiPP Biosynthesis and Application to mRNA Display.  
 Chemical modifications of peptide libraries are increasingly being used and validated, 
often focused on macrocyclization.15,17,20–25 But the chemistries available remain simple and mild 
because they must be done in water, they must not harm living organisms, and they must not 
degrade RNA.26 Conversely, enzymes are now stepping up to provide complex, regioselective, 
and stereoselective modifications that are inherently compatible with living organisms and RNA. 
Many of the enzymes used with peptide display come from promiscuous natural product 
biosynthesis. Indeed, a few recent reports show how lantibiotic cyclases can be used to screen 
libraries of lantibiotics with stereo- and regiospecific modifications;12,13,27 a problem reported for 
chemically made lantibiotic libraries.10 
 Lantibiotics belong to a class of natural products called, “Ribosomally Synthesized and 
Post-translationally Modified Peptides” or RiPPs.28  Biosynthesis of RiPPs begins when a small  
 
Figure 1.2. RiPP biosynthesis. A small gene called a precursor peptide containing a core and 
recognition sequences is translated by the ribosome. Subsequently, recognition sequences recruit 
biosynthetic enzymes to install chemical modifications into the core. Finally, the recognition 
sequences are removed, and the natural product is released. 
gene is translated by the ribosome into a precursor peptide. This small peptide contains recognition 




chemical modifications are placed. Biosynthesis is finished when the core modifications are 
complete, and the recognition sequences are removed, figure 1.2.  The use of recognition sequences 
to separate substrate affinity and substrate modification, gives RiPPs a heightened degree of 
promiscuity compared with other enzymes and allows RiPPs to be easily programmed for new 
substrates.29 Because RiPP enzymes are promiscuous, programmable, and act on peptides, they 
are groomed for the transformation of peptide libraries.  Lantibiotics represent the first example of 
this,12,13,27 but there are many different RiPPs that can be applied in this manner. Application of 
new RiPPs has been slow because there are no good techniques to measure RiPP enzyme 
modification of a peptide library. Therefore, new experiments that quickly measure how well a 
RiPP can modify a diverse library of substrates would be of great use to couple more RiPPs with 
peptide display. 
1.4 Thiopeptides are a Good Scaffold for mRNA Display Selections.  
 Thiopeptides are RiPPs that contain three major functional groups: azoles, dehydroalanine 
/ dehydrobutyrine, and a central pyridine ring figure 1.3.30 These are useful modifications to turn 
simple peptides into more bioavailable molecules, conforming towards “beyond rule of 5’” 
suggestions31 by reducing molecular weight, hydrogen bond donors and acceptors, the number of 
rotatable bonds,32 and polar surface area. Thiopeptides are privileged having a wide range of 
activities, such as antibacterial, antimalarial, anticancer, proteasome inhibition, transcription factor 
regulation, and mitophagy induction.33–36 Privileged scaffolds are a good resource to discover new 
activities.37 Finally, mature thiopeptides contain a highly decorated macrocycle, with an open C-
terminal tail that we predict will readily accept an RNA tag for use in mRNA display, figure 1.3. 




their inherent modifications can promote bioavailability, and because the scaffold is already 
privileged towards many bioactivities.  
 
 
Figure 1.3. Thiopeptides are distinguished by three distinct functional groups. Thiopeptides are 
made from linear peptides by the installation of azoles, dehydroalanines / dehydrobutyrines, and a 
pyridine ring is formed during macrocyclization and RS removal. “RS” means recognition 
sequences. 
 
  The enzymes that make thiopeptides have been extensively studied.38–51 In fact, the 
biosynthetic gene clusters for hallmark thiopeptides like Thiocillin, GE37468, and Thiostrepton 
have been engineered to make libraries of thiopeptide analogs, reinforcing the promiscuity of 
RiPPs.32,42,52–57 But, while promiscuous to make analogs, a single thiopeptide BGC can only make 
its cognate class of thiopeptide, i.e. enzymes for thiocillin biosynthesis cannot make 




characteristic backbone.58 Often, these enzymes are found to have difficult cofactors or are unable  
to be expressed and purified from E. coli; this is an essential element for using enzymes in mRNA 
 
Figure 1.4. Chemoenzymatic synthesis of thiopeptides. (1) Azole containing peptides can be 
synthesized using solid phase peptide synthesis with a recognition sequence “RS” for a thiopeptide 
pyridine synthase. (2) With dibromohexaediamide, cysteines can be eliminated to dehydro-
alanine. (3) A select pyridine synthase from thiopeptide biosynthesis can be expressed, purified, 




display. Because of this, a chemoenzymatic strategy which reduces the number of enzymes and 
allows the preparation of multiple structurally disparate thiopeptides could accelerate this class of 
natural product to best be used in peptide display technologies. Interestingly, a few recent reports 
use chemoenzymatic synthesis to make different thiopeptides by using only a single enzyme from 
the natural BGC.43,55,59–61 This enzyme is the pyridine synthase which performs the final 
macrocyclization and installs the hallmark pyridine while eliminating recognition sequences, 
figure 1.4. Currently this chemoenzymatic synthesis is not amenable to peptide display, but, with 
some clever alterations it could be.  
1.5 Bioinformatic Expansion of Thiopeptides and Chemoenzymatic Synthesis Could Lead to 
Optimal Enzymes for mRNA Display of Thiopeptides. 
 
 Most thiopeptides have been discovered using a “top down” approach; meaning the 
compound was discovered first based on an observed activity, extracted, and then structurally 
characterized without knowledge of the biosynthetic gene cluster.62 With the rapid speed at which 
new genomes have been sequenced and stored in GenBank, swaths of genomic information are 
now available for a “bottom up” approach to discover new thiopeptides. By applying bioinformatic 
tools like BLAST, RODEO, and antiSMASH biosynthetic gene clusters of specific natural 
products can be targeted and collected. Additionally, with the help of sequence similarity 
networks, the diversity found therein can be visualized. This can greatly aid the discovery of new 
natural products, especially RiPPs, and prioritize gene clusters for characterization.  
 A key enzyme to chemoenzymatically make thiopeptides compatible with mRNA display 
is the pyridine synthase. To date there are only 5 pyridine synthases characterized in vitro: TclM 
(thiocillin),59 TbtD (thiomuracin),39 PbtD (thiomuracin),39 and LazC (lactazole),63 and MroD 
(pyritide).61 While these enzymes may or may not work well for mRNA display, a thorough 




there are many lantibiotic cyclases. One in particular, ProcM, has 29 diverse but natural 
substrates,64 an indication of heightened promiscuity. Indeed, promiscuity was confirmed65 and 
now ProcM has been used successfully in peptide display campaigns.12,27  
 In 2018 a report showed that the unknown chemical space of thiopeptides is much more 
diverse than what is currently known.40 Furthermore, the same group showed the strength of 
chemoenzymatic synthesis by characterizing the unknown pyridine synthase, MroD, without the 
preceding associated enzymes.61  This demonstrates the usefulness and power of combining 
bioinformatics with chemoenzymatic synthesis to illuminate new thiopeptides. But, what the 2018 
report failed to do is provide any useful analysis and prioritization of new thiopeptides for 
chemoenzymatic discovery.  Ergo, a new bioinformatic endeavor is warranted that collects what 
new thiopeptides that have been added to GenBank since 2018 and provides analysis of interesting 
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CHAPTER 2: EXPLORING THE POST-TRANSLATIONAL ENZYMOLOGY OF PAAA  
BY MRNA DISPLAY1  
2.1 Introduction 
 
 Ribosomally synthesized and post-translationally modified peptides (RiPPs) are an 
exciting family of natural products that have seen a surge in research due to exceptional versatility 
of their biosynthetic enzymes.1 Recent studies have shown that, in many cases, RiPP chemistry is 
guided by specific interactions between a RiPP recognition element (RRE) and the peptide 
substrate.2−6 The RRE binds one region of the substrate and feeds the remainder into the catalytic 
domain for modification. This modular strategy allows for remarkable substrate promiscuity, and 
as a result, RiPP enzymes are increasingly being exploited to make complex libraries of peptide 
derivatives.7−16 Most recently, RiPPs have been paired with phage and yeast display to identify 
high affinity, RiPP-based peptide binders.17−19 While this work hints at the extraordinary 
promiscuity and generality of RiPP enzymes, verifying and measuring enzymatic modification of 
library members remains a significant challenge. Indeed, in many display libraries where chemical 
modification is used, including phage,20,21 mRNA display,22 and even DNA-encoded libraries 
(DELs),23,24 panning hits wind up being the most significant evidence that chemistry worked. In 
the case of RiPP enzymes, quantitative assessment, and comparison of  
   
 
1This chapter was adapted from a communication that previously appeared in the Journal of the 
American Chemical Society. The original citation is as follows: Fleming, S.R., Himes, P.M., 




enzymatic modifications on large display libraries could inform broadly on substrate promiscuity 
and mechanistic features of these enzymes, leading the way to their more effective implementation 
in benchtop campaigns. 
 Inspired by several reports of high-throughput assays for proteases and ligases,25−28 we 
envisioned a coupled mRNA display assay that might allow expedient study of RiPP enzymology 
and promiscuity. mRNA display is a powerful peptide display technology where peptides are 
linked to their own encoding RNA during in vitro ribosomal translation.29 mRNA display allows 
the easy incorporation of non-natural amino acids by Flexizyme reprogramming,30 which could 
aid in our assay design and significantly expand library diversity one day. To substantiate mRNA 
display as a biochemical tool to study RiPPs, we first chose PaaA, an RRE-containing RiPP 
enzyme from the biosynthesis of the antibiotic Pantocin A (figure 2.1a, 1).31−33 PaaA is a ThiF/E1-
like activating enzyme that catalyzes the double dehydration and decarboxylation of two glutamic 
acid residues (E16 and E17) in substrate peptide, PaaP, to form the fused-bicyclic core of the active 
tripeptide natural product. Interestingly, the enzymatic mechanism may proceed by either of two 
imide intermediates to achieve the same product (figure 2.1b).34 Since PaaA chemically modifies 
two glutamic acids, we could use the indiscriminate Glu-protease GluC to cleave unmodified 
substrate analogues in an mRNA display library and report on PaaA activity. This approach would 
confirm and measure PaaA modification of substrate peptide mutants and constitute a first 
application of RiPP enzymes to mRNA display libraries.   
2.2 Results and Discussion 
 To implement this approach, we first sought to confirm that PaaA could modify an mRNA 
displayed PaaP substrate: we established a gel shift assay, wherein treatment of 35S-Met-labeled 





Figure 2.1. Pantocin A biosynthesis and mRNA display activity assay to study PaaA. (a) Pantocin 
A gene cluster, including paaA, an ATP-dependent ThiF/E1-like enzyme; paaB, α-ketogluterate-
dependent iron oxidase; paaC, efflux pump; and paaP, precursor peptide. (b) Potential mechanisms 
for PaaA catalyzed modification of PaaP. (c) Overview of mRNA display assay with N-terminal 
biotinylated (blue) PaaP linked to mRNA via puromycin “P”. Modified substrates are enriched by 
streptavidin (green) pulldown and analyzed by qPCR or next generation sequencing (NGS). “x” is 
any given peptide, “wt” is wild type. (d) E scores for each single mutant PaaP peptide analyzed 
after PaaA activity selection. Blue indicates sequence enrichment worse than WT, and orange 
indicates sequence enrichment better than WT. Each square represents an average (n = 3). 
 
figure A.1a).  To further optimize reaction conditions with mRNA display substrates and allow for 
enrichment of modified peptides from larger libraries, we adapted this assay to include affinity 
purification and qPCR-based quantitation (figure 2.1c).  This new iteration of the assay involves 
four key steps: (1) display of an N-terminal biotinylated PaaP substrate via Flexizyme codon 
reprogramming, (2) treatment with PaaA, (3) protease treatment with GluC to remove RNA tags 
from unmodified substrates, and finally (4) streptavidin enrichment of only modified substrates. 
The assay was optimized for GluC cleavage conditions, PaaA concentration, and reaction time 
(Appendix figure A.1b-d). With a functioning activity assay in hand we next designed a saturation 




affect PaaA activity. The library was treated with 1 μM PaaA for 5, 22.5, and 60 min before GluC 
treatment and streptavidin purification. Recovered sequences were PCR amplified and submitted 
for next generation sequencing (NGS). The sequencing data was processed by calculating E scores 
(figure 2.1c),35 which are normalized values for the success of each mutant compared to wild type 
(WT). In this analysis a score >1 is better than WT and a score < 1 is worse than WT (figure 2.1d, 
Appendix figure A.2 and A.3). As an important assay control, we examined Glu mutants within 
the leader and follower. Because these mutations lie outside the core, we anticipate that they will 
go unmodified and thus be readily cleaved by GluC irrespective of PaaA activity at E16 and E17. 
Satisfyingly, these Glu mutants have consistently low E scores, demonstrating that the assay 
selection conditions are stringent (figure 2.1d, gray arrow). Beyond this internal control four key 
trends are readily apparent. (1) First, PaaA is broadly tolerant of point mutations. Of the 26 
positions within the leader and follower probed by saturation mutagenesis, 22 appear numb to 
mutation. This is especially evident in the follower sequence as no single mutations strongly 
inhibited PaaA processing. (2) While the leader sequence also shows high tolerance to mutations, 
four positions (F4, L7, R10, and I11) consistently enriched poorly when mutated (figure 2.1d, 
black arrows). With increasing PaaA incubation time this result lessened suggesting that these 
mutations slow the reaction but do not prevent it. However, aspartic acid replacements at these 
positions appear to severely inhibit PaaA processing (figure 1d and Appendix figure A.3ab). Given 
that PaaA exhibits an RRE domain, we speculate that this FXXLXXRI motif may be involved in 
substrate recognition at the RRE / peptide interface where backbone hydrogen bonding typically 
drives β-strand interactions and hydrophobic residues fill key hotspots.2−6 (3) The smSVL data 
also shows that while E16 mutations were highly susceptible to GluC cleavage, E17 mutants were 




that PaaA may exhibit a preference for activation of E16 over E17, which may further play a role 
in the mechanism of modification (figure 2.1b). (4) Finally, core residue N18 also displays a high 
tolerance to mutation (figure 2.1d, red arrow), suggesting that PaaA can be used to make new 
Pantocin A analogues.  
 To validate selection results, we chose several mutants for confirmation by in vitro 
enzymatic assay and mass spectrometric characterization. Each substrate was translated with NEB 
PURExpress, then treated with 1 μM PaaA, and reaction products were analyzed by MALDI-TOF. 
As seen in the smSVL data, PaaA proved promiscuous to point mutations within the leader and 
follower peptides (figure 2.2a, Appendix figure A.9, Appendix Table A.1). Notably, N18D was 
processed to the final bicycle demonstrating that PaaA can be used for preparation of novel 
Pantocin A analogues. Also, aligned with the smSVL data, qualitative analysis shows that PaaA 
struggles to process F4D, L7D, R10D, and I11D mutants, and the quadruple alanine mutant went 
completely unmodified. In contrast a quadruple mutant outside these four residues was accepted 
(K3A, T6A, S8A, T15A). These data further support that PaaA has a wide tolerance for single 
mutations and strengthens the importance of F4, L7, R10, and I11 for PaaA reactivity. To 
investigate whether these four residues are involved in PaaA recognition, we prepared synthetic 
variants of the N-terminal 12 residues of PaaP and a TAMRA-labeled fluorescent probe that could 
be used for competitive fluorescence polarization (FP) assays. In these FP assays, only WT and 
T6D peptides competed effectively with TAMRA-WT for PaaA binding (figure 2.2b and 
Appendix figure A.4). This was further substantiated by isothermal titration calorimetry (ITC, 
figure 2.2b and Appendix figure A.5). Together, the MALDI-TOF data and binding experiments 
confirm that PaaA is a promiscuous RiPP enzyme and that these four residues are essential for 





Figure 2.2. PaaA substrate promiscuity, binding, and processing. (a) MALDI-TOF analysis of 
PaaA activity on PaaP mutants. Total extracted ion integration areas for substrate remaining “S” 
and observed products “P” were summated and used to calculate percent substrate or products for 
display in a heatmap. (b) PaaA binding to PaaP measured by competitive fluorescence polarization 
(FP, mean and error for n = 3) and isothermal calorimetry (ITC, mean and error for n = 2). (c,d) 
MALDI-TOF analysis of PaaA catalyzed dehydration (−18 Da) of PaaP core E mutants. (e) PaaP 
A13C was prepared by native chemical ligation with 13C-labeled E17. Orange dots indicate 
labeled carbons. Reaction of E17 labeled PaaP A13C with PaaA leads to a mass shift of 81 Da 
indicating loss of a single 13C atom due to E17 decarboxylation. (f) Weblogo analysis of 996 most 
enriched sequences with PaaP NNK 6. 
 
shows significant conservation across the central third of the precursor peptide (L7-Y21, Appendix 
figure A.6). F4, L7, R10, and I11 are heavily conserved, as are many others, thus highlighting the 
power of this approach in effectively discriminating between essential residues where 
bioinformatics could not.   
 We next turned to the difference in enrichment between E16 and E17 mutants (figure 2.1d, 
blue arrows). To better understand this result, we first validated several core E mutants in MALDI-
TOF assays. Notably, as exemplified by E17A and E17Q (figure 2.2c), E17 mutants were readily 
modified to a single dehydration product, suggesting partial processing to putative imide 




mutations to E16 are converted to this intermediate (figure 2.2d and Appendix Table A.2). The 
mechanism of PaaA can be reasonably written from a first step condensation of either E16 or E17, 
and both routes could yield the same bicyclic Pantocin A core (figure 2.1b and Appendix figure 
A.7).  If E16 is condensed first, then E17 must undergo decarboxylation and vice versa. The 
general rejection of E16 mutations suggests that the E16 side chain is the preferred initial substrate. 
To confirm this biosynthetic timing, we prepared a PaaA substrate selectively 13C-enriched at E17 
(Appendix figure A.8).  Treatment with PaaA transformed the peptide into the product with a mass 
shift consistent with loss of a single 13C label (figure 2.2e, E17 Decarboxylation, Appendix Table 
A.3). The loss of a 13C label agrees with a mechanism in which E16 is modified first, followed by 
E17 cyclization and decarboxylation.  
 The smSVL experiment proved informative for studying point mutations, but the power of 
mRNA display is its capacity to screen much larger libraries, containing multiple simultaneous 
mutations. To show that RiPPs and mRNA display might be compatible with larger and more 
diverse libraries, we prepared a ∼34 million-member library where the 6 positions from T6-I11 
were simultaneously randomized with NNK codons. This library was treated with 1 μM PaaA 
before purification, GluC treatment, and streptavidin pull-down. After enrichment, the recovered 
DNA was PCR amplified, submitted for NGS and analyzed by Weblogo. Significantly, positions 
7, 10, and 11 showed strong enrichment to a generalized version of the natural epitope evinced by 
smSVL experiments: FXXBXXRB (B = V, L, or I, figure 2.2f). Additionally, this data shows that 
other residues are significantly less important for substrate recognition and processing. Such broad 
permissiveness has previously been hypothesized in RRE substrate interactions but not validated 






 In summary, we successfully deployed an mRNA display based enzyme activity assay to 
study the RiPP enzyme PaaA. This assay provides rapid insight into the broad promiscuity, 
sequence dependent substrate recognition, and residue specific processing of the PaaP core all in 
one set of experiments. The results suggest that PaaA is broadly promiscuous outside of its core 
and binding epitope and might be readily adapted to synthesize new Pantocin analogues or 
incorporate the indolizidinone core into peptide libraries.36,37 The present version of this assay is 
limited to reporting on glutamate modification because of reliance on GluC, but future iterations 
might probe other amino acids by exploiting alternative proteases or biorthogonal chemistries.38 
mRNA display is particularly well-suited to broadly probe peptide post-translational enzymatic 
chemistry in this manner because of the ready introduction of non-natural functionality through 
Flexizyme codon reprogramming. Perhaps most importantly, this work demonstrates the 
compatibility of a RiPP enzyme, here PaaA, with a C-terminal mRNA display tag, suggesting that 
others might also be used in this manner. These results ultimately pave the way for using RiPP 
enzymes to transform mRNA display libraries into more natural product-like molecules for 
inhibitor discovery. 
2.4 Experimental. 
2.4.1 Materials and General Methods 
 All oligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA), 
Twist Bioscience (San Francisco, CA), or Eton Bioscience (San Diego, CA).  Enzymes such as 
Q5 DNA polymerase, T4 RNA Ligase I, T7 RNA polymerase, and DNAseI optizyme were 
purchased from New England Biolabs (Ipswich, MA). Taq DNA polymerase was expressed and 




Sigma (Burlington, MA). Two different PURExpress translation kits were purchased and used as 
directed from New England Biolabs. For translation of peptides and analysis by MALDI-TOF -aa, 
-tRNA (E6840S) was used and for mRNA display -aa, -tRNA, -RF123 (E6850Z) was used. All 
amino acids used to make custom mixes for translations were purchased from Sigma-Aldrich, 
Alpha Aesar, or Fisher Biotech. Most protected amino acids for solid phase peptide synthesis were 
purchased from Chem-Impex International.  13C, 15N labeled protected glutamic acid was 
purchased from Cambridge Isotopes (Tewksbury, MA). Any other solvents, reagents, and 
chemicals were purchased from Fisher Scientific (Hampton, NH) unless otherwise specified.  
Preparatory HPLC was performed using a Shimadzu UFLC CBM-20A with a dual channel 
wavelength detector at 220 nm and 260 nm with a LUNA 10 µm C18 (2) 100 A, AXIA 
(Phenomenex) semi-preparatory column with a 15 mL / min flow rate. Peptide purification was 
carried out in a two-solvent system (Solvent A: 0.1 % trifluoroacetic acid and water; Solvent B: 
0.1 % trifluoroacetic acid and acetonitrile) using a gradient flow from A to B. High-resolution 
liquid chromatography and mass spectrometry was conducted with a Kinetex 2.6 u C18 column 
and mass spectrometry data was collected with an Agilent 6520 Accurate-Mass Q-TOF ESI 
positive in high-resolution mode. All MALDI-TOF samples were first loaded onto C18 stage tips 
(Thermo Fisher Scientific, Waltham, MA) washed with 4 % acetonitrile and eluted directly onto a 
MALDI plate with 80 % acetonitrile and half saturated MALDI matrix α-cyano-4-
hydroxycinnamic acid.  Data was collected on an AB SCIEX TOF / TOF 5800 system in reflector, 
positive mode. Next generation sequencing (NGS) samples were submitted to Genewiz for 
Amplicon EZ analysis which provides > 50,000 reads per sample.  Sequencing data was analyzed 





2.4.2 Expression and Purification of PaaA-His6  
 This procedure was adapted from the previous report.32 Buffers were filter sterilized and 
made with DEPC treated water while the Ni2+ IMAC column was stripped and regenerated before 
use.  PaaA (from paaA-pET28b, C-terminal 6xHis tag) was expressed in BL21 (DE3) E. coli cells 
in LB medium containing 40 μg / mL kanamycin.  Cells were grown at 37 °C until an OD600 of 
0.5 was attained, at which point the temperature was lowered to 18°C. At an OD600 of 0.8, protein 
expression was induced with the addition of 0.1 mM isopropyl-1-thio-D-galactopyranoside (IPTG) 
and incubated overnight at 18 °C. Cells were collected and pelleted by centrifugation. Cell pellets 
were suspended in Buffer A (20 mM Tris, pH 7.5, 30 mM imidazole, 300 mM NaCl, 5% Glycerol, 
1 mM DTT) supplemented with 0.5 mL of 25 mg / mL T4 lysozyme, 0.5 mL of 150 mM PMSF, 
80 μl of DNaseI (1 u / μl), one tablet of Pierce Protease Inhibitor Tablets (EDTA Free from Thermo 
Scientific), and then incubated on ice for 10 minutes.  The cell pellet was then sonicated.  The 
lysate was clarified by centrifugation at 15,000 rpm at 4 oC for 15 minutes.  The supernatant was 
collected and filtered through a 0.45 μm syringe filter.  The flow through from the filter was then 
passed over a Ni2+ IMAC column (His-Trap HP 5-mL, GE Healthcare) coupled to an FPLC (NGC-
Quest-10 Bio-Rad).  The Ni2+ IMAC column was washed with 5 column volumes (CV) of Buffer 
A.  Protein was eluted with Buffer B (20 mM Tris, pH=7.5, 500 mM imidazole, 300 mM NaCl, 5 
% glycerol, 1 mM DTT) in a gradient of 0-14% B over 2 CV, 14-14 % B over 2 CV, and then 14-
100 % B over 10 CV.    Purity of eluted fractions was assessed by SDS-PAGE. Purest fractions 
were combined and concentrated in a 30,000 MWCO filter in an Amicon stirred cell.  The 
concentrated protein was then exchanged into 50 mM HEPES pH 7.5, 150 mM NaCl, 5 % glycerol, 
and 1 mM DTT by passage over a Sephadex PD-10 column (GE Healthcare).  The protein 




2.4.3 DNA Preparation for NEB PURExpress Translations 
 Genes used for NEB PURExpess transcription and translation reactions were purchased 
from Twist Bioscience (see Appendix A Translation Genes) and amplified using Taq polymerase 
(table 2.1) and the following primers: 
T7 Forward (5’→3’): GAAATTAATACGACTCACTATAGGGG 
T7 Terminator (5’→3’): GCTAGTTATTGCTCAGCGG 
Amplification Cycles (Cycle 25x between denature, annealing, and elongation): 
Table 2.1. Taq polymerase amplification cycles for translation genes. 
Stage Temperature Time 
Initial Denature 95 oC 2 min 
Denature 95 oC 30 sec 
Annealing 51 oC 30 sec 
Elongation 72 oC 2 min 
Final Elongation 72 oC 5 min 
 
After amplification, DNA products were column purified using Thermo Scientific GeneJET PCR 
Purification Kit.  Purity was assessed by 3 % agarose gel and concentrations checked by nanodrop 
were ~100 ng / µL. Templates were stored at -20 oC and directly used for PURExpress reactions.  
2.4.4 DNA Preparation of Transcription Templates 
 DNA transcription templates for Flexizyme, tRNA, and PaaP NNK6 for T7 RNA 
polymerase reactions were prepared as previously described.37  Briefly, each template was 








Table 2.2. Flexizyme and mRNA display primers. 
1 T7-Prom-F GGCGTAATACGACTCACTATAG 
2 eFx-extension-F GTAATACGACTCACTATAGGATCGAAAGATTTCCGC 
3 eFx-extension-R ACCTAACGCTAATCCCCTTTCGGGGCCGCGGAAATCTTTC
GATCC 



























* (mG) designates 2’Ome guanosine RNA 
PCR Cycling Protocols 
Table 2.3. Extension protocol (5 cycles of annealing and elongation): 
Stage Temperature Time 
Initial Denature 95 oC 2 min 
Annealing 50 oC 1 min 
Elongation 72 oC 1 min 





Table 2.4. PCR1 protocol (5 cycles): 
Stage Temperature Time 
Initial Denature 95 oC 2 min 
Denature 95 oC 40 sec 
Annealing 50 oC 40 sec 
Elongation 72 oC 40 sec 
Final Elongation 72 oC 5 min 
 
Table 2.5. PCR2 protocol (12 cycles): 
Stage Temperature Time 
Initial Denature 95 oC 2 min 
Denature 95 oC 40 sec 
Annealing 50 oC 40 sec 
Elongation 72 oC 40 sec 
Final Elongation 72 oC 5 min 
 
Table 2.6. PCR3 protocol (25 cycles): 
Stage Temperature Time 
Initial Denature 95 oC 2 min 
Denature 95 oC 30 sec 
Annealing 57 oC 30 sec 
Elongation 72 oC 2 min 
Final Elongation 72 oC 5 min 
 
Table 2.7. PCR4 protocol (30 cycles): 
Stage Temperature Time 
Initial Denature 98 oC 30 sec 
Denature 98 oC 10 sec 
Annealing 57 oC 20 sec 
Elongation 72 oC 30 sec 






eFx DNA Template Preparation 
 eFx Taq polymerase extension was performed with primers 2 and 3 using cycles 
“Extension Protocol”. Subsequently, 5 µL of product was transferred to 1 mL of Taq polymerase 
PCR with primers 1 and 4 and amplified using cycles “PCR2 Protocol”.  DNA product was purified 
by phenol / chloroform extraction, concentrated by ethanol precipitation, air dried, and 
resuspended in 100 µL of water ready for T7 RNA transcription. 
Initiator tRNA DNA Template Preparation 
 Initiator tRNA (itRNA) Taq polymerase extension was performed with primers 5 and 6 
using cycles “Extension Protocol”. Then 10 µL of extension product was transferred to a 200 µL 
Taq polymerase PCR using primers 1 and 7 using cycles “PCR1 Protocol”. Subsequently 5 µL of 
PCR1 product was transferred to 1 mL Taq polymerase PCR with primers 1 and 8 using cycles 
“PCR2 Protocol”. DNA product was purified by phenol / chloroform extraction, concentrated by 
ethanol precipitation, air dried, and resuspended in 100 µL of water ready for T7 RNA 
transcription. 
PaaP Wild Type mRNA display DNA Template Preparation 
 The WT PaaP gene for mRNA display was purchased from Twist Bioscience (San 
Francisco, CA) and Taq PCR amplified with primers 9 and 10 using cycles “PCR 3 Protocol”. 
PCR product was purified by Thermo Scientific GeneJET PCR Purification Kit, eluted in 20 µL 
of water, and directly used for T7 RNA transcription. 
PaaP Saturation Mutagenesis Single Variant Library (smSVL) DNA Template Preparation 
 PaaP smSVL was purchased from Twist Bioscience.  The library was designed to contain 
no “Pro” mutations at positions E16, E17, and N18 and no “met” or “Stop” mutations at all 




Q5 polymerase with cycle protocol “PCR4 Protocol”. PCR product was purified by Thermo 
Scientific GeneJET PCR Purification Kit, eluted in 20 µL of water, and directly used for T7 RNA 
transcription. 
PaaP NNK6 Library DNA Template Preparation 
 Primers to prepare PaaP NNK6 library were purchased from Integrated DNA Technologies 
(Coralville, IA) and assembled via primer extension and PCR techniques.  First, 100 µL Taq 
polymerase extension reaction was performed using primers 13 and 14 using “Extension Protocol”. 
All 100 µL was added to a 1 mL Taq PCR reaction with primers 11 and 12 using “PCR1 Protocol”. 
Product DNA was purified by phenol / chloroform extraction, concentrated by ethanol 
precipitation, air-dried, and resuspended in 100 µL of water ready for T7 RNA polymerase 
transcription. 
2.4.5 Transcription with T7 RNA polymerase and Urea Gel Purification 
 T7 RNA transcription reactions were performed on a 1 mL scale according to NEB 
protocols with100 µL of prepared DNA template. The only change from NEB protocol was the 
addition of extra MgCl2 (eFx final concentration: 30 mM; itRNA final concentration: 22.5 mM; 
mRNA display templates PaaP WT, PaaP smSVL: 28.5 mM; and mRNA display template PaaP 
NNK 6: 25 mM). Transcriptions were left at 37 oC overnight and treated with 115 µL of 10 x 
DNAseI buffer and 30 µL of DNAseI (Thermo Scientific, EN0521) for 1 hour at 37 oC. Upon 
successful transcriptions, magnesium pyrophosphate precipitates, so, 200 µL of 0.5 M 
ethylenediaminetetraacetic acid (EDTA) was added to clear the solution. RNA was precipitated 
by adding 135 µL of 3 M NaCl and 1190 µL of isopropanol and pelleted by centrifugation at 
16,000 x g; 25 oC for 15 min. The supernatant was disposed of and the pellet was washed with 500 




the pellet dried at room temperature. RNAs were resolubilized in 100 µL of water before adding 
RNA loading dye (2x) and loading onto a 12 % (eFx) or 8 % (itRNA and mRNA display templates) 
Urea-PAGE gel to run for 1 hour at 230 V in Tris-Borate-EDTA (TBE) buffer. The RNA band 
was visualized by UV shadowing (254 nm) on a silica-coated thin-layer chromatography plate and 
cut out of the gel. The removed gel slab was crushed into fine pieces and the RNA extracted twice 
with 0.3 M NaCl at room temperature. The combined extractions were filtered through a 0.45 µm 
sterile syringe filter and a 2x volume of ethanol was added to precipitate the RNA for collection 
by centrifugation at 4,000 rpm for 25 min (Eppendorf swing-bucket rotor A-4-81). The supernatant 
was removed, and the remaining pellet washed with 5 mL of 70 % ethanol followed by 
centrifugation at 4,000 rpm for 5 min. The final RNA pellet was recovered and dried at room 
temperature before resuspending in water. Both eFx and itRNA were diluted to a working stock 
of 250 µM and stored at -20 oC. mRNA display templates were diluted to 10 µM working stocks 
and stored at -80 oC. The above protocol was adjusted for only a 50 µL T7 RNA transcription 
reaction for PaaP WT and PaaP smSVL mRNA display templates. 
2.4.6 N-Biotin-L-Phenylalanine itRNA Acylation Conditions 
 N-biotin-L-phenylalanine cyanomethyl ester was synthesized as in the following report.38 
Flexizyme assays were performed as described.30 Briefly, reactions were carried out at 4 oC for 2 
hours in 50 mM HEPES-KOH (pH 7.5), 600 mM MgCl2, 20 % DMSO, 25 µM eFx, 25 µM itRNA, 
5 mM biotin-L-phenylalanine cyanomethyl ester. Acylated tRNAs were precipitated with 0.3 M 







2.4.7 mRNA Display Protocols 
General Strategy for Linking mRNA Templates to Puromycin 
 mRNA templates were covalently linked to puromycin via Y-ligation strategy adapted 
from the previous report.39 Briefly, 1 µM RNA was incubated with T4 RNA ligase I (NEB, 
M0204S) at room temperature using manufacture protocols with 20 % DMSO and 1.5 µM of P-
linker (d(pCTCCCGCCCCCCGTCC)-(SPC18)5-d(CC)-puromycin).  The reaction was stopped 
after 30 mins by adding a 1 x volume of quenching solution (0.6 M NaCl and 10 mM EDTA). 
Puromycin-linked RNA was precipitated by adding 2.2 x volume of 100 % ethanol and centrifuged 
at 16,000 x g for 15 min.  Discarding the supernatant, the resultant pellet was washed with 70 % 
ethanol and centrifuged again 16,000 x g for 5 min. The pellet was collected and air dried before 
resuspending in 1 / 10 the volume of water as the original T4 RNA ligation reaction. This was 
stored at -80 oC and directly used in PURExpress translation reactions (vide infra).   
Peptide - RNA Fusion Formation and Reverse Transcription 
 mRNA display reactions were adapted from the previous report.4 Translations were 
performed according to PURExpress protocol using kit (-aa, -tRNA, -RF123) with minor changes. 
A 19 amino acid mix devoid of methionine was prepared with 5 mM of each amino acid and added 
to the translation instead of the provided 20 amino acid mix. Puromycin -linked mRNA template 
was added to 20 % of the final translation volume in addition to 100 µM Biotin-Phe-itRNA 
(solubilized in 1 mM NaOAc pH 5.2). Translations were incubated at 37 oC for 30 min and then 
12 min at room temperature to enhance fusion formation before adding 16.7 mM EDTA for 30 
min at 37 oC to dissociate the ribosome. Before selection, RNA was reverse transcribed by adding 
to the displayed library 250 nM dNTPs, 2 µM reverse primer, 25 mM Tris-HCl (pH 8.3), 15 mM 




M3681, supplied at 40x) and incubating at 42 oC for 1 hour. To make 75 µL of peptide-RNA 
fusions, translation reaction volume was 37.5 µL and final volume after reverse transcription was 
75 µL. 
qPCR Analysis 
 To quantitate mRNA display experiments, qPCR was performed using Applied Biosystems 
ViiA7 qPCR Real-Time qPCR Instrument. For each sample, 1 µL was mixed with 19 µL of 
SsoAdvanced Universal SYBR Green Supermix, Bio-Rad (Hercules, CA). qPCR standards were 
made by reverse transcribing a known amount of RNA into cDNA, assuming 100 % yield and 
diluting to 2E9, 2E8, 2E7, 2E6, and 2E5 molecules. Experiments were initiated by heating at 50 
oC for 2 min followed by a 10 min 95 oC incubation to activate the polymerase.  Cycling then 
ensued between 95 oC for 15 sec and 60 oC for 1 min, and cycler heating acceleration was held at 
1.6 oC / s between each step.  During each elongation, SYBR green fluorescence was measured 
with ROX as a passive reference.  Standard curves were made and used to calculate mRNA display 
quantities.  
Determination of Optimal GluC Cleavage Conditions 
 PaaP wild type was displayed as above and to 75 µL of prepared fusions was added Bicine 
buffer pH 9.0 to a final concentration of 100 mM Bicine and a final volume of 200 µL. The solution 
was split into two 93.75 µL halves and to each was added 93.75 µL of 2 x PaaA reaction mix (100 
mM Bicine pH 9.0, 8 mM MgCl2, 2 mM ATP, and 2 µM PaaA) or 2 x reaction mix (100 mM 
Bicine pH 9.0, 8 mM MgCl2, 2 mM ATP).  The reactions were incubated at room temperature for 
1 hour before quenching by adding 41.5 µL 0.5 M EDTA pH 8.0. To make the solution less basic, 
186 µL of 500 mM HEPES pH 7.5 and 0.05 % Tween-20 was added to each reaction (final volume: 




and incubated with 4 µL of Anti-HA magnetic beads (Pierce, 88837) and left rotating at 4 oC for 
1 hr. Magnetic beads were washed 3 x with wash buffer A (50 mM Ammonium Bicarbonate pH 
7.8, 0.05% Tween-20) and finally resuspended in 5 µL wash buffer A.  Purified PaaP WT fusions 
were then eluted and collected by adding 5 µL of 4 mg / mL HA Peptide (Thermo Fisher Scientific, 
26184) in water for 1 hour at room temperature with rotation. The magnetic beads were pulled to 
the side, the supernatant collected, and to it was added 10 µL of 2 x GluC solution (50 mM 
Ammonium Bicarbonate pH 7.8, 0.05% Tween-20, and x µg / µL GluC, where x is 0.2, 0.02, 
0.002, 0.0002, or 0 µg / µL).  Each GluC treatment was done in triplicate and placed at 37 oC for 
2 hours.  Samples were then placed on ice and 4 µL of magnetic Dynabeads M-280 streptavidin 
(Thermo Fisher Scientific, 11205D) equilibrated with wash buffer B (50 mM Tris pH 7.5, 150 mM 
NaCl, 0.05% Tween-20) were added and samples rotated at 4 oC for 30 mins. After washing 3 x 
with 100 µL of wash buffer B, each sample was eluted by heating at 95 oC for 5 min in 40 µL PCR 
buffer (10 mM Tris-HCl pH 9.0, 50 mM KCl, and 0.1 % Triton X-100) and submitted for qPCR 
analysis. We noticed a significant variance in GluC activity between different purchased lots. For 
each GluC lot purchased, the optimal GluC concentration was determined which provided the 
greatest fold enrichment of fusion recovery between PaaA treated and untreated samples.  
Determination of Optimal PaaA Reaction Concentration 
 PaaP wild type was displayed as above and to 36 µL of prepared fusions was added 54 µL 
of 50 mM Bicine buffer pH 9.0. and subsequently aliquoted into 18, 5 µL samples. To each aliquot 
was added 5 µL of 2 x PaaA reaction mix (50 mM Bicine pH 9.0, 8 mM MgCl2, 2 mM ATP, and 
x µM PaaA where x is 0, 0.02, 0.2, 2.0, and 20). Each [PaaA] was done in triplicate and the 
reactions were incubated for 1 hour before adding 10 µL of 500 mM HEPES pH 7.5 and purified 




3 x with 100 µL wash buffer B (50 mM Tris pH 7.5, 150 mM NaCl, 0.05% Tween-20), then 
washed once with 5 µL of wash buffer A (50 mM Ammonium Bicarbonate pH 7.8, 0.05% Tween) 
and finally resuspended in 5 µL wash buffer A.  Purified PaaP WT fusions were then eluted and 
collected by adding 5 µL of 4 mg / mL HA Peptide in water for 1 hour at room temperature with 
rotation. The supernatant was collected by pulling the magnetic beads to the side and to it was 
added 10 µL of 2 x GluC solution (50 mM Ammonium Bicarbonate pH 7.8, 0.05% Tween-20, and 
GluC*) for 2 hours at 37 oC. Samples were moved to ice and 4 µL of magnetic Dynabeads M-280 
streptavidin equilibrated with wash buffer B (50 mM Tris pH 7.5, 150 mM NaCl, 0.05% Tween-
20) were added and samples rotated at 4 oC for 30 mins. After washing 3 x with 100 µL of wash 
buffer B, each sample was eluted by heating a 95 oC for 5 min in 40 µL PCR buffer (10 mM Tris-
HCl pH 9.0, 50 mM KCl, and 0.1 % Triton X-100) and submitted for qPCR analysis. 
*see section “Determination of Optimal GluC Cleavage Conditions” 
Determination of Optimal PaaA Reaction Time 
 PaaP wild type was displayed as above and to 36 µL of prepared fusions was added 59 µL 
of 50 mM Bicine buffer pH 9.0, before dispensing 18, 5 µL samples. To each was added 5 µL of 
2 x PaaA reaction mix (50 mM Bicine pH 9.0, 8 mM MgCl2, 2 mM ATP, and 2 µM PaaA). 
Reactions were incubated in triplicate for 0 (containing no PaaA), 5, 15, 30, 45, and 60 min at 
room temperature before adding 2.0 µL of 0.5 M EDTA pH 8.0 to quench the reaction. To make 
the solution less basic, 8 µL of 500 mM HEPES pH 7.5 and 0.05 % Tween-20 was added to each 
sample (final volume: 20 µL). PaaP-WT fusions were purified with 4 µL of Anti-HA magnetic 
beads rotating at 4 oC for 1 hr. Magnetic beads were then washed 3 x with 100 µL wash buffer B 
(50 mM Tris pH 7.5, 150 mM NaCl, 0.05% Tween-20), then washed once with 5 µL of wash 




5 µL wash buffer A.  Purified PaaP WT fusions were then eluted and collected by adding 5 µL of 
4 mg / mL HA Peptide in water for 1 hour at room temperature with rotation.  The supernatant was 
collected by pulling the magnetic beads to the side and to it was added 10 µL of 2 x GluC solution 
(50 mM Ammonium Bicarbonate pH 7.8, 0.05% Tween-20, and GluC*) for 2 hours at 37 oC.  
Samples were moved to ice and 4 µL of magnetic Dynabeads M-280 streptavidin equilibrated with 
wash buffer B (50 mM Tris pH 7.5, 150 mM NaCl, 0.05% Tween-20) were added and samples 
rotated at 4 oC for 30 mins. After washing 3 x with 100 µL of wash buffer B, each sample was 
eluted by heating at 95 oC for 5 min in 40 µL PCR buffer (10 mM Tris-HCl pH 9.0, 50 mM KCl, 
and 0.1 % Triton X-100) and submitted for qPCR analysis.  
*see section “Determination of Optimal GluC Cleavage Conditions” 
PaaP Saturated Mutagenesis Single Variant Library Selection and NGS analysis 
 PaaP wild type and PaaP smSVL were displayed as above and to 36 µL of prepared fusions 
was added Bicine buffer pH 9.0 to a final concentration of 100 mM Bicine and a final volume of 
95 µL. Both PaaP WT fusions and PaaP smSVL fusions were split into 5 µL aliquots and to each 
was added 5 µL of 2 x PaaA reaction mix (100 mM Bicine pH 9.0, 8 mM MgCl2, 2 mM ATP, and 
2 µM PaaA).  The reactions were incubated at room temperature for 0 (containing no PaaA), 5, 
22.5, or 60 min before quenching by adding 2.0 µL 0.5 M EDTA pH 8.0. To make the solution 
less basic, 8 µL of 500 mM HEPES pH 7.5 and 0.05 % Tween-20 was added to each sample (final 
volume: 20 µL).  Fusions for WT and smSVL were then incubated with 4 µL of Anti-HA magnetic 
beads and left rotating at 4 oC for 1 hr. Magnetic beads were washed 3 x with wash buffer A (50 
mM Ammonium Bicarbonate pH 7.8, 0.05% Tween-20) and finally resuspended in 5 µL wash 
buffer A.  Purified fusions were then eluted and collected by adding 5 µL of 4 mg / mL HA Peptide 




the magnetic beads to the side and to it was added 10 µL of 2 x GluC solution (50 mM Ammonium 
Bicarbonate pH 7.8, 0.05% Tween-20, and GluC*) for 2 hours at 37 oC.  Samples were then placed 
on ice and 4 µL of magnetic streptavidin beads equilibrated with wash buffer B (50 mM Tris pH 
7.5, 150 mM NaCl, 0.05% Tween-20) were added and samples rotated at 4 oC for 30 mins. After 
washing 3 x with 100 µL of wash buffer B, each sample was eluted by heating at 95 oC for 5 min 
in 40 µL PCR buffer (10 mM Tris-HCl pH 9.0, 50 mM KCl, and 0.1 % Triton X-100) and 
submitted for qPCR.  Results from PaaP wild type samples were analyzed to make sure the 
selection functioned properly.  Then 3 samples from each smSVL condition (0, 5, 22.5, and 60 
min PaaA treatment) including an HA purified control with no GluC pressure (input) were PCR 
amplified with Amplicon EZ NGS adapters (sequence provided by Genewiz) and submitted to 
Genewiz for Amplicon EZ sequencing. For each NGS sample, every sequence was translated along 
its open reading frame. All sequences not expected from our smSVL design were removed and the 
percent of each peptide within input and selection samples calculated. By dividing the percentage 
of a single peptide within the selection sample by the input sample an enrichment score (e score) 
was generated.  These e scores were then normalized to obtain a fitness value for each mutant (E 
score) by dividing each mutant e score by the WT. E scores were displayed as a heatmap for ease 
of visualization using in-house python scripts. Each E score is an average of three independent 
samples split after translation and fusion formation. 
*see section “Determination of Optimal GluC Cleavage Conditions” 
PaaP NNK6 mRNA Display and NGS analysis 
 PaaP NNK6 was displayed as above and to 12 µL of prepared fusions was added Bicine 
buffer pH 9.0 to a final concentration of 100 mM Bicine and a final volume of 30 µL. PaaP smSVL 




2 mM ATP, and 2 µM PaaA) for 30 min before adding 6 µL of 0.5 M EDTA pH 8.0 to quench the 
reaction.  Subsequently, 64 µL of 500 mM HEPES pH 7.5, 0.05 % Tween-20 was added and 20 
µL was aliquoted for 6 samples.  To each 20 µL sample was added 4 µL of Anti-HA magnetic 
beads and left rotating at 4 oC for 1 hr. Magnetic beads were washed 3 x with 100 µL of wash 
buffer A (50 mM Ammonium Bicarbonate pH 7.8, 0.05% Tween-20) and finally resuspended in 
5 µL wash buffer A.  Purified fusions were then eluted and collected by adding 5 µL of 4 mg / mL 
HA Peptide in water for 1 hour at room temperature with rotation. The supernatant was collected 
by pulling the magnetic beads to the side and to it was added 10 µL of 2 x GluC solution (50 mM 
Ammonium Bicarbonate pH 7.8, 0.05% Tween-20, and GluC*).  As a control, to 3 samples was 
added 2x GluC solution with GluC omitted.  These samples were incubated at 37 oC for 2 hours.  
Samples were then placed on ice and 4 µL of magnetic streptavidin beads equilibrated with wash 
buffer B (50 mM Tris pH 7.5, 150 mM NaCl, 0.05% Tween-20) were added and samples rotated 
at 4 oC for 30 mins. After washing 3 x with 100 µL of wash buffer B, each sample was eluted by 
heating at 95 oC for 5 min in 40 µL PCR buffer (10 mM Tris-HCl pH 9.0, 50 mM KCl, and 0.1 % 
Triton X-100) and submitted for qPCR analysis before PCR amplification. Collected DNA was 
pooled and transcribed into RNA for ensuing selection rounds.  After 4 rounds of selection, the 
NNK 6 library streptavidin recovery matched recovery of a WT control peptide. At this point the 
DNA amplification products were appended with Amplicon EZ primers containing NGS adapters 
via PCR and submitted for Amplicon EZ sequencing.  To generate the Weblogo in figure 2f, the 
sequencing data was translated and peptides of length 49 – 51 amino acids were extracted. Each 
peptide was counted and divided by the total number of peptides to give a percent. Of the 1000 
most enriched sequences 996 of them were the correct length of 50 amino acids and used in 




2.4.8 MALDI-TOF Experiments 
MALDI-TOF Analysis of PaaA Reaction on PaaP Mutants 
 PaaA substrates were translated (2.5 µL) for 1 hour at 37 oC using PURExpress protocols 
(-aa, -tRNA).  Reaction solutions were made at 1.25 x with and without PaaA (125 mM Bicine pH 
9.0, 5 mM MgCl2, 1.25 mM ATP, and 1.25 µM PaaA).  A microliter of PURExpress solution was 
added to 4 µL of each reaction solution and incubated at room temperature for 22.5 min before 
quenching with 5 µL of 100 mM EDTA pH 8.0. Samples were desalted with C18 stage tips and 
analyzed by MALDI-TOF.  For PaaA treated samples, extracted ion integration areas were 
calculated for each expected mass of unmodified and modified PaaP peptides (-1 H2O; -2 H2O; -1 
H2O, -1 CO2; and -2 H2O, -1 CO2). All modified PaaA mass areas were summated as products.  
The area for the unmodified substrate and the summated area of products was divided by the total 
area to calculate a percent yield and visualized by a heatmap generated using python scripts.  
MALDI-TOF Analysis of PaaA Reaction on E16 and E17 PaaP Mutants 
 Theses samples were treated as above, except reaction quenching was achieved by direct 
loading of the reaction directly onto C18 stage tips after 22.5 min of PaaA incubation.  
2.4.9 Binding Experiments 
Fluorescence Polarization Assay  
 Binding between PaaA and TAMRA-PaaP1-12 was measured by fluorescence polarization 
using 5 nM of peptide and titrating PaaA concentration from 25 µM to 0.763 nM in binding buffer 
(100 mM Bicine pH 9.0, 150 mM NaCl, 2 % DMF, and 0.005% Tween-20).  Binding 
measurements were performed in triplicate and analyzed by Tecan infinite M1000 Pro (Excitation: 
530 nm, Emission: 586 nm, Gain: 152, Number of Flashes: 10, Settle Time: 0 ms, Z-Position: 




subtracted from the mP signals to remove background fluorescence. Data was fit to a nonlinear fit, 
[inhibitor] vs. response, variable slope (four parameter) to calculate EC50.  
Competitive Fluorescence Polarization Assay  
 To assess how aspartic acid mutations to PaaP1-12 affect binding to PaaA, a competitive 
assay was set up with 5 nM TAMRA-PaaP1-12, 100 nM PaaA, and increasing competitor 
concentrations from 50 µM – 6.1 nM in binding buffer (100 mM Bicine pH 9.0, 150 mM NaCl, 1 
% DMF, and 0.005% Tween-20). Each Asp mutant was performed in triplicate and FP measured 
by Tecan infinite M1000 Pro (Excitation: 530 nm, Emission: 586 nm, Gain: 136, Number of 
Flashes: 10, Settle Time: 0 ms, Z-Position: 20000 µm, G-Factor: 1). Data was analyzed using a 
nonlinear fit, [inhibitor] vs. response, variable slope (four parameter) to calculate IC50 values.  
Isothermal Calorimetry Assay 
 PaaA was buffer exchanged and diluted into binding buffer (100 mM Bicine pH 9.0, 150 
mM NaCl, 2 % DMF). Peptides were massed out and solubilized in the above binding buffer to 
100 µM.  Centrifugation showed no precipitation.  Data was acquired using a Microcal 
AutoITC200. Using the above stocks. PaaA was loaded into the cell followed by 19, 2 µL titrations 
performed at 25 oC with stirring at 750 rpm.  The final plateaued 1-6 points were subtracted from 
each run to account for the buffer heat of dilution.  Data was analyzed using Origin software and 
the data was fit using one-site binding.  
2.4.10 Peptide Synthesis 
Solid Phase Peptide Synthesis of Aspartic Acid Mutants PaaP1-12 
 All peptides were synthesized with standard solid phase peptide synthesis (SPPS) 
fluorenyl-methoxycarbonyl (Fmoc) procedures on Rink Amide ChemMatrix resin (0.48 mmol / 




1:1 DCM:DMF (dimethylformamide) using a miniblock for shaking at 670 rpm at room 
temperature. Deprotections were performed for 10 min at room temperature in 20 % Piperidine in 
DMF with shaking. For each coupling, 5 equivalents (eq) of Fmoc-Amino acid was dissolved in 
DMF and preactivated with 5 eq of O-(1H-6-Chlorobenzotriazole-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate (HCTU) and 10 eq of Diisopropylethylamine (DIEA).  
After mixing, the activated amino acid was transferred to the swollen and deprotected solid support 
for 15 min couplings at room temperature with shaking. Between every deprotection and coupling, 
the resin was drained, and washed 3 x with ~5 mL of DMF. When synthesis was complete, 50 mg 
of resin was air dried and the peptide cleaved by addition of 2 mL of cleavage cocktail containing 
Trifluoroacetic acid (TFA): Triisopropylsilane (TIS): Water (95:2.5:2.5) for 1.5 hours at 37 oC.  
The remaining resin was filtered away and the TFA was evaporated under nitrogen before the 
addition of 35 mL of diethyl ether, freezing at -80 oC for 30 min, and collection by centrifugation. 
The supernatant was decanted, the peptide dried and resuspended in 1:1 Water:Acetonitrile and 
loaded onto prep HPLC for gradient purification. Fractions containing product were frozen and 
lyophilized. Fractions with unpurified product were solubilized in 0.1 % TFA and again loaded 
onto prep HPLC for re-purification. Purified fractions were frozen, lyophilized and dissolved to 5 
mM in DMF.  For the preparation for TAMRA labeled substrate, the final coupling was completed 
as described for the other amino acids but using 5(6)-TAMRA (5-(and-6)-Carboxytetramethyl-
rhodamine (Chemodex, C0038; St. Gallen, Switzerland). 
SPPS of N-terminal N-MeDbz PaaP1-12 
 Procedure was adapted from the literature.40 For preparation of 15N and 13C labeled PaaA 
substrate, the N-terminus was synthesized out by microwave assisted SPPS, ChemMatrix solid 




performed twice with 20 % Piperidine for 3 min and then 10 min, washing 4 x with 1 mL of DMF 
before each coupling. Fmoc-Amino Acids-OH (5 eq, 0.1 M in DMF) were mixed with 
Hexafluorophosphate Azabenzotriazole Tetramethyl Uronium (HATU, 4.9 eq, 0.2 M in DMF) and 
DIEA (10 eq, 0.2 M in DMF) in the reaction vessel for 5 min at 75 oC with mixing for each 
coupling step. Subsequently, the resin was washed 2 x with 1 mL of DMF. After the first coupling 
and the last deprotection any free amines were acetylated by adding Acetic Anhydride (50 eq, 5 
M in DMF) and DIEA (50 eq, 0.5 M in DMF).  The only deviation from this protocol was coupling 
of Fmoc-MeDbz-OH which was accomplished by addition of Fmoc-MeDbz-OH (5 eq, 0.1 M in 
DMF) with Hydroxybenzotriazole (HOBT, 5 eq, 0.5 M in DMF), 2-(1H-Benzotriazole-1-yl)-
1,1,3,3-tetramethylaminium tetrafluoroborate (TBTU, 4.9 eq, 0.6 M in DMF), and DIEA (10 eq, 
0.2 M in DMF) in the reaction vessel for 5 min at 75 oC.  The reaction vessel was then drained and 
washed 4 x with DMF and then DCM.  Directly following the synthesis, the peptide was acylated 
with p-nitrophenyl chloroformate (10.0 eq, 0.25 M in DCM) for 1 hr at 37 oC.  The resin was 
washed extensively with DCM before washing with DMF and formation of the N-acyl urea was 
initiated by addition of DIEA (40 eq, 1 M in DMF) for 1 hr at room temperature. After extensive 
washing with DMF and then DCM 100 mg of resin was dried, and the peptide was cleaved in 4 
mL of cleavage cocktail TFA:TIS:Water (95:2.5:2.5) for 1 hr at 37 oC.  The remaining resin was 
filtered away and TFA was evaporated under nitrogen before the addition of 25 mL of diethyl ether 
to precipitate the peptide which was collected by centrifugation. The supernatant was decanted, 
the peptide dried, resuspended in 1:1 Water:Acetonitrile, and loaded onto prep HPLC for gradient 






SPPS of C-terminal PaaP13-30   
 Synthesis of C-terminal A13C PaaP13-30 was accomplished by microwave assisted SPPS 
on Rink Amide ChemMatrix as described above for the N-terminal N-meDbz PaaP1-12 using only 
natural Fmoc-AA-OH.  The only deviation was the use of L-Glutamic Acid-N-Fmoc, Gamma-
Tert-Butyl Ester (13C5, 99%; 15N, 99%; Cambridge Isotope Laboratories, Tewksbury, MA).  
Native Chemical Ligation and In Situ PaaA Reaction 
 NCL procedure was adapted from the literature.6 A13C PaaP13-30 (0.47 µmol) was 
dissolved in 7.2 µL of DMSO and added to 230 µL of NCL reaction buffer (20 mM NaH2PO4 pH 
7.0, 6 M Guanidine HCl, 120 mM TCEP, and 100 mM 4-Mercaptophenylacetic Acid). Then 0.72 
µmol of PaaP1-12 N-MeDbz was dissolved in 10 µL of DMSO and added to the NCL reaction.  The 
solution was pipet mixed and sat at room temperature for 2 hours before 1 µL was removed and 
added to PaaA reaction solution containing 100 mM Bicine pH 9.0, 4 mM MgCl2, 1 mM ATP, 1 
mM TCEP, and 2.5 µM PaaA (or no PaaA for control reaction).  Reactions were mixed and 
incubated overnight at room temperature and directly analyzed by high-resolution liquid 
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CHAPTER 3: FLEXIZYME-ENABLED BENCHTOP BIOSYNTHESIS OF 
THIOPEPTIDES1 
3.1 Introduction 
 Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a growing 
family of peptide-derived natural products that exhibit natural combinatorial biosynthetic logic.1  
RiPP biosyntheses initiate from a gene-encoded precursor peptide, which contains a core region 
that undergoes enzymatic post-translational modification, and a leader region, which is typically 
responsible for recruiting and coordinating these enzymes through specific recognition sequences 
(RSs).  These RSs have affinity for select domains of RiPP biosynthetic enzymes, increasing 
substrate local concentration to the otherwise promiscuous enzyme active sites and allowing the 
modification of diverse cores.2,3  Natural pathways exhibit leader peptides with multiple RSs and 
recruit whole suites of post-translational modifying enzymes to convert precursor peptides into 
mature natural products. The combination of RS-programmable recruitment and promiscuous 
enzymes inspires recent efforts at repurposing this strategy to scaffold new-to-nature hybrid 
biosynthetic pathways.4−8   
 Thiopeptides are one of the most extensive natural examples of this combinatorial, RS-
directed biosynthesis,9,10 and the three class-defining transformations include the formation of 
azoles, dehydroamino acids, and pyridines from serine and cysteine residues. Many of these 
enzymes are remarkably promiscuous, and thiopeptide pathways have proven capable of 
1This chapter was adapted from a communication that previously appeared in the Journal of the 
American Chemical Society. The original citation is as follows: Fleming, S.R., Bartges, T.E., 
Vinogradov, A.A., Kirkpatrick, C.L., Goto, Y., Suga, H., Hicks, L.M., Bowers, A.A. J. Am. Chem. 





Figure 3.1. Flexizyme-enabled benchtop biosynthesis of thiopeptide scaffolds. (a) Biosynthetic 
gene clusters of thiocillins, thiomuracin GZ, and aesturamide.  Genes for key enzymes used in this 
work are highlighted with asterisks. (b) Proposed hybrid route to the thiocillin core. 
 
generating many variants.11,12  For example, hundreds of mutants of thiocillin, GE37468, and 
thiostrepton have been generated by gene replacement strategies.13−15  However, competition 
between the pathway enzymes for functional groups on non-native substrates can give rise to 
complex mixtures of products and slower processing of mutant substrates, or host toxicity can 
restrict production of potential compounds. The in vitro reconstitution of whole thiopeptide 
biosynthetic pathways, which has recently been achieved for thiomuracin, can circumvent some 
of these problems but relies on access to soluble, well-behaved proteins.16,17  This can be especially 
challenging for the tRNA dependent lantibiotic-type dehydratases.  Additionally, this strategy still 




approach, could allow rapid access to novel structural variants and ease characterization of new 
thiopeptides and thiopeptide-associated enzymes.18   
 We envisioned that carefully chosen RiPP enzymes might be combined with orthogonal 
chemical handles to create a flexible in vitro platform for the benchtop preparation of thiopeptides 
(figure 3.1).19,20  More specifically, in vitro transcription−translation could be used to express 
designer hybrid leader peptide substrates displaying RSs for the cyclodehydratase, LynD, from 
aesturamide biosynthesis and pyridine synthase, TclM, from thiocillin biosynthesis. Both enzymes 
have well-defined RS motifs and broad substrate promiscuity. Additionally, LynD exhibits 
excellent selectivity for Cys conversion to thiazolines while ignoring Ser / Thr residues.21,22  
Alternatively, if oxazoles are of interest, then PatD, which acts on Ser / Thr / Cys, could be used 
in place of LynD.20  Oxidation of thiazolines to thiazoles might be effected by the azoline oxidase, 
TbtE from thiomuracin biosynthesis, which acts in a leader peptide independent manner.16  In place 
of lantibiotic dehydratases, we would use robust Flexizyme technology to introduce the unnatural 
amino acid Se-phenylselenocysteine (SecPh), which undergoes oxidative elimination with H2O2 
to generate dehydroalanines (Dhas) for the pyridine forming cycloaddition.23−25  Flexizymes are 
aptamers developed to condense a wide array of amino acid esters with tRNAs of choice 
(Appendix figure B.6), allowing codon reprograming in in vitro transcription−translation 
systems.26,27  In total, this would cut the number of enzymes or proteins necessary to prepare a 
thiopeptide in vitro from six, in the case of thiocillin (Tcl IJKLMN), to three (LynD, TbtE, and 
TclM, figure 3.1b).  Although quantities of peptide made by in vitro transcription−translation and 
Flexizyme reprogramming are small relative to other technologies, such as amber codon 
suppression / in cell expression or solid-phase peptide synthesis, the approach is rapid (∼2 h), 




might ultimately enable rapid characterization of new pyridine synthases and associated enzymes 
and aid elucidation of new thiopeptides.   
3.2 Results and Discussion 
 
Figure 3.2. Flexizyme-enabled benchtop biosynthesis of a thiocillin scaffold. (a) Sequence of the 
designer precursor peptide, including a pMCSG7-derived sequence, the LynD RS, and TclM RS. 
The Trp codon was reprogrammed to incorporate SecPh. EICs for SecPh and hexathiazole 
precursor peptide after LynD/TbtE treatment (b), hexathiazole and Dha-containing product after 
oxidative elimination (c), and fully cyclized thiocillin core (d). 
 To validate this strategy, we first had to confirm that existing Flexizymes could incorporate 




cysteine adjacent positions. We confirmed that the dinitrobenzyl (Dnb) ester-specific Flexizyme 
dFx could ligate the Dnb ester of SecPh by means of an in vitro microhelix assay (Appendix figure 
B.2).25  Hybrid substrates were prepared by codon reprogramming the tryptophan codon – although 
Flexizyme allows a number of codons to be reprogrammed – because of the scarcity of Trp residues 
in thiopeptides, using the AsnE2 tRNA body.28  The loaded AsnE2trp-tRNA was used to 
incorporate SecPh at positions Ser1 and Ser10 of the thiocillin core.  For ease, initial DNA 
templates were prepared by cloning into plasmid pMCSG7 which necessarily incorporated an N-
terminal sequence tag leading to the design of our test substrate (figure 3.2a), and 
transcription−translation reactions were prepared on a 2.5μL analytical scale using NEB 
PURExpress.26,27  In the event, LynD was able to convert all six cysteines in several test substrates 
into thiazolines, which were further processed to thiazoles by TbtE as confirmed by high-
resolution liquid chromatography and mass spectrometry (HR LC/MS) (figure 3.2b and Appendix 
figure B.4). Subsequent treatment with 1 M H2O2 efficiently converted both SecPh residues to 
Dhas (figure 3.2c).  In the last proof-of-concept step, the excess H2O2 could be quenched by 
addition of tris(2-carboxyethyl)-phosphine hydrochloride (TCEP) and TclM added in situ provided 
complete conversion of the linear substrate into a cyclic thiopeptide (figure 3.2d), confirming that 
TclM is compatible with this designed leader strategy.   
 We next began to explore the requirements of the designer leader peptide.  The N-termini 
of natural thiopeptide leader peptides have been implicated in an affinity enhancing interaction 
with pyridine synthase enzymes.29  Although our studies have shown this interaction dispensable 
for pyridine synthase processing,22 we chose to test the potential impact of changes to the N-
terminus on processing of designer leader peptide substrates.  Thus, we prepared two new hybrid 





Table 3.1. Results of flexizyme-enabled benchtop biosynthesis with mutant leader peptides (1A) 
and cores (1B). EIC areas are relative to entry 2 as a standard. Checks indicate a detected EIC. An 
“X” indicates no EIC detected above the noise threshold of 1.0 × 102. 
excerpts from the N-terminus of TclE, the native precursor peptide for TclM (table 3.1A, entries 
3 and 4).  In a third substrate, we truncated the leader peptide leaving only a short MSSQ tag before 
the LynD RS (table 3.1A, entry 1). The relative impact of these changes was assessed by 
integration of extracted ion chromatograms (EICs) for the product (table 3.1A, entry 2; figure 
3.2c,d). Interestingly, the TclE fragment sequences decrease thiopeptide formation and seem to 
negatively impact LynD processing.  Moreover, removal of the pMCSG7-derived sequence greatly 
reduces processing by the LynD / TbtE pair. Taken together, these results further confirm that the 
N-terminus of TclE is dispensable for TclM processing, but LynD may be sensitive to the location 




a series of leader sequences in which spacers were introduced between the LynD RS and TclM RS 
(table 3.1A, entries 5−10).20  In almost all cases, the substrates were converted to thiopeptides, 
suggesting that LynD is broadly tolerant of diverse sequence space between the RS and core, 
although at reduced efficiency.  As an extreme example of this spacing promiscuity, a substrate 
with the LynD RS sequence N-terminal to the complete native TclE leader peptide was made and 
subsequently processed to the mature thiopeptide (table 3.1A, entry 10). This last result suggests 
a potentially broadly applicable strategy for circumventing reconstitution of all pathway enzymes 
in thiopeptide formation: express the full leader as a C-terminal fusion to LynD RS.   
 We next examined allowable changes to the core sequence.  The TclM-containing thiocillin 
pathway has been shown to tolerate a wide array of changes to the core peptide in vivo; we 
therefore focused on changes to the core that were unproductive in those studies.13,30  For example, 
Val6 of native thiocillin had been recalcitrant to charged or hydrophilic residues, such as lysine or 
aspartic acid.  This limitation is a barrier to antibiotic development, as Val6 appears to be an ideal 
position for modulating the solubility.31  In contrast, hybrid substrates bearing a V6D or V6K 
mutation were readily transformed to the cyclic thiopeptide in vitro (table 3.1B, entries 4 and 5). 
Additionally, the LynD / TbtE pair in vitro provided greater product control relative to the native 
thiocillin enzymes, TclI, TclJ, and TclN, as exemplified by a C7S mutant (table 3.1B, entry 6). In 
the in vivo system, a similar mutant gave mixtures of different modifications and apparent 
misprocessing. LynD, however, modifies all cysteines indiscriminately and left the newly 
introduced serine untouched. We focused considerably more mutagenesis on the C-terminus of the 
core, because studies have suggested TclM might be sensitive to C-terminal modifications,22,32 and 
such modifications would be necessary for linking the current hybrid substrates with mRNA 




terminus was unfavorable for TclM and / or LynD processing (table 3.1B, entries 7−10). In 
contrast, extending the C-terminus (table 3.1B, entry 13) did not significantly impact enzymatic 
processing. These data suggest that the hybrid strategy is amenable to C-terminal extensions and 
new sequences not previously accessible by in vivo engineering approaches. However, more 
extensive investigations will be needed to understand the limitations.   
 We last sought to test whether this strategy could be used to reconstitute new pyridine 
synthases. Recent work has suggested that only a fraction of genetically encoded thiopeptides have 
been isolated.33  Of the >500 predicted thiopeptide gene clusters, the largest family comprises 
members that contain a close homologue of LazC, the predicted pyridine synthase from lactazole 
biosynthesis.34  Additionally, while the LazC homology is high in this family, the core peptide 
diversity is broad, suggesting LazC and its homologues may exhibit unique substrate promiscuity 
(Appendix figure B.5). Despite the preponderance of predicted LazC homologues, LazC has not 
yet been reconstituted in vitro. Therefore, we expressed and purified LazC as its MBP-fusion and 
designed three new hybrid sequences as potential substrates (Appendix figure B.3). In one LazC 
substrate, we integrated LynD RS directly into the native lactazole leader at a site with apparent 
natural homology (termed LacHyb1, figure 3.3a), while in the other two, LynD RS was encoded 
15 or 25 residues N-terminal to the core (termed LacHyb2 and 3, respectively).  Additionally, Trp2 
and oxazole-forming Ser11 were replaced with a serine and thiazole-forming cysteine, respectively 
(Appendix figure B.3).  Both mutations were previously produced by a gene replacement strategy, 
suggesting that the double mutant may also be a LazC substrate and render the core compatible 
with Trp reprogramed SecPh incorporation. Upon treatment with LynD / TbtE, the four cysteines 





Figure 3.3. Flexizyme-enabled benchtop biosynthesis of lactazole W2S, S11C. (a) Sequence of 
designer precursor peptide, LacHyb1. (b) Proposed route to lactazole scaffolds. EICs for the 
thiazole and Dha containing product of treatment with LynD / TbtE and H2O2 (c) and fully cyclized 




introduced the four Dhas (figure 3.3c). Lastly, treatment with LazC efficiently yielded the new, 
pyridine-containing masses, thus confirming activity of LazC as a pyridine synthase (figure 3.3d).  
This result was consistent for all three hybrid lactazole leader peptides (Appendix figure B.4.22-
24 and B.4.42-44) and suggests that the hybrid in vitro strategy should work on many other, yet 
uncharacterized pyridine synthases and could ultimately allow elucidation of new thiopeptides.   
3.3 Conclusion 
 In summary, we have developed a new, facile strategy to access thiopeptide backbones.  
This approach combines robust, Flexizyme-assisted incorporation of chemical handles into in vitro 
transcribed-translated peptides with three unrelated RiPP enzymes (LynD, TbtE, and TclM) by 
using designer leader peptides. We demonstrate the ability to make thiocillin variants previously 
unattainable through natural biosynthetic processes and use this strategy to reconstitute the 
pyridine synthase LazC to make lactazoles for the first time in vitro. We anticipate this approach 
will be useful in making new thiopeptide variants with therapeutic potential, in studying more 
pyridine synthases and associated enzymes, and may aid elucidation of new thiopeptide structures. 
Finally, we anticipate that this strategy will be compatible with high-throughput screening 
techniques, such as mRNA display, which is a current focus in our lab. 
3.4 Experimental  
3.4.1 General Information. 
 All molecular biology materials including the PURExpress kit (E6840S) were purchased 
from New England BioLabs (Ipswich, MA) and Thermo Fisher Scientific (Waltham, MA). DNA 
and primers were purchased from Integrated DNA Technologies (Coralville, IA) and Eton 




(DE3)-RIPL strains were used for plasmid maintenance and protein expression. Genes infused into 
plasmids pMCSG7 and pMCSG9 were sequenced by Genewiz (South Plainfield, NJ). Nano-
LCESI-MS data was collected using nanoAcquity (Waters, Milford, MA) coupled to a 
TripleTOF5600 (AB Sciex, Framingham, MA). All Nano-LCESI-MS data was collected and 
converted to mzml files and analyzed using MZMine2.35 Extracted ion chromatograms were 
generated with a 10-ppm error cutoff. Peak areas were calculated using the targeted peak detection 
analysis with intensity tolerance of 50%, m/z tolerance of 10 ppm, noise level of 1.0E2, and 
retention time tolerance of 1.0 min. For nickel affinity purification of proteins, HiTrap columns 
were used and purchased from GE Healthcare (Chicago, IL). All chemical reactions were 
performed in oven-baked round-bottom-flasks under inert argon atmosphere with stirring. 
Solvents, reagents, and chemicals were purchased through Fisher Scientific. N-Boc-L-Serine-beta-
Lactone was purchased from Ark Pharm (Arlington Heights, IL). Spectra for 1H were recorded at 
room temperature with Varian Inova 400 (400 MHz). Chemical shifts are reported in δ (ppm) 
relative units to residual solvent peaks CDCl3 (7.26 ppm) and DMSO -d6 (2.5 ppm). Splitting 
patterns are assigned as s (singlet), d (doublet), t (triplet), q (quartet), quint (quintet), multiplet (m), 
and dd (doublet of doublets).  
3.4.2 Protein Cloning. 
 The genes for LynD and TbtE were purchased as gBlocks from IDT®, PCR amplified with 
Q5 polymerase, and cloned into pMCSG7 and pMCSG9, respectively using the following primers:  
LynD-Forward (5’→3’): TACTTCCAATCCAATGCGATGCAAAGCACACCACTGC 









The PCR product was phosphorylated with T4 PNK and treated with T4 DNA polymerase to create 
LIC-overhangs. Plasmids pMCSG7 and pMCSG9 were linearized with SSPI, dephosphorylated 
with Antarctic Phosphatase, and treated with T4 DNA Polymerase to create LIC-overhangs. 
Prepared vectors and PCR products were incubated for 10 min at room temperature and then 
transformed into One-Shot® Top 10. pMCSG7-LynD was then transformed and expressed in 
BL21-CodonPlus (DE3)-RIPL Competent Cells (Agilent). pMCSG9-TbtE was then transformed 
into BL21 (DE3) electrocompetent cells. 
TclM was cloned as in the following report.18 
MBP-LazC containing plasmid was purchased from JGI. 
3.4.3 Protein Expression Purification. 
Expression and Purification of His6-LynD  
 His6-LynD protein was expressed and purified from E. coli RIPL cells as in the following 
report.21 A 5 mL saturated culture was used to inoculate 1 L of Luria-Bertani (LB) medium 
supplemented with ampicillin (100 µg/mL) and chloramphenicol (34 µg/mL).  The culture was 
incubated at 37 oC and shaken 220 rpm until reaching an OD 600 of 0.6-0.8 at which point the 
medium was supplemented with 0.2 mM IPTG. Culture was then cooled to 18 oC and grown 




resuspended in 40 mL of wash buffer (20 mM Tris pH 8.0, 200 mM NaCl, 50 mM Imidazole, and 
1 mM TCEP) supplemented with 1.5 mM Phenylmethylsulfonyl fluoride (PMSF), 80 units of 
DNAseI, 0.25mg lysozyme and sonicated twice with intermittent pulses with a 30 % maximum 
amplitude for 1:30 min. The soluble protein was recovered by pelleting the cell debris by 
centrifugation at 4 oC 15,000 rpm for 60 mins and was filtered through a 0.45µm sterile syringe 
filter. The supernatant was loaded onto a 5-mL HisTrap (Ni2+) IMAC column and washed with 5 
column volumes (CV) of wash buffer. Protein was eluted with elution buffer (20 mM Tris pH 8.0, 
200 mM NaCl, 500 mM imidazole, 1 mM TCEP) over a gradient 0-100 % over 10 CV. Fractions 
collected which contained purified protein were collected and concentrated to 2.5 mL using a 
Centricon (10,000 Da MWCO) concentrator (EMD Millipore®). The concentrated protein was 
then buffer exchanged using PD-10 column (GE Healthcare Life Sciences®) into storage buffer 
(10 mM HEPES pH 7.4, 150 mM NaCl, 1 mM TCEP and stored at -80 oC. A 1 L culture yielded 
~22.6 mg of protein. 
Expression and Purification of His6-MBP-TbtE  
 His6-MBP-TbtE protein was expressed in E. coli (DE3) cells as in the following report.16 
A 5 mL saturated culture was used to inoculate 1L of LB medium supplemented with ampicillin 
(100 µg/mL).  The culture was incubated at 37 oC and shaken 220 rpm until reaching an OD 600 
of 0.6-0.8 at which point the medium was supplemented with 0.2 mM IPTG. Culture was then 
cooled to 16 oC and grown overnight ~20 hours. Cells were pelleted and stored at -80 oC until 
purification. Pellets were resupended in 40 mL of wash buffer (50 mM Tris pH 7.5, 150 mM NaCl, 
2.5 % glycerol, 0.1 % Triton X-100) supplemented with 1.5 mM PMSF, 80 units of DNAse I, 0.25 
mg lysozyme and sonicated twice with intermittent pulses with a 30% maximum amplitude for 




15,000 rpm for 60 mins and was filtered through a 0.45 µm sterile syringe filter. The supernatant 
was loaded onto a 5-mL HisTrap (Ni2+) IMAC column and washed with 5 column volumes (CV) 
of wash buffer (50 mM Tris pH 7.5, 400 mM NaCl, 2.5% glycerol, 50 mM imidazole). Protein 
was eluted with elution buffer (50 mM Tris pH 7.5, 300 mM NaCl, 2.5% glycerol, 500 mM 
imidazole) over a gradient 0-100% over 10 CV. Fractions collected which contained purified 
protein were collected and concentrated to < 5.0 mL using a Centricon (30,000 Da MWCO) 
concentrator (EMD Millipore®). The concentrated protein was then buffer exchanged by diluting 
the concentrated protein in ~10-15 mL of storage buffer (50 mM HEPES pH 7.5, 300 mM NaCl, 
2.5% glycerol), and re-concentrating. This was repeated 4 times and the protein was stored at -80 
oC. A 1 L culture yielded ~33.12 mg of protein.  
Expression and Purification of His6-MBP-TclM  
 His6-MBP-TclM was expressed and purified as in the following report.18 Briefly, MBP-
TclM protein was expressed in E. coli RIPL cells. A 5 mL saturated culture was used to inoculate 
1L of LB medium supplemented with ampicillin (100 µg/mL) and chloramphenicol (34 µg/mL).  
The culture was incubated at 37 oC and shaken 220 rpm until reaching an OD 600 of 0.6-0.8 at 
which point the medium was supplemented with 0.2 mM IPTG. Culture was then cooled to 16 oC 
and grown overnight ~24 hours. Cells were pelleted by centrifugation (5,000 rpm, 4 oC, 30 mins) 
and stored at -80 oC until purification. Pellets were resuspended in 40 mL of wash buffer (50 mM 
KHPO4 pH 7.0, 250 mM KCl, 10 mM Imidazole, 10 % glycerol) supplemented with 1.5mM 
PMSF, 1 mg DNAseI, and 1 protease inhibitor tablet (ThermoFisher, 88666) and sonicated twice 
with intermittent pulses with a 30% maximum amplitude for 1:30 min. The soluble protein was 
recovered by pelleting the cell debris by centrifugation at 4 oC 15,000rpm for 60 mins and was 




(Ni2+) IMAC column and washed with 10 CV of wash buffer. Protein was eluted with elution 
buffer (50 mM KHPO4 pH 7.0, 250 mM KCl, 500 mM imidazole, 10 % glycerol) over a gradient 
0-100% over 10 CV. Fractions collected which contained purified protein were collected and were 
determined to be too impure for assays. The protein was desalted using a PD-10 column and loaded 
again onto a 5-mL HisTrap (Ni2+) IMAC column and washed with 10 CV of wash buffer with 
increased imidazole concentration (50 mM KHPO4 pH 7.0, 250 mM KCl, 50 mM imidazole, 10% 
glycerol). Protein was eluted with elution buffer (50 mM KHPO4 pH 7.0, 250 mM KCl, 500 mM 
Imidazole, 10% glycerol) over a gradient 0-100% over 10 CV. Fractions containing pure protein 
were collected and concentrated to 2.5 mL using a Centricon (50,000 Da MWCO) concentrator 
(EMD Millipore®). The concentrated protein was then buffer exchanged using PD-10 column (GE 
Healthcare Life Sciences®) into storage buffer (50 mM KHPO4 pH 7.0, 250 mM KCl, 10% 
glycerol), concentrated to 1 mL, and stored at -80 oC. A 1 L culture yielded ~2.8 mg of protein. 
Expression and Purification of His6-MBP-LazC  
 His6-MBP-LazC protein was expressed in E. coli cells. A 5 mL saturated culture was used 
to inoculate 1L of LB medium supplemented with ampicillin (100µg/mL).  The culture was 
incubated at 37 oC and shaken 220 rpm until reaching an OD600 of 0.6-0.8 at which point the 
medium was supplemented with 0.2 mM IPTG. Culture was then cooled to 16 oC and grown 
overnight ~21 hours. Cells were pelleted by centrifugation (5,000 rpm, 4 oC, 30 mins) and stored 
at -80 oC until purification. Pellets were resuspended in 40 mL of wash buffer (50 mM KHPO4 pH 
7.0, 250 mM KCl, 50 mM imidazole, 10% glycerol) supplemented with 1.5 mM PMSF, 80 units 
DNAseI, and 1 protease inhibitor tablet (ThermoFisher, 88666) and lysed using a french press with 
a maximum pressure of 1500 psi. The soluble protein was recovered by pelleting the cell debris 




filter. The supernatant was loaded onto a 5-mL HisTrap (Ni2+) IMAC column and washed with 
10 CV of wash buffer. Protein was eluted with elution buffer (50 mM KHPO4 pH 7.0, 250 mM 
KCl, 500 mM imidazole, 10% glycerol) over a gradient 0-100% over 10 CV. Fractions containing 
pure protein were collected and concentrated to 2.5 mL using a Centricon (50,000 Da MWCO) 
concentrator (EMD Millipore®). The concentrated protein was then buffer exchanged using PD-
10 column (GE Healthcare Life Sciences®) into storage buffer (50 mM KHPO4 pH 7.0, 250 mM 
KCl, 10% glycerol), and stored at -80 oC. A 1 L culture yielded ~34 mg of protein. 






































































3.4.5 DNA and RNA Preparation. 
 DNA templates for T7 RNA polymerase reactions were prepared for tRNA and flexizyme 
(dFx), through extension of extension primers and then PCR reactions with forward and reverse 
PCR primers (see Appendix B Translation Genes). DNA extension and amplification reactions 
were performed with Taq Polymerase.36 
Table 3.2. Extension protocol (5 cycles of annealing and elongation) 
  Stage Temperature Time 
Denature 95 oC 1 min 
Annealing 50 oC 1 min 
Elongation 72 oC 1 min 
Final Elongation 72 oC 2 min 
 
Table 3.3. PCR1 protocol (5 cycles of denature, annealing, and elongation) 
Stage Temperature Time 
Initial Denature 95 oC 1 min 
Denature 95 oC 40 sec 
Annealing 50 oC 40 sec 
Elongation 72 oC 40 sec 
Final Elongation 72 oC 2 min 
 
Table 3.4 PCR2 protocol (12 cycles of denature, annealing, and elongation) 
Stage Temperature Time 
Initial Denature 95 oC 1 min 
Denature 95 oC 40 sec 
Annealing 50 oC 40 sec 
Elongation 72 oC 40 sec 





dFx DNA Template (5’→3’):  
GGCGGTAATACGACTCACTATAGGATCGAAAGATTTCCGCATCCCCGAAAGGGTAC
ATGGCGTTAGGT 
AsnE2trp DNA Template (5’→3’): 
GGCGTAATACGACTCACTATAGGCTCTGTAGTTCAGTCGGTAGAACGGCGGACTCCA
AATCCGTATGTCACTGGTTCGAGTCCAGTCAGAGCCGCCA 
Table 3.5. dFx and AsnE2 primers 
1 dFx_Ex_F GTAATACGACTCACTATAGGATCGAAAGATTTCCGC 
2 dFx_Ex_R ACCTAACGCCATGTACCCTTTCGGGGATGCGGAAATCTTTCGAT
CC 
3 T7_Prom_F GGCGTAATACGACTCACTATAG 















Primers: (mG) designates 2’Ome Guanosine RNA 
dFx DNA template preparation 
 dFx extension was performed with primers 1 and 2 using extension protocol. 5uL of the 
extension product was used to amplify 1 mL dFx using PCR2 protocol with primers 3 and 4. DNA 
was then purified and concentrated by phenol/chloroform/isoamyl alcohol extraction and ethanol 





AsnE2trp tRNA DNA template preparation 
 AsnE2trp extension was performed with primers 5 and 6 using extension protocol. 10uL 
of the extension product was used to amplify 200 µL AsnE2 PCR1 reaction using primers 7 and 
8. 5 µL of PCR1 product was directly added to 1 mL PCR2 reaction with primers 7 and 9. DNA 
was then purified and concentrated by phenol / chloroform / isoamyl alcohol extraction and ethanol 
precipitation. DNA was resolubilized in 100uL of water and directly used for T7 RNA 
transcription. 
General T7 RNA polymerase transcription and RNA purification 
 T7 RNA transcription reactions were performed on a 1 mL scale according to NEB 
protocols with 100 µL of prepared DNA template. The only change from NEB protocol was the 
addition of extra MgCl2 (dFx final concentration: 30 mM, AsnE2 tRNA final concentration:  22.5 
mM) Transcriptions were left at 37 oC overnight and treated with 115 µL of 10x DNAseI buffer 
and 30 U of DNaseI (Thermo Scientific, EN0521) for 1 hour at 37 oC. Upon successful translations, 
magnesium pyrophosphate precipitates, so, 200 µL of 0.5 M ethylenediaminetetraacetic acid 
(EDTA) was added to clear the solution. RNA was precipitated by adding and mixing 1190 µL of 
isopropanol and pelleted by centrifugation at 13,000 rpm, 25 oC for 15 min. The supernatant was 
disposed of and the pellet was washed with 500 µL of 70 % ethanol, centrifuged for 3 min at 
13,000 rpm. Again, the supernatant was disposed of and the pellet was dried for 5 min at room 
temperature. Both dFx and AsnE2 tRNA were resolubilized in 100 µL of water. 2x RNA loading 
dye was then added and the RNA was loaded onto a 12 % (dFx) or 8 % (AsnE2trp tRNA) Urea-
PAGE gel and run for 1 hour at 230 V in TBE (Tris-Borate-EDTA) buffer. The RNA band was 
visualized by TLC shadowing and cut out of the gel. The removed gel slab was crushed into fine 




extractions were filtered through a 0.45 µm syringe filter and a 2x volume of ethanol was added 
to precipitate RNA. RNA was pelleted via centrifugation at 4,000 rpm for 25 min. The supernatant 
was removed, and the pellet washed with 5 mL of 70% ethanol and centrifuged at 4,000 rpm for 5 
min and the supernatant discarded. The RNA pellets were then dried at room temperature for 5 
min and resolubilized in water. Both dFx and AsnE2trp tRNA were diluted to a working stock of 
250 µM and stored at -20 oC. 
DNA Preparations for Translation Templates for NEB PURExpress® 
 Genes with a 6xHis-Tag, were cloned into plasmid pMCSG7 (Appendix B Translation 
Genes). Other genes were purchased as shown from IDT® and amplified with Q5 high fidelity 
Polymerase or Taq polymerase. The primers used were: 
T7 Forward (5’→3’): GAAATTAATACGACTCACTATAGGGG 
T7 Terminator (5’→3’): GCTAGTTATTGCTCAGCGG 
Q5 amplification cycles:  
 Perform 20 cycles starting at an annealing temp. of 58 oC and lowering by 0.5 oC for each 
subsequent cycle until 45 oC. Then, perform 20 more cycles with an annealing temp of 45 oC. 
Table 3.6. Q5 PCR amplification 
Stage Temperature Time 
Initial Denature 98 oC 30 sec 
Denature 98 oC 15 sec 
Annealing 58 oC- 45 oC 20 sec 
Elongation 72 oC 1 min 





Taq amplification cycles: (25 cycles of denature, anneal, elongate) 
Table 3.7. Taq PCR amplification  
Stage Temperature Time 
Initial Denature 95 oC 2 min 
Denature 95 oC 30 sec 
Annealing 51 oC 30 sec 
Elongation 72 oC 2 min 
Final Elongation 72 oC 5 min 
 
 After amplification DNA products were column purified using Thermo Scientific GeneJET 
PCR Purification Kit® and analyzed by 3 % agarose gel. Concentrations were checked on 
nanodrop to be between 80-200 ng / µL, PCR products were stored at -20 oC and directly used in 
translation reactions. 
3.4.6 Flexizyme tRNA Acylation of Se-phenylselenocysteine. 
 Flexizyme assays were performed as described in the following report.37 Briefly, reactions 
were carried out at 4 oC for 24-72 hours in 50 mM HEPES-KOH (pH 8.0), 600 mM MgCl2, 20 % 
DMSO, 25 µM dFx, 25 µM tRNA, 5 mM Se-phenylselenocysteine dinitrobenzyl ester.  
 3.4.7 Translations. 
 Translations were performed on a 2.5 µL scale using NEB PURExpress® Δ (aa, tRNA: 
NEB # E6840). For Flexizyme codon reprogramming, a 19 amino acid mix containing 5 mM of 
each amino acid except tryptophan was made in milliQ water and added to translation en lieu of 
the 20 amino acid mix provided with the kit along with 50-100 µM amino acyl-tRNA. Before 
adding to translation, acyl-tRNAs were thawed on ice and resuspended in 1 mM NaOAc (pH 5.2). 




3.4.8 Enzyme Reactions and Oxidative Elimination. 
His6-LynD /  His6-MBP-TbtE Reactions 
 As translation reactions were incubating, a 2x enzyme mix was made containing 8 µM 
LynD, 6 µM TbtE, 10 mM ATP, 10 mM HEPES (pH 7.5), 150 mM NaCl, and 10 mM MgCl2. 
When translations finished 2x enzyme solution was added to make 1x and the reactions were 
incubated at 25 oC overnight for ~16-24 hours. For MS analysis, 0.25 µL of 500 U/mL 
endoproteinase GluC was added and incubated at 37 oC for > 5 hours before desalting using C18 
stage tips. 
Oxidative elimination and tris(2-carboxyethyl)phosphine (TCEP) Reduction 
 After LynD / TbtE enzyme reactions the sample was placed on ice and a 2x elimination 
solution was made containing 2M hydrogen peroxide and 397.89mM HEPES pH 9.0. After the 
solution was cooled, 2x elimination solution was added to 1x, allowed to incubate 1 hour on ice, 
and quenched with a final concentration of 250 mM TCEP (pH 9.0) at 37 oC for 1 hour. For MS 
analysis, 0.25 µL of 500 U/mL endoproteinase GluC was added and incubated at 37 oC for > 5 
hours before desalting using C18 stage tips. 
MBP-TclM/MBP-LazC Reactions 
 To complete processing of the thiopeptide core, pyridine synthases were added at a final 
concentration of 2 µM to the Dha and thiazole containing substrate and allowed to incubate at 
room temperature. Initial reactions were incubated overnight, but it was discovered that 1-hour 





3.4.9 Desalting Protocol and Preparation for LC / MS. 
 After translation and / or enzymatic reactions, samples were desalted using Pierce® C18 
stage tips according to manufacture protocols. Briefly, a large hole was made in the cap of a 1.7 
mL snap cap tube to accommodate the stage tip. A stage tip was added to the tube, 15 µL of elution 
solution (80 % acetonitrile, 0.5 % acetic acid) was dispensed into the top of the tip and centrifuged 
using a tabletop centrifuge to wet the tip. 15 µL of wash solution (4% acetonitrile, 0.5% acetic 
acid) was added and again centrifuged through the tip using a tabletop centrifuge. Up to ~20 µL 
of sample was added and centrifuged to load the tip. The tip was then washed twice by adding 15 
µL of wash solution and centrifuged. Finally, the tip was removed from the 1.7 mL tube, placed 
into a clean tube and eluted with 4 µL of elution solution via centrifugation. The eluted solution 
was then diluted with 6 µL of 0.1 % formic acid and submitted for nano-LC ESI-MS / MS. 
3.4.10 Synthesis of Se-phenylselenocysteine dinitrobenzyl ester. 
Boc-Se-phenylselenocysteine (1) 
 
 Boc-Se-phenylselenocysteine was synthesized using protocols found in the following 
report.38 508.4 mg of N-boc-serine lactone was added to a 25 mL oven-dried round bottom flask 
with 4.94 mL of anhydrous dimethylformamide (DMF) under inert atmosphere (argon). To it was 




where it was kept for 2 hours and the reaction monitored by TLC (9:1 DCM:MeOH). Upon 
completion, the reaction was quenched by the addition of 12-14 mL of 0.33M NaOH and washed 
with 30mL of diethyl ether. The organic layer was discarded, and the aqueous remains was 
acidified to pH 3.0 with 1N HCl and extracted multiple times with 50 mL ethyl acetate. All 
extractions were combined and dried over Na2SO4, filtered, and concentrated under reduced 
pressure to produce a soft yellow oil (840 mg).  
1H NMR (400 MHz, Chloroform-d) δ 7.56 – 7.50 (m, 2H), 7.22 (p, J = 4.0, 3.5 Hz, 3H), 5.37 (d, 
J = 7.7 Hz, 1H), 4.64 (q, J = 6.1, 5.7 Hz, 1H), 3.46 – 3.35 (m, 1H), 3.31 (dd, J = 13.0, 5.4 Hz, 1H), 
1.38 (s, 9H). 
Se-phenylselenocysteine dinitrobenzyl ester (2) 
 
 Boc-Se-phenylselenocysteine dinitrobenzyl ester was synthesized as in the following 
report.37 120 mg of 1 was added to a 10-mL round bottom flask with 83 mg of 3, 5 dinitrobenzyl 
chloride and solubilized in 417 µL of anhydrous dimethylformamide under inert atmosphere. 67 
µL (35.5 mg) of diisopropylethylamine was added and allowed to stir overnight at room 
temperature. The product was then extracted with 7 mL of diethyl ether and washed 2x with 4 mL 
0.5 M HCl, 2x with saturated NaHCO3, and finally 2x with saturated NaCl. Finally, the organic 




product was then purified by normal phase chromatography with hexanes and ethyl acetate. 
Purified fractions were collected and concentrated under reduced pressure. To the dried product 
was added 1 mL of 95:5 trifluoroacetic acid (TFA):triisopropylsilane under inert atmosphere and 
allowed to stir up to 1.5 hours. Reaction progress was monitored by TLC and the TFA was 
removed under reduced pressure. After 5 washes with DCM, the product changed from a yellow 
oil to a white powder. This was solubilized in minimal acetonitrile and precipitated with 10x 
diethyl ether. The product was collected by centrifugation, the supernatant was discarded, and the 
pellet dried (75 mg).  
1H NMR (400 MHz, DMSO-d6) δ 8.81 (t, J = 2.1 Hz, 1H), 8.66 (dd, J = 1.8, 1.0 Hz, 2H), 7.55 – 
7.49 (m, 2H), 7.31 – 7.24 (m, 3H), 5.41 – 5.36 (m, 1H), 5.24 – 5.19 (m, 1H), 4.46 (t, J = 5.9 Hz, 
1H), 3.47 – 3.38 (m, 3H). 
3.4.11 Liquid Chromatography and Mass Spectrometry.  
 Reaction products were analyzed via a nano-LC ESI MS / MS platform: nanoAcquity 
(Waters, Milford, MA) coupled to a TripleTOF5600 (AB Sciex, Framingham, MA). GluC treated, 
and undigested samples were diluted, 2.5x and 1.5x respectively, in water with 5 % acetonitrile 
and 0.1 % formic acid prior in LC MS / MS analysis. 5 μL of each sample was injected onto a trap 
column (NanoAcquity UPLC 2G-W/M Trap 5 μm Symmetry C18, 180 μm × 20 mm: Waters) 
coupled to an analytical C18 column (10k PSI, 100 Å, 1.8 μm, 75 μm × 250 mm: Waters). Peptide 
separation was carried out at a flow rate of 0.3 μL / min using a linear ramp of 5%−50% B (mobile 
phase A, 0.1% formic acid; mobile phase B, 0.1% formic acid in acetonitrile) over 30 min. The 
MS was operated in positive-ion, high-sensitivity mode with the MS survey spectrum using a mass 




first 20 features above 150 counts threshold and having a charge state of + 2 to + 5 were fragmented 
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CHAPTER 4: BIOINFORMATIC EXPANSION OF THIOPEPTIDES AND  
PRIORITIZATION FOR CHEMOENZYMATIC DISCOVERY 
4.1 Introduction. 
 Thiopeptides are active and structurally complex molecules. They are part of an ever-
growing class of natural products called ribosomally synthesized and post-translationally modified 
peptides or RiPPs.1 As the name suggests, the biosynthesis of RiPPs begins with the ribosomal 
translation of a small structural gene to make a precursor peptide. For thiopeptides, core 
biosynthesis contains three specific peptide transformations: 1) azole formation, 2) dehydration to 
dehydroalanine (Dha) or dehydrobutyrine (Dhb), and 3) macrocyclization via pyridine formation, 
figure 4.1. Thiopeptides are quite potent and have anticancer, antiplasmodial, immunosuppressive, 
renin inhibitory, RNA polymerase inhibitory, antifungal, proteasome inhibitory and stimulates 
mitophagy.2,3 Because of their broad therapeutic potential, much effort has been given to 
understand how thiopeptides are made and how their biosynthesis might be engineered to make 
more active or more soluble analogs that might perform well in the clinic. Additionally, the target 
for thiopeptides seems to be dictated by the number of atoms within the core macrocycle.4–8 It is 
expected, then, that the discovery of thiopeptides with new backbone topologies will reveal 
thiopeptides with novel activities. However, since the report on lactazole9 only one new class of 
thiopeptide-related RiPP has been discovered, the pyritides.10 
 In addition to antibiosis, thiopeptides can act as signaling molecules. For instance, a broad 
group of thiopeptides have been measured to bind the MerR-like stress response transcription 




other genes.11,12 Another report by Bleich et al, demonstrates that thiopeptides also broadly  
stimulate biofilm production in a kinD-independent manner in Bacillus subtilis.13  While the 
molecular mechanism for biofilm stimulation is still unknown, it is highly probable to be regulated  
 
Figure 4.1. Thiopeptide biosynthetic gene cluster for thiocillin. Named enzymes are colored 
according to their corresponding chemical modifications of the thiocillin core scaffold. 
 
by a TipA homolog. The pfam family for just the C-terminal thiopeptide binding domain of TipA 
(TipAS, PF07739) contains 2,634 sequences across 1,934 species. The most highly represented 
bacteria are Actinobacteria (705 species) and Firmicutes (706 species). Moreover, Habezettl et al. 
note that many streptomyces strains have a tipA gene but do not themselves make a thiopeptide.14 
This suggests that thiopeptide receptors may be more prolific than thiopeptide gene clusters, 
implying that thiopeptide producers may play a significant role in shaping bacterial communities 




 New chemoenzymatic approaches are now available that might be used to structurally 
validate cryptic thiopeptides and avoid the headaches of heterologous expression or protein 
purification of many cognate biosynthetic enzymes.10,15–19 Herein, we use the bioinformatic tool 
RODEO20 to collect nucleotide sequences for all possible thiopeptide biosynthetic gene clusters 
currently available in GenBank and employ the RODEO thiopeptide scoring algorithm to help 
predict the sometimes-elusive structural genes. Using sequence similarity networks,21 we show the 
current diversity of thiopeptide pyridine synthases and precusor peptides and with antiSMASH22 
visualize the concomitant biosynthetic gene clusters. We report on 14 currently uncharacterized 
thiopeptide BGCs that have very little similarity to already known thiopeptides and have been 
prioritized based on their likelihood of success in current chemoenzymatic approaches to elucidate 
thiopeptide structures. Furthermore, we use an SSN to visualize the diversity of TipAS homologs 
which further confirms that these proteins are prolific within Actinobacteria and Firmicutes and 
cluster based on phyla. It is likely that the different TipAs proteins cluster according to their 
respective thiopeptide ligand. We anticipate that our bioinformatic approach to organize cryptic 
thiopeptides in combination with current chemoenzymatic strategies to make thiopeptides will aid 
in the rapid discovery of new thiopeptides. Further studies will allow the interpretation of 
thiopeptide-TipAs pairings and how their interactions dictate interspecies communication within 
complex bacterial communities. 
4.2. Diversity of the Publicly Available Pyridine Synthases from Thiopeptide Biosynthesis. 
 The central pyridine ring is the hallmark transformation of thiopeptides (and now 
pyritides), as it is not found in any other RiPP natural product. Because of this, bioinformatic 
studies aimed to discover new thiopeptide gene clusters use pyridine synthases to focus database 




unique thiopeptide pyridine synthases and organized as many thiopeptide BGCs using RODEO.23 
Therein, 9 different pyridine synthases were used in a BLAST search of the GenBank database 
and hits were subsequently filtered using Hidden Markov Models (HMMs) for four different 
thiopeptides: thiostrepton, thiomuracin, berninamycin, and lactazole. Since then, many more 
sequences have been added to GenBank, and I suspect that the stringent use of HMMs to filter 
their dataset based on highly studied thiopeptides may have greatly reduced the chances to discover 
new thiopeptide archetypes.  
 To collect any new thiopeptides that may have been added since 2018, and to encourage 
the collection of new thiopeptide archetypes, we collected the sequences of 24 thiopeptide pyridine 
synthases and applied them all to a BLAST search on GenBank without an HMM filter. All 
sequences with an E-value cutoff of 0.05 were collected and duplicates removed revealing 1110 
predicted proteins; almost double the amount previously found. Accession numbers were 
submitted to RODEO with the fetch distance adjusted for 15,000 bp to gather all cooccurring 
biosynthetic and structural genes. RODEO is a RiPP specialized mining tool with a thiopeptide 
model that aids in the prediction and discovery of thiopeptide precursor peptides. One major 
advantage is that RODEO will also search unannotated genomic regions for thiopeptide structural 
genes that may be missing annotation in GenBank.  
 In a report by Cogan et al, pyridine synthases were found to be structurally related to Lan 
B C-terminal glutamyl elimination domains.24  In fact, they both share the common ferrodoxin-
like domain as found in the epimerase LsrG.  Insertions and deletions within common scaffolds 
often lead to new activities. Indeed, pyridine synthases likely evolved divergently from Lan B C-
terminal elimination domains with the addition of 3 minor insertions that were found in TbtD and 





Figure 4.2. Sequence similarity network of pyridine synthases and analysis of sequence length.  A 
group of 24 known pyridine synthases were BLASTed against the NCBI database to acquire 1110 
unique putative pyridine synthases. These proteins were submitted to EFI-EST to create an SSN 
with an alignment score cutoff of 43. Pyridine synthase accessions were submitted to RODEO to 
obtain cooccurring genes. Sequence lengths of predicted pyridine synthases and neighboring split 
lanB elimination enzymes were measured and displayed as a histogram.  
 
broadly found in our collection of pyridine synthases, the length of each predicted pyridine 
synthase was mapped out on a histogram alongside the length of RODEO collected single domain 
Lan B C-terminal glutamyl elimination domains, figure 4.2. Indeed, there is a clear increase in 




among pyridine synthases. Additionally, this increases our confidence that the collected proteins 
are correctly annotated as pyridine synthases and not Lan B elimination domains, even though we 
did not stringently filter with HMMs. Ergo, the diversity of our 1110 pyridine synthases was 
visualized using a sequence similarity network, figure 4.2. Of the 35 clusters that were formed 
with 3 or greater sequences, only 10 contained a thiopeptide of known structure, suggesting that 
the yet unknown diversity of thiopeptides is much larger than the known.  
4.3 Diversity of Thiopeptide Precursor Peptides. 
 RODEO returned 73,578 sequences which could be potential thiopeptide structural 
peptides. Of those, only 1674 had a thiopeptide score of 20 and were predicted by RODEO to be 
valid thiopeptides. But some expected sequences were missing, like the pyritide from 
Micromonspora rosaria.10 So, for precursor peptides below a thiopeptide score of 20, the best 
scoring gene per biosynthetic cluster was kept. Additionally, precursors scoring between 5 and 19 
were manually curated for thiopeptide-looking structural genes. Finally, any duplicates were 
removed to give a final list of 1,393 possible thiopeptide precursor peptides with 293 total 
sequences with an unvalidated thiopeptide score below 20. This was done on purpose to allow 
room for the discovery of new thiopeptides that may look very different than what RODEO is 
currently trained to find. The sequence diversity of precursor peptides collected were analyzed by 
sequence similarity network, figure 4.3. Due to concatenation 1,393 sequences were represented 
in 1085 nodes and 38 clusters with 3 or more sequences were analyzed. Only 11 clusters contain 
a known thiopeptide leaving 27 yet uncharacterized, further supporting that thiopeptide diversity 
is much larger than currently known.  
 Phylogenetic analysis of the species represented in this dataset shows that the recovered 





Figure 4.3. Sequence similarity network of predicted thiopeptide structural genes. Pie charts show 
the representative bacterial phyla and genera which contain thiopeptides.  A manually curated 
dataset of predicted thiopeptide structural genes were collected using RODEO and a sequence 







Figure 4.4. WEBLOGOs of clustered thiopeptide cores. Clusters from figure 4.3 were numbered, 
and thiopeptide precursor sequences were extracted and aligned using MUSCLE. Alignments were 
uploaded to https://weblogo.berkeley.edu/logo.cgi and WEBLOGOs created. Leader peptide 
cleavage sites were manually determined.  
 
represented at 81.7 %. It is therefore not surprising that almost half (45.1%) of the species are 
Streptomyces. The number of species reported is about half as many as thiopeptide precursors 
presented due to some species carrying multiple thiopeptide BGCs and some clusters harboring 
multiple predicted precursors.  
 Precursor peptides from each of the 38 clusters were extracted, aligned using MUSCLE, 
and trimmed with trimAL. For each alignment, WEBLOGOs were created and putative leader 
peptides, which contain only recognition sequences, were removed, figure 4.4. Average RODEO 
thiopeptide scores were calculated and only 4 of the 38 clusters scored below the “valid 




analysis of the BGCs for 7 and 31 illuminates all the necessary traits for pyridine cyclization. In 
fact, a recent report characterized a member from group 7 as a pyridine cyclized peptide devoid of 
azoles. Because azoles are found in all other thiopeptides, group 7 RiPPs were newly termed, 
“Pyritides”.10 Further inspection of BGCs for cluster 8 and 35 suggest that they are not 
thiopeptides, but, in fact, linear azol(in)e containing peptides and lantibiotics, respectively. Each 
of these natural products have dehydrated amino acids as seen in thiopeptide biosynthesis and 
contain a Lan B C-terminal elimination domain misannotated as a pyridine synthase by our 
BLAST search. This highlights the difficulty of distinguishing Lan B elimination proteins from 
pyridine synthases. But, encouragingly, even with our more relaxed search for pyridine synthases, 
only 2 clusters out of 38 appear not to be thiopeptides.  
 It is clear from the SSN and the WEBLOGOS that structures and activities of many new 
thiopeptides remain to be elucidated. A goal of this study is to prioritize cryptic thiopeptide BGCs 
for analysis using chemoenzymatic synthesis. Current chemoenzymatic approaches to make 
thiopeptides favor core peptides with limited number of Ser, Thr, and Cys content. These amino 
acids, exclusively, are modified to dehydrated amino acids, azol(in)es, or a pyridine to make the 
thiopeptide backbone.2 By inspection of putative core sequences, modifications can be predicted, 
but determining the type of modification must be experimentally validated via successful 
cyclization by the cognate pyridine synthase. Therefore, the fewer the Ser, Thr, and Cys that are 
present in a core the fewer the pyridine synthase substrates that need to be made and tested for 
cyclization. Initial inspection of the WEBLOGOs shows that many clusters would not be good 
candidates for chemoenzymatic discovery. For instance, clusters 5, 6, 10, 13, 15, 19, 24, 27, 34, 
and 37 all average > 20 CST residues per RODEO predicted core. Alternatively, some clusters, 





Figure 4.5. Known thiopeptide biosynthetic gene clusters. Enzymes which make the thiopeptide 
core scaffold are colored by their concomitant transformation. Sidechain related enzymes are 
colored in light blue. Structural peptides for each BGC are bifurcated to highlight the ‘leader’ and 
‘core’ sequences. For each core, pyridine cyclization is indicated by a bar connecting two serine 
residues.  
 
fewer CST residues (Appendix table C.1). 
4.4 Prioritization of Unknown Thiopeptide Biosynthetic Gene Clusters for Chemoenzymatic 
Discovery. 
 
 Known thiopeptides have been extensively studied over the past decades and several 
biosynthetic gene clusters have been discovered and validated, figure 4.5.9,10,25–31 Thiocillin is a 





Figure 4.6. Unknown thiopeptide biosynthetic gene clusters. Enzymes which make the thiopeptide 
core scaffold are colored by their concomitant transformation. RODEO predicted structural 
peptides for each BGC are bifurcated to highlight potential ‘leader’ and ‘core’ sequences. ‘*’ 




and shown to work in vitro, because of solubility issues, the biosynthetic gene cluster has been 
heterologously expressed and libraries of many different thiocillin analogs have been made. 
Additionally, using only the pyridine synthase, TclM, various thiocillin analogs have been 
produced in several reports using chemoenzymatic synthesis.15,16,19 To make the core macrocyclic 
ring of thiocillin, three proteins are needed to install azoles, two enzymes to install dehydroalanines 
or dehydrobutyrines, and a single pyridine synthase cyclizes the peptide introducing the hallmark 
pyridine. This core biosynthetic structure is highly shared by other thiopeptides, including 
Nosiheptide, Thiomuracin, and Cyclothiazomycin. Slight deviations to this archetype are found in 
the number of enzymes present for these core transformations. For instance, in Thiostrepton and 
Berninamycin BGCs, an extra enzyme is indicated for dehydratase activity and azol(in)e 
formation, respectively. Interestingly, lactazole biosynthesis has only five total proteins as a single 
enzyme contains domains for both dehydratase and dehydrogenase activity, allowing this enzyme 
to participate in Dha and azole installation.39,40 Lastly, pyritides do not contain any enzymes for 
azol(in)e biosynthesis and represent the shortest BGCs to make pyridine cyclized peptides.10 
 Looking though our dataset of putative thiopeptides, fourteen different precursors were 
prioritized and selected based on short cores, limited CST residues, increased promiscuity 
indicated by multiple precursor peptides, and dissimilarities from known thiopeptides, figure 4.6. 
Interestingly, the BGCs for most of these unknown thiopeptides contain the same protein 
architecture as noted for thiocillin, except for gene order. Almost, exclusively, deviations occur 
with the number of azol(in)e forming enzymes as seen with Berninamycin. Of note the gene cluster 
from Bacillus 107 contains only 1 and is the only BGC missing a predicted dehydrogenase, 
suggesting the formation of azolines and not azoles. As observed in lactazole biosynthesis, all 




dehydration. Cluster 1 Sub 1, 2 Sub 3, and 31 all contain multiple different thiopeptide cores. This 
is reminiscent of certain lantibiotics, like the prochlorosins, which have a heightened promiscuity 
at a kinetic cost.41,42 It may also be suggestive of a two-component system as seen for 
lantibiotics.43–45 Known thiopeptides are highly hydrophobic leading to poor solubility in water.2 
Notably, predicted thiopeptides cluster 2 sub 3 and 2 sub 5 contain 8 and 10 charged residues, 
respectively, likely allowing these thiopeptides to be very soluble. YcaO cyclodehydratases do not 
readily modify Cys amino acids on the C-terminus of substrates.46 We see this in cyclothiazomycin 
biosynthesis where the C-terminal Cys is not cyclodehydrated, but instead is used for external 
cyclization giving cyclothiazomycin its secondary ring.29 Similarly, clusters 2 sub 4 and 3 also end 
in a C-terminal Cys. It is likely, then, that these cysteines are not transformed into azoles and are, 
in fact, used for an ancillary modification.  
 Presenting and organizing these unknown thiopeptide gene clusters and precursor peptides 
enables easy design and application of chemoenzymatic synthesis for thiopeptide discovery. We 
expect that several new thiopeptides can be structurally validated in this manner, and new 
bioactivities found. One unknown that we have selected from Bacillus sp. 107 is of particular 
interest as a report by Bleich et al., shows that this cryptic thiopeptide may stimulate biofilm 
production in Bacillus subtilis.13 This activity was measured for several different thiopeptides and 
is hypothesized to be regulated by a TipA-like transcription factor; a protein that broadly binds 
thiopeptides and regulates its multi drug resistant gene expression.14   
4.5 Diversity of Thiopeptide Binding Receptors. 
 Several studies now indicate that Thiostrepton and a broad range of other thiopeptides can 
regulate gene expression via the transcription factor TipA; a MerR-like stress response 




instance, MerR is activated by a Hg-complex which forms between 3 different cysteines.49 In a 
similar fashion, thiopeptides contain thiol-reactive dehydroalanines and dehydrobutyrines that are 
covalently attacked by a C-terminal cysteine upon interaction with TipA. Consequent structural 
changes in the protein subsequently activate TipA to autogenously regulate its own transcription 
and possibly other genes.14,47  
 Interestingly, another report shows that thiopeptides can broadly stimulate biofilm 
production in Bacillus subtilus in an unknown, kinD-independent manner.13 The structural 
similarities between the thiopeptides that induce tipA expression in S. lividans and biofilm 
production in B. subtilis suggests that thiopeptide sensing and gene regulation via MerR-like 
transcription factors might be a broad phenomenon among Actinobacteria and Firmicutes.14 
 To gain an understanding of just how widespread thiopeptide signaling via TipA may be, 
TipAS (the thiopeptide binding domain of TipA) was used to focus a BLAST search on NCBI and 
2,311 non-redundant thiopeptide receptors were recovered. By submitting these sequences to EFI-
EST an SSN was created and due to the large number of edges, proteins were concatenated at a 
sequence similarity of 75 %, figure 4.7.  As seen with the thiopeptides, the most abundant phyla 
are, indeed, Actinobacteria and Firmicutes and clustering is highly phyla specific. TipAS was 
shown to bind a wide range of structurally distinct thiopeptides that all contain a conserved four-
ring motif.14 The discrete clustering within phyla suggests that there may exist many thiopeptide 
specific receptor pairings. It has also been suggested that bacterial strains that produce thiopeptides 





Figure 4.7. Sequence similarity network of thiopeptide receptors.  A group of 2311 thiopeptide 
receptors were collected from NCBI using BLASTP.  Pie charts show the representative bacterial 
phyla and genera which contain these receptors. Sequences were submitted to EFI-EST to make a 
sequence similarity network with an alignment score of 80 and sequences of 75% identity were 
grouped within the same node. Nodes are colored by phyla. Blue, purple, light brown, black, and 
grey are Actinobacteria, Firmicutes, Deinococcus-Thermus, Actinobacteria and Firmicutes, and 
other respectively. TipAS sequences were collected by Sarah Barr. 
 
produce thiopeptides also contain a TipAS homolog but only 19 times were these TipAS genes 
found near a thiopeptide cluster, potentially serving as a resistance mediator. Therefore, 75 % of 
the bacteria which make a thiopeptide do not themselves have a thiopeptide receptor. This means 




communities acting both as an antibiotic and a signaling molecule. For strains that express a TipAS 
homolog and a thiopeptide, it will be interesting to determine if the two interact, or if the TipAS 
senses a disparate thiopeptide produced by bacterial neighbors. With the aid of chemoenzymatic 
synthesis, we expect that many new thiopeptides can be made and their associated TipAS homolog 
revealed, leading to a better understanding of how thiopeptides shape bacterial communities. 
4.6 Conclusion. 
 Here, we have bioinformatically expanded the natural product class of thiopeptides. 
Previous attempts to do so contain ~half the number of predicted pyridine synthases, and do not 
organize and prioritize new thiopeptide biosynthetic gene clusters for discovery. In our assessment, 
we employed a somewhat more relaxed method for collecting pyridine synthases, i.e. without the 
use of HMMs, but we thought that the decreased stringency would better allow for the discovery 
of new thiopeptides. While this would also give for more negative hits, we expected that these 
might be filtered out as singletons during SSN creation and true thiopeptides would cluster by 
leader peptides as previously seen.23 In fact, this is what we found as only 2 of the 38 clusters 
presented are suspected not to be thiopeptides. Furthermore, our analysis now includes at least 10 
more clusters of precursor peptides with three or more nodes, including the previously missed 
pyritides. Of the 38 thiopeptide clusters analyzed in this study, only 11 contain a thiopeptide of 
known structure. It is clear from these data that the diversity of thiopeptides is much broader than 
currently known and with increasing genomes being added to NCBI, we expect this family of 
natural products to continue to grow and certain clusters to become more prolific. We also found 
that most thiopeptide BGCs, known and unknown, follow a similar core architecture to the well-
known thiopeptide thiocillin, and that deviations are largely found in the number of azole 




thiopeptides, we empower the natural product community with the necessary information to unveil 
the structures of these compounds using chemoenzymatic synthesis or other methods.  
 As new, structurally diverse thiopeptides are discovered, we anticipate a commensurate 
revelation in TipAS guided activities. Currently, we know of thiopeptides with dual activity, like 
Thiostrepton; an antibiotic and TipA regulator. But thiopeptides like lactazole exist that have no 
antibiotic activity and, in fact, have no known activity. We hypothesize that such thiopeptides may 
act solely through TipA signaling to help shape interspecies bacterial communities. The clustering 
of TipAS homologs seen in figure 4.7 may be indicative of different thiopeptide binding partners. 
With the advent of new chemoenzymatic tools to illuminate cryptic thiopeptides, we anticipate 
that new TipAS-Thiopeptide interactions will be discovered and new thiopeptide regulated 
bioactivates unveiled.  
4.7 Experimental 
 
4.7.1 Collecting pyridine synthases from GenBank and RODEO.  
 
 Protein sequences for 24 different pyridine synthases were collected and BLASTed against 
the NCBI GenBank database with an E-value cutoff of 0.05. The search recovered 4,930 proteins, 
1,110 of which were unique. Accessions for each unique predicted pyridine synthase were 
organized and submitted to RODEO to obtain neighboring proteins and structural genes. The 
RODEO module to predict thiopeptide precursor peptides was engaged, the fetch distance for 
nucleotide sequences was adjusted to 15,000 bp, and precursor peptides were only included if the 
amino acid length was between 38 and 100.  


































































































































































































































































4.7.2 Curating Thiopeptide Precursor Peptides. 
 
 RODEO provides a score for each thiopeptide. If the score is 20 or greater, then the 
precursor peptide is predicted to be a valid thiopeptide. All of these precursors were collected.  For 
some thiopeptide gene clusters, no precursor scored 20 or above. In this case, the best scoring 
precursor or precursors were kept. Additionally, all predicted precursors with a thiopeptide score 
between 5 and 19 were manually analyzed and sequences with hallmark thiopeptide characteristics 
were added. The final dataset was filtered for duplicates and 1,393 predicted thiopeptide precursors 
remained. 
4.7.3 Creating Sequence Similarity Networks. 
 All sequences for pyridine synthases, thiopeptide precursors and TipAS homolgos were 
organized in fasta format and submitted to EFI-EST to make a sequence similarity network. For 
each dataset, the default settings were left unchanged. For pyridine synthases, precursors and 
TipAS homologs alignment scores of 43, 8, and 80 were employed, respectively. All were 
concatenated at 100 % sequence identity except for TipAS homologs which were concatenated at 
75% sequence identity. All networks were visualized with CytoScape with an organic layout. 
4.7.4 WEBLOGOs for Predicted Thiopeptide Cores. 
 Sequences from each of the 38 selected clusters from the precursor SSN (figure 4.3), were 
extracted, organized into fasta format, and aligned using MUSCLE. Alignments were trimmed 
using trimAL50 before submitting to https://weblogo.berkeley.edu/logo.cgi to make WEBLOGOs. 





4.7.5 Thiopeptide Predicted Gene Clusters with antiSMASH 
 Nucleotide accessions obtained from RODEO were used to download 708 available 
RefSeq and GenBank assemblies. These were submitted to antiSMASH and all predicted gene 
clusters containing an accession number for a predicted pyridine synthase were collected. For ease 
of viewing different gene clusters, the antiSMASH files were input into BiG-SCAPE51 and 
selected gene clusters were downloaded as .SVG files. Enzyme activities were predicted based on 
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CHAPTER 5: CONCLUSION 
5.1 Concluding Remarks. 
 Genetically encoded peptide libraries are becoming increasingly important, and there has 
been a sustained effort to diversify these libraries with modifications. Of particular note is the 
success of chemical cyclization strategies leading to many tight binding inhibitors.1–4 While 
chemical techniques have been valuable, there is a limited number of reactions that are display 
compatible.5  To increase the types of peptide transformations available to peptide display, the 
power of enzymes as library biocatalysts is being explored. Specifically, RiPPs are being targeted 
for the preparation of peptide libraries because they are promiscuous, programmable, and act on 
peptides.6 Lantibiotics are the first class of RiPP to be successfully applied for the discovery of 
novel inhibitors,7–9 but there exist many other types of RiPPs that may perform well in peptide 
display selections.  
 mRNA display has a few advantages over other display technologies;  namely, (1) diversity 
is not dependent on transformation efficiency, (2) libraries can be quickly prepared, (3) the tag is 
small, (4) unnatural amino acids can be readily incorporated, and (5) selections are fast.10,11 
Because of these advantages, my work has focused on uniting RiPP biochemistry with mRNA 
display. The initial experiments presented with PaaA showed for the first time that RiPP enzymes 
could modify RNA linked substrates, provided assays to measure peptide library modification, and 




 Thiopeptides are another class of RiPP expected to perform well in peptide display 
selections. This is because thiopeptides are privileged, having many known bioactivities;12 their 
structure lends to the technique, having an open C-terminus; and their functional groups may one 
day be helpful for tuning the bioavailability of a peptide library.13  To date thiopeptides  have not 
been used with display, because no versatile display-ready synthesis exists. Ergo, my work has 
focused on overcoming this limitation by designing and implementing a new chemoenzymatic 
strategy to make thiopeptides that is display compatible. My strategy uses a couple of highly 
promiscuous RiPP enzymes from disparate biosyntheses14,15 paired with nucleotide compatible 
chemistry16,17 to make the complex multi-azole / Dha substrate for thiopeptide pyridine 
synthases,18 that complete the transformation to the thiopeptide core. In this manner, different 
thiopeptide classes can be made in an mRNA display-ready fashion by simply exchanging the 
pyridine synthase.  
 Currently, there are 5 pyridine synthase that have been reconstituted in vitro15,19–21 that we 
can use for the display of thiopeptides. But it is not certain that these will be the best enzymes for 
mRNA display. Previous chemoenzymatic synthesis and my reported synthesis readily lends 
themselves to the speedy reconstitution of new thiopeptides via a kindred pyridine synthase.21 To 
advance the discovery of uncharacterized pyridine synthases, my work has also focused on using 
current bioinformatic tools22,23 to collect a database of thiopeptide BGCs from which we have 
prioritized 14 gene clusters for chemoenzymatic discovery. This work primes experiments for the 
realization of new thiopeptides and will provide a toolbox of the best pyridine synthases to be used 
for peptide display.  
 Overall, my work has greatly advanced the diversification of peptide libraries by uniting 




can be used in this manner, and we anticipate that the work herein will be of significant use and 















































(1) Kale, S. S.; Villequey, C.; Kong, X.-D.; Zorzi, A.; Deyle, K.; Heinis, C. Nat. Chem. 2018, 10, 
715. 
(2) Millward, S. W.; Takahashi, T. T.; Roberts, R. W. J. Am. Chem. Soc. 2005, 127, 14142. 
(3) Passioura, T.; Suga, H. Chem. Comm. 2017, 53, 1931. 
(4) Hacker, D. E.; Abrigo, N. A.; Hoinka, J.; Richardson, S. L.; Przytycka, T. M.; Hartman, M. 
C. T. Direct, ACS Comb. Sci. 2020, 22, 306. 
(5) Malone, M. L.; Paegel, B. M. ACS Comb. Sci. 2016, 18, 182. 
(6) Montalbán-López, M.; Scott, T. A.; Ramesh, S.; Rahman, I. R.; Heel, A. J. van; Viel, J. H.; 
Bandarian, V.; Dittmann, E.; Genilloud, O.; Goto, Y.; Burgos, M. J. G.; Hill, C.; Kim, S.; 
Koehnke, J.; Latham, J. A.; Link, A. J.; Martínez, B.; Nair, S. K.; Nicolet, Y.; Rebuffat, S.; Sahl, 
H.-G.; Sareen, D.; Schmidt, E. W.; Schmitt, L.; Severinov, K.; Süssmuth, R. D.; Truman, A. W.; 
Wang, H.; Weng, J.-K.; Wezel, G. P. van; Zhang, Q.; Zhong, J.; Piel, J.; Mitchell, D. A.; 
Kuipers, O. P.; van der Donk, W. A. Nat. Prod. Rep. 2020, Advance Article 
(7) Urban, J. H.; Moosmeier, M. A.; Aumüller, T.; Thein, M.; Bosma, T.; Rink, R.; Groth, K.; 
Zulley, M.; Siegers, K.; Tissot, K.; Moll, G. N.; Prassler, J. Nat. Comm. 2017, 8, 1500. 
(8) Yang, X.; Lennard, K. R.; He, C.; Walker, M. C.; Ball, A. T.; Doigneaux, C.; Tavassoli, A.; 
van der Donk, W. A. Nat. Chem. Biol. 2018, 14, 375. 
(9) Hetrick, K. J.; Walker, M. C.; van der Donk, W. A. ACS Cent. Sci. 2018, 4, 458. 
(10) Huang, Y.; Wiedmann, M. M.; Suga, H. Chem. Rev. 2019, 119, 10360. 
(11) Goto, Y.; Katoh, T.; Suga, H. Nat. Protoc. 2011, 6, 779.  
(12) Just-Baringo, X.; Albericio, F.; Álvarez, M. Marine Drugs 2014, 12, 317. 
(13) Matsson, P.; Doak, B. C.; Over, B.; Kihlberg, J. Adv. Drug Deliver. Rev. 2016, 101, 42. 
(14) Koehnke, J.; Mann, G.; Bent, A. F.; Ludewig, H.; Shirran, S.; Botting, C.; Lebl, T.; 
Houssen, W. E.; Jaspars, M.; Naismith, J. H. Nat. Chem. Biol. 2015, 11, 558. 
(15) Hudson, G. A.; Zhang, Z.; Tietz, J. I.; van der Donk, W. A.; Mitchell, D. A. J. Am. Chem. 
Soc. 2015, 137, 16012. 
(16) Okeley, N.; Zhu, Y.; van der Donk, W. A. Org. Lett. 2000, 2, 3603. 




(18) Wever, W. J.; Bogart, J. W.; Baccile, J. A.; Chan, A. N.; Schroeder, F. C.; Bowers, A. A. J. 
Am. Chem. Soc. 2015, 137, 3494. 
(19) Wever, W. J.; Bogart, J. W.; Bowers, A. A. J. Am. Chem. Soc. 2016, 138, 13461. 
(20) Fleming, S. R.; Bartges, T. E.; Vinogradov, A. A.; Kirkpatrick, C. L.; Goto, Y.; Suga, H.; 
Hicks, L. M.; Bowers, A. A. J. Am. Chem. Soc. 2019, 141, 758. 
(21) Hudson, G. A.; Hooper, A. R.; DiCaprio, A. J.; Sarlah, D.; Mitchell, D. A. Org. Lett. 2020, 
XXXX, XXX, XXX-XXX 
(22) Blin, K.; Shaw, S.; Steinke, K.; Villebro, R.; Ziemert, N.; Lee, S. Y.; Medema, M. H.; 
Weber, T. Nucleic Acids Res. 2019, 47, W81. 
(23) Tietz, J. I.; Schwalen, C. J.; Patel, P. S.; Maxson, T.; Blair, P. M.; Tai, H.-C.; Zakai, U. I.; 

































APPENDIX A. SUPPLEMENTARY FIGURES AND TABLES FOR CHAPTER 2 
 
Figure A.1 PaaA Effected GluC protection of PaaP. (a)  PaaP (MIKFSTLSQRISAITEEN-
AMYTKGQVIVLS) was displayed with 35S-methionine.  Treatment with GluC cleaves off the 
N-terminus noted by band shift that is protected in the presence of PaaA.  This data was collected 
by Dr. Paul Himes. (b) Diagram of working PaaP-display construct for streptavidin pullout-based 
selections. (c)  A dot plot showing the difference in streptavidin bead recovery between PaaA 
treated and non-treated PaaP-mRNA fusions with increasing µg of GluC measured by qPCR.  Error 
bars represent the standard error of the mean (SEM, n=3). PaaA treated streptavidin recoveries 
were divided by non-PaaA treated streptavidin recoveries to calculate a fold enrichment effected 
by PaaA per GluC treatment. Error bars represent the SEM, n=3. (d) Dot plots showing the 
dependence of PaaA concentration and reaction time on streptavidin recovery of PaaP-mRNA 


















Figure A.2. NGS analysis of E scores. No correlation between input counts and E scores is found 










Figure A.3. PaaP smSVL with 5 min and 60 min PaaA Treatments. PaaP-mRNA fusions of 
smSVL were treated with PaaA for (a) 5 min and (b) 60 min before purification, GluC treatment, 
and streptavidin enrichment. Each square represents an average (n=3). (c) smSVL streptavidin 
recoveries were monitored by qPCR for PaaA reaction times of 0, 5, 22.5, and 60 mins and 











Figure A.4. Fluorescence Polarization of Tamra-WT-PaaP1-12 and PaaA. (a) Binding between 
TAMRA-PaaP1-12 was measured by fluorescence polarization by keeping peptide constant at 5 nM 
and titrating PaaA from 25 µM - 0.763 nM. EC50 = 1.869 ± 0.485 µM. (b) Six different aspartic 
acid mutations were synthesized and tested for competitive binding with 5 nM TAMRA-PaaP1-12 
at 100 nM PaaA.  Competing peptides were titrated from 50 - 0.0061 µM. WT IC50 = 0.3482 ± 
0.044 µM; T6D IC50 = 1.471 ± 0.238 µM. IC50 values for other mutants were not determined as 
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Figure A.5. Isothermal Calorimetry (ITC) of PaaP Peptides. To further substantiate the FP data, 
ITC experiments were run for each synthesized PaaP peptide. The (a) WT and (b) T6D peptides 
were run in duplicate and mutants (c) F4D, (d) L7D, (e) R10D, and (f) I11D were performed once 
since no binding isotherms were detected. WT Kd = 0.357 ± 0.08; T6D Kd = 0.707 ± 0.02. Error is 




















Figure A.6. Alignment of PaaP Homologs. PaaP was used in a BLAST search on NCBI and all 
sequences of an e-value cut off of 5.0 were obtained. Sequences obviously not PaaP homologs 
were removed and extended N-terminal sequence was trimmed (42 total sequences).  All homologs 
were aligned according to the core glutamic acids and visualized using JalView. Blue highlights 
are shaded by percent identity. Black arrows represent the positions discovered by the smSVL data 













Figure A.8. PaaP A13C NCL Reaction Scheme. The following procedure was adapted from a 
previous report6 to synthesize E17 labeled PaaA substrate Ac-MIKFSTLSQRISCITEE*NATYT-
KGQVIVLS. Trifluoroacetic acid = TFA, Triisopropylsilane = TIS, Tris(2-carboxyethyl)phos-




















Figure A.9. MALDI-TOF Traces. PaaA substrates were transcribed and translated using NEB 
PURExpress and treated with 1 µM PaaA, 4 mM MgCl2, 1 mM ATP and 100 mM Bicine pH 9.0 
for 22.5 min before quenching with 50 mM EDTA.  Reactions were desalted with C18 stage tips 
and analyzed by MALDI-TOF. For expected and observed masses see Table A.1. For each peptide, 
top traces are translation controls and bottom traces are analysis of the PaaA reaction. All masses 
are measured with a formylated N-terminus [M+H]+1. S = substrate, -18 = - H2O; -36 = -2 H2O; -











































































































Table A.1. MALDI-TOF Masses and Integration Areas of PaaA Reaction Products. All peptide 
masses are measured in Daltons, include an N-terminal formyl group and are protonated [M+H]1+. 































Table A.2.  MALDI-TOF Mass Analysis of PaaA Reactions on Core E Mutants. All peptide 
masses are measured in Daltons, include an N-terminal formyl group and are protonated [M+H]1+. 







Table A.3. Calculated mass error for 13C-enriched PaaP A13C modification with PaaA.  Masses 



































[M+H]1+ observed: 1409.7840 














[M+H]1+ observed: 1377.7457 














[M+H]1+ observed: 1411.7435 















[M+H]1+ observed: 1368.7172 














[M+H]1+ observed: 1411.7274 














[M+H]1+ observed: 1423.7621 













[M+H]1+ observed: 1821.9294 











































































































































































































































































































































































































APPENDIX B. SUPPLEMENTARY TABLES AND FIGURES FOR CHAPTER 3 
 
Figure B.1. Purification of His6-LynD, His6-MBP-TbtE, His6-MBP-TclM, and His6-MBP-LazC. 
lynD was cloned into pMCSG7 as an N-terminal His6 fusion. The remaining genes were cloned 
into pMCSG9 as N-terminal His6 maltose binding protein fusions. Proteins were expressed in E. 

















Figure B.2. Optimization of Sec(Ph) acylation of microhelix.1 6 µL of 500 mM HEPES-KOH pH 
8.0, 6 µL of 250 µM of dFx, 6 µL of 250 µM microhelix, and 18 uL of water were pipetted together 
and heated for 2 min at 95 oC. The solution was cooled for 5 min at room temperature before 12 
µL of 3 M MgCl2 was added and mixed. After another 5 min incubation at room temperature, 10 
µL of 25 mM Sec(Ph)-DBE in DMSO was added (or DMSO only for negative sample), mixed and 
the solution placed on ice. 10 µL aliquots were removed at 6, 24, 48, and 72 hours and quenched 
with 40 µL 0.3 M AcONa and ethanol precipitated. Pellets were dried and resuspended in 1.5 µL 
of 10 mM NaOAc pH 5.2 and further diluted with 14 µL of acid page RNA loading buffer. 1 µL 
of each sample was loaded onto a 20% Urea-Acid-PAGE gel and run for 150 min at 120 V in 50 
mM AcONa pH 5.2 as running buffer. The gel was soaked in ethidium bromide and visualized by 






Figure B.3. Design of LazC substrates. Shown is a wild type sequence for the lactazole and three 
newly designed precursor peptides to make lactazole analogs using our developed strategy. The 
LynD RS is colored in blue, amino acids colored in red are transformed into Dhas, amino acids 
colored in green are transformed into thiazoles / oxazoles, and the tryptophan codon is 
reprogrammed for Sec(Ph).  
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Figure B.4.1-B.4.44 Nano-LCESI-MS Traces. Designed precursor peptides were made as 
described earlier. Condition 1a: Samples were translated, treated with 4 µM LynD / 3 µM MBP-
TbtE (~20hrs, 25 oC) and then 0.125 U endoproteinase GluC (37 oC, overnight). Condition 1b: 
Samples were translated with tryptophan reprogrammed for Sec(Ph), treated with 4 µM LynD / 3 
µM MBP-TbtE (~20hrs, 25 oC), 1 M H2O2 (1hr, 4 
oC), 500 mM TCEP (1 hr, 37 oC), and 0.125 U 
endoproteinase GluC (37 oC, >5 hrs). Condition 2: Samples were translated with tryptophan 
reprogrammed for Sec(Ph), treated with 4 µM LynD / 3 µM MBP-TbtE (~20hrs, 25 oC), 1 M H2O2 
(1hr, 4 oC), 500 mM TCEP (1 hr, 37 oC), and 2 µM MBP-TclM or MBP-LazC (1-22 hrs, 25oC) 
All reactions were desalted using c18 stage tips and analyzed by LC-ESI-Q/TOF MS. All traces 
were generated as extracted ion chromatograms (XIC) within 10 ppm error between 25 and 45 
minutes. In spectra with multiple major peaks an arrow indicates the peak used to generate MS 
spectra. Additional peaks were found to not contain the correct exact mass or charge state.  
B.4.1. (Table 3.1B, entry 1) Condition 1a 
MHHHHHHSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGASCTTCVCTCSCCTT 




B.4.2. (Table 3.1B, entry 2) Condition 1a 
MHHHHHHSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAFCTTCVCTCFCCTT 











B.4.3. (Table 3.1B, entry 3) Condition 1a  
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTTCVCTCWCCTT 





B.4.4.  (Table 3.1A, entry 1) Condition 1b  
MSSQLAELSEEALGDAENEALEIMGAWCTTCVCTCWCCTT 




B.4.5.  (Table 3.1A, entry 3) Condition 1b 
MSEIKKALNTLEIEDFLAELSEEALGDAENEALEIMGAWCTTCVCTCWCCTT 








B.4.6.  (Table 3.1A, entry 4) Condition 1b 
MSEIKKALNTLEIEDFDAIEMVDVDAMPLAELSEEALGDAENEALEIMGAWCTTCVCTCWCCTT 





B.4.7.  (Table 3.1A, entry 5) Condition 1b 
MSSGVDLGTENLYFQSNALAELSEEALGDAAAAAAENEALEIMGAWCTTCVCTCWCCTT 




B.4.8.  (Table 3.1A, entry 6) Condition 1b 
MSSGVDLGTENLYFQSNALAELSEEALGDAGGGGGENEALEIMGAWCTTCVCTCWCCTT 









B.4.9.  (Table 3.1A, entry 7) Condition 1b 
MSSGVDLGTENLYFQSNALAELSEEALGDAKKKKKENEALEIMGAWCTTCVCTCWCCTT 




B.4.10.  (Table 3.1A, entry 8) Condition 1b 
MSSGVDLGTENLYFQSNALAELSEEALGDADDDDDENEALEIMGAWCTTCVCTCWCCTT 




B.4.11.  (Table 3.1A, entry 9) Condition 1b 
MSSGVDLGTENLYFQSNALAELSEEALGDAPPPPPENEALEIMGAWCTTCVCTCWCCTT 










B.4.12.  (Table 3.1A, entry 10) Condition 1b 
MLAELSEEALGDASEIKKALNTLEIEDFDAIEMVDVDAMPENEALEIMGAWCTTCVCTCWCCTT 




B.4.13.  (Table 3.1B, entry 4) Condition 1b 
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTTCKCTCWCCAA 




B.4.14.  (Table 3.1B, entry 5) Condition 1b 
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTTCDCTCWCCAA 










B.4.15.  (Table 3.1B, entry 6) Condition 1b 
 
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTACVSACWCCAA 





B.4.16.  (Table 3.1B, entry 7) Condition 1b 
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTACACACWCA 




B.4.17.  (Table 3.1B, entry 9) Condition 1b 
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTACACACWCCA 









B.4.18.  (Table 3.1B, entry 10) Condition 1b  
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTACACACWCCT 





B.4.19.  (Table 3.1B, entry 11) Condition 1b  
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTACACACWCCAA 





B.4.20.  (Table 3.1B, entry 12) Condition 1b  
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTACACACWCCAG 









B.4.21.  (Table 3.1B, entry 13) Condition 1b  
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTTCVCTCWCCAANSGGVS 





B.4.22.  (figure S3, LacHyb1) Condition 1b  
MSDITASRVESLDLQDLDLAELSEEALRDTVALPENGAWSGSCWCQAWCWCAQP 





B.4.23.  (figure S3, LacHyb2) Condition 1b  
MSDITASRVESLAELSEEALGDAVTSLRDTVALPENGAWSGSCWCQAWCWCAQP 








B.4.24.  (figure S3, LacHyb3) Condition 1b 
MLAELSEEALGDALQDLDLSELTVTSLRDTVALPENGAWSGSCWCQAWCWCAQP 




B.4.25.  (Table 3.1A, entry 1) Condition 2 
MSSQLAELSEEALGDAENEALEIMGAWCTTCVCTCWCCTT  




B.4.26.  (Table 3.1A, entry 3) Condition 2 
MSEIKKALNTLEIEDFLAELSEEALGDAENEALEIMGAWCTTCVCTCWCCTT  









B.4.27.  (Table 3.1A, entry 4) Condition 2 
MSEIKKALNTLEIEDFDAIEMVDVDAMPLAELSEEALGDAENEALEIMGAWCTTCVCTCWCCTT 




B.4.28.  (Table 3.1A, entry 5) Condition 2 
MSSGVDLGTENLYFQSNALAELSEEALGDAAAAAAENEALEIMGAWCTTCVCTCWCCTT 





B.4.29.  (Table 3.1A, entry 6) Condition 2 
MSSGVDLGTENLYFQSNALAELSEEALGDAGGGGGENEALEIMGAWCTTCVCTCWCCTT 








B.4.30.  (Table 3.1A, entry 7) Condition 2 
MSSGVDLGTENLYFQSNALAELSEEALGDAKKKKKENEALEIMGAWCTTCVCTCWCCTT 




B.4.31.  (Table 3.1A, entry 8) Condition 2 
MSSGVDLGTENLYFQSNALAELSEEALGDADDDDDENEALEIMGAWCTTCVCTCWCCTT 





B.4.32.  (Table 3.1A, entry 9) Condition 2 
MSSGVDLGTENLYFQSNALAELSEEALGDAPPPPPENEALEIMGAWCTTCVCTCWCCTT 









B.4.33.  (Table 3.1A, entry 10) Condition 2 
MLAELSEEALGDASEIKKALNTLEIEDFDAIEMVDVDAMPENEALEIMGAWCTTCVCTCWCCTT 





B.4.34.  (Table 3.1B, entry 4) Condition 2 
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTTCKCTCWCCAA 




B.4.35.  (Table 3.1B, entry 5) Condition 2 
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTTCDCTCWCCAA 
 









B.4.36.  (Table 3.1B, entry 6) Condition 2 
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTACVSACWCCAA 




B.4.37.  (Table 3.1B, entry 9) Condition 2  
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTACACACWCCA 


















B.4.39.  (Table 3.1B, entry 11) Condition 2  
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTACACACWCCAA 




B.4.40.  (Table 3.1B, entry 12) Condition 2  
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTACACACWCCAG 




B.4.41.  (Table 3.1B, entry 13) Condition 2 
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTTCVCTCWCCAANSGGVS 










B.4.42.  (figure S3, LacHyb1) Condition 2  
MSDITASRVESLDLQDLDLAELSEEALRDTVALPENGAWSGSCWCQAWCWCAQP 





B.4.43.  (figure S3, LacHyb2) Condition 2  
MSDITASRVESLAELSEEALGDAVTSLRDTVALPENGAWSGSCWCQAWCWCAQP 




B.4.44.  (figure S3, LacHyb3) Condition 2  
MLAELSEEALGDALQDLDLSELTVTSLRDTVALPENGAWSGSCWCQAWCWCAQP 








Figure B.5.  Lactazole Bioinformatics. (a) Accession numbers from the following report2 of 508 
thiopeptide pyridine synthase homologs were used to bulk download their respective sequences in 
fasta file format from NCBI. These sequences were then uploaded to Enzyme Function Initiative 
Enzyme Similarity Tool (EFI-EST) (https://efi.igb.illinois.edu/) to generate a sequence similarity 
network (SSN) with 100% sequence conflation and an alignment score of 43. LazC is highlighted 
in red and its cluster of close homologs is highlighted in blue. (b) Full thiopeptide precursor 
peptides2 were used to generate a sequence similarity network with alignment score 8 and 
sequences with 100 % identity were conflated. Lactazole homologs are colored in magenta and 
lactazole is colored in turquoise. (c) The cores of the lactazole homologs were aligned using 
ClustalW, Muscle. Sequences were then aligned to the first serine residue and cores larger than 30 
residues or beginning with threonine were removed. These sequences were analyzed by Weblogo. 













Figure B.6. Flexizyme Reaction. (a) Aminoacyl tRNA synthetases (aaRS) are enzymes which 
activate amino acids and acylate them onto tRNAs.3 They are often specific for their evolved amino 
acid substrate and tRNA. (b) Flexizymes are laboratory evolved RNAs which catalyze the 
acylation of synthetically activated amino acids onto a tRNA of choice. dFX is a flexizyme which 















Table B.1. Translation Genes 























































































































































CACTGGGCGACGCGGAAAACGAAGCGCTTGAAATTATGGGAGCGTGG TGT ACA AC









CACTGGGCGACGCGGAAAACGAAGCGCTTGAAATTATGGGAGCGTGG TGT ACT AC


















Table 3.1B, Entry 7 
MSSGVDLGTENLYFQSNALAELSEEALGDAENEALEIMGAWCTACACACWCA 
GCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTA
GAAATAATTTTGTTTAACTTTAAGAAGGAGATATACATATG TCT TCC GGT GTA GA
T TTA GGT ACA GAA AAC CTT TAC TTC CAA TCT AAT GCG CTT GCT GAG CTT TC
T GAG GAG GCT CTG GGCGAT GCC GAG AAT GAG GCC CTT GAG ATC ATG GGA G


































































CACTGGGCGACGCGGAAAACGAAGCGCTTGAAATTATGGGAGCGTGG TGT ACC AC

















GAAATAATTTTGTTTAACTTTAAGAAGGAGATATACATATG AGT GAT ATT ACA GC
C AGT CGC GTA GAG AGT TTA GCG GAA TTG TCC GAA GAA GCA CTT GGA GAC G
CA GTA ACA TCC TTG CGCGAT ACT GTT GCG TTG CCT GAG AAT GGT GCG TGG T
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APPENDIX C. SUPPLEMENTARY TABLES AND FIGURES FOR CHAPTER 4 
 
Table C.1. Precursor SSN table of statistics. For each cluster in the precursor ssn (figure 4.3), the 
average RODEO predicted thiopeptide score was calculated, the number of peptides in each cluster 
was counted, and the average number of cys, ser, and thr residues are reported.  
 
Cluster Thiopeptide Score Ave. Thiopeptide Score Stdev.  ‘C’ Ave. ‘C’ Stdev. ‘S’ Ave. 
clust_1  26.67   6.04   3.79  1.72  8.13 
clust_2  26.12   5.80   4.35  1.94  5.87 
clust_3  32.68   4.35   3.39  1.47  8.84 
clust_4  32.33   1.69   4.74  0.86  10.41 
clust_5  30.33   1.63   8.04  0.62  16.13 
clust_6  30.81   1.68   2.90  0.34  13.40 
clust_7  13.43   7.55   0.14  0.38  2.29 
clust_8  11.81   2.54   2.00  0.63  9.81 
clust_9  30.56   2.88   7.78  2.64  4.11 
clust_10  30.18   1.59   8.18  0.53  15.29 
clust_11  32.38   4.17   5.38  0.51  4.46 
clust_12  35.26   1.85   5.00  0.00  6.00 
clust_13  31.67   1.58   4.67  0.50  12.11 
clust_14  29.41   1.99   1.00  0.00  9.00 
clust_15  31.59   1.06   8.00  0.00  14.88 
clust_16  32.75   1.60   8.50  0.52  2.67 
clust_17  23.93   1.82   3.00  0.00  6.07 
clust_18  36.73   0.92   7.88  0.33  4.12 
clust_19  30.50   0.94   7.00  0.00  18.93 
clust_20  35.47   2.33   2.40  0.63  8.40 
clust_21  30.00   0.58   6.00  0.00  2.43 
clust_22  28.00   0.00   10.00  0.00  4.40 
clust_23  29.14   2.27   6.00  0.00  11.86 
clust_24  32.63   2.07   7.63  0.74  16.75 
clust_25  21.00   5.18   3.00  0.00  7.50 
clust_26  31.00   0.00   5.00  0.00  10.00 
clust_27  26.20   1.92   5.40  2.07  12.40 
clust_28  27.83   0.75   6.00  0.00  9.50 
clust_29  33.00   0.63   1.00  0.00  10.50 
clust_30  28.75   3.30   4.00  0.00  2.50 
clust_31  19.00   0.00   2.00  0.00  3.00 
clust_32  22.67   0.58   0.67  0.58  12.33 
clust_33  29.50   2.74   3.00  0.00  6.50 
clust_34  30.00   1.73   8.00  2.65  14.00 
clust_35  2.33   1.15   0.67  1.15  6.00 
clust_36  25.20   0.84   6.00  0.00  3.00 
clust_37  30.00   1.00   6.00  1.73  20.67 














Cluster  ‘S’ Stdev. ‘T’ Ave.  ‘T’ Stdev. ‘CST’ Ave. ‘CST’ Stdev. Total 
            Peptide 
clust_1  3.04  1.77  1.97  13.69  5.33  197 
clust_2  2.22  1.42  1.35  11.64  2.94  105 
clust_3  1.76  1.79  1.11  14.02  2.05  97 
clust_4  1.12  2.48  0.70  17.63  1.15  27 
clust_5  1.60  5.21  1.02  29.38  1.66  24 
clust_6  1.50  8.15  1.01  24.45  1.95  105 
clust_7  0.49  0.71  0.76  3.14  1.35  7 
clust_8  1.81  3.33  1.24  15.14  1.49  21 
clust_9  2.09  1.56  0.53  13.44  2.13  9 
clust_10  0.47  5.71  0.77  29.18  0.53  17 
clust_11  0.52  2.00  0.00  11.85  0.38  13 
clust_12  0.88  3.26  0.99  14.26  1.66  19 
clust_13  1.36  7.33  1.00  24.11  1.36  9 
clust_14  0.00  3.00  1.02  13.00  1.02  22 
clust_15  0.49  3.41  0.71  26.29  0.69  17 
clust_16  0.49  0.58  0.51  11.75  0.97  12 
clust_17  0.27  1.43  0.51  10.50  0.65  14 
clust_18  0.33  1.15  0.46  13.15  0.37  26 
clust_19  0.27  6.50  0.52  32.43  0.51  14 
clust_20  0.91  4.33  1.91  15.13  1.51  15 
clust_21  1.13  5.29  0.76  13.71  1.89  7 
clust_22  0.51  0.00  0.00  14.40  0.51  15 
clust_23  1.77  2.00  0.00  19.86  1.77  7 
clust_24  0.71  4.63  1.19  29.00  1.31  8 
clust_25  0.84  0.33  0.82  10.83  0.98  6 
clust_26  0.00  3.00  0.00  18.00  0.00  6 
clust_27  2.79  5.20  1.30  23.00  5.10  5 
clust_28  0.55  2.00  1.10  17.50  1.05  6 
clust_29  0.55  3.33  0.52  14.83  0.41  6 
clust_30  0.58  2.00  0.00  8.50  0.58  4 
clust_31  0.00  0.00  0.00  5.00  0.00  3 
clust_32  1.15  3.67  0.58  16.67  1.53  3 
clust_33  0.55  4.00  0.00  13.50  0.55  6 
clust_34  2.65  4.33  2.31  26.33  2.89  3 
clust_35  1.73  2.67  0.58  9.33  1.15  3 
clust_36  0.00  0.00  0.00  9.00  0.00  5 
clust_37  3.21  9.67  0.58  36.33  1.15  3 
















Table C.2. Sequences of RODEO predicted thiopeptide precursor peptides. Each entry contains a 
unique number, “X_” followed by the NCBI accession number for the associated pyridine 
synthase.  Additionally, the bacterial species is presented, followed by the genome nucleotide 
sequence for the predicted peptide, and the RODEO thiopeptide score (TS).  
 




2_WP_083975908.1 Kitasatospora azatica KCTC 9699 517547 517547 TS=39 
MEGFDNLVLDDSAFELVDLGEVVPASVTAGYGLTELSASKGSSSCCCCCPCCSCT 
 
3_EJJ05679.1 Streptomyces auratus AGR0001 3879982 3879982 TS=39 
MDAVEELDLNALEISDLIEDSNYSDETLSQAMAASTTTTGCTTSSCSSSSS 
 
4_WP_091614370.1 Amycolatopsis saalfeldensis 714664 714664 TS=38 
MSAPTSIQANVGVAGLTGLDTDTLEISDYLDETLLDSHDLTETMASSSSCTTCICTCSCSS 
 
5_WP_133205963.1 Arthrobacter sp. JH1-1 25821 25821 TS=38 
MTITLPDLDFDGIEVLSVRESVAVPETGATSGSSSSNSSSCCGSSSCCSS 
 
6_WP_083975908.1 Kitasatospora azatica KCTC 9699 517775 517775 TS=38 
MEGFDNLVLDDSTFELVDLGEVVPASVTAGYGLTELSASGGASSCCCCCPCCSCT 
 
7_WP_007074886.1 Micromonospora sp. ATCC 39149 4703451 4703451 TS=38 
MDANATTVGVDGLTGLDIDTFEIGDYLDETVLDTADLTETMTSSSSCTTCICTCSCSS 
 
8_WP_153464103.1 Streptomyces kaniharaensis 4883725 4883725 TS=38 
MEGFEDLVLDDGAFELVDLGEVVPTSVTAGYGLTELSASGGQSSCCCCCPCCSCT 
 
9_WP_153464103.1 Streptomyces kaniharaensis 4883953 4883953 TS=38 
MEGFEDLVLDDGAFELVDLGEVVPASVTAGYGLTELSASGGASSCCCCCPCCSCT 
 
10_WP_073444392.1 Streptomyces noursei 494011 494011 TS=38 
MDSTQELDLNALEISDLIEDSNYSDETLSQAMAASTTTTGCTTSSCSSSSS 
 
11_WP_073444392.1 Streptomyces noursei 494258 494258 TS=38 
MDSTQELDLNALEISDLIEDSNYSDETLSQAMAASTTTTGCTTSSCSSSSS 
 
12_WP_067348540.1 Streptomyces noursei ATCC 11455 4423573 4423573 TS=38 
MDSTQELDLNALEISDLIEDSNYSDETLSQAMAASTTTTGCTTSSCSSSSS 
 











15_WP_073741099.1 Streptomyces sp. CB02115 809522 809522 TS=38 
MFDSFDIEELDTMEIADGVALPEMAASSLPVTCCSSSSSSCCCC 
 
16_WP_058927704.1 Streptomyces sp. CdTB01 9686259 9686259 TS=38 
MEEFDELVLDDSAFELVDLGKVVPASVTAGYGLTELSASGGASSCCCCCPCCSCT 
 
17_WP_058927704.1 Streptomyces sp. CdTB01 9686492 9686492 TS=38 
MEEFDELVLDDSAFELVDLGKVVPASVTAGYGLTELSASGGQSSCCCCCPCCSCT 
 
18_WP_047180975.1 Streptomyces sp. MNU77 2814790 2814790 TS=38 
MRSTLETADVDAMFDSFDIEELDTMEIADGVALPEMAASSLPVTCCSSSSSSCCCC 
 
19_WP_097963940.1 Streptomyces sp. or20 78898 78898 TS=38 
MDVDAMFDSFDIEELDTMEIADGVALPEMAASSLPVTCCSSSSSSCCCC 
 
20_WP_050360717.1 Streptomyces sp. or3 87798 87798 TS=38 
MFDSFDIEELDTMEIADGVALPEMAASSLPVTCCSSSSSSCCCC 
 
21_WP_109601719.1 Actinoplanes xinjiangensis 67568 67568 TS=37 
MSAELRATETNAADLSALDIESLEISEFLDDNRLEDSEVVAKVMSASCTTCECCCSCSS 
 
22_WP_034091981.1 Streptacidiphilus albus 87319 87319 TS=37 
MEGFDDLVLDDSSFELVDLGAVVPESVTAGYGLTELSASGGQSSCCCCCPCCSCT 
 
23_WP_034091981.1 Streptacidiphilus albus 87541 87541 TS=37 
MEGFDDLVLDDSSFELVDLGAVVPESVTAGYGLTELSASGGASSCCCCCPCCSCT 
 
24_WP_110629793.1 Streptomyces actuosus 4914932 4914932 TS=37 
MDAAHLSDLDIDALEISEFLDESRLEDSEVVAKVMSASCTTCECCCSCSS 
 




26_WP_120757588.1 Streptomyces klenkii 92932 92932 TS=37 
MEKNGIEGLDLSDLDVESLEFSADSEGGLESLRMGHGLTEVGASCCCSTSSCSCST 
 
27_WP_037746661.1 Streptomyces mirabilis 82938 82938 TS=37 
MEEFDELVLDDSAFELVDLGKVVPASVTAGYGLTELSASGGASSCCCCCPCCSCT 
 





29_WP_097239509.1 Streptomyces sp. 1114.5 4871787 4871787 TS=37 
MEDFDNLVLEDSAFELVDLGEVVPASVTAGYGLTELSASGGASSCCCCCPCCSCT 
 
30_WP_097239509.1 Streptomyces sp. 1114.5 4872016 4872016 TS=37 
MEDFDNLVLEDSAFELVDLGEVVPASVTAGYGLTELSASGGASSCCCCCPCCSCT 
 
31_WP_148643628.1 Streptomyces sp. CB01881 1909152 1909152 TS=37 
MTEHHRAGRTESPADPTELEIEELSVLELGDAIALPEMGASNWGGWFCCSSSSSATCCC 
 
32_WP_148643628.1 Streptomyces sp. CB01881 1909525 1909525 TS=37 
MSESINTPQVESAEVPAVDVEELSVLEVGDAAALPEMGASSGGTMCCSSSSSTCCC 
 
33_WP_148643628.1 Streptomyces sp. CB01881 1909820 1909820 TS=37 
MSESVNTPQVESAEVPAVDVEELSVLEVGDAAALPEMGASSGGTMCCSSSSSTCCC 
 
34_WP_087767808.1 Streptomyces sp. CS057 2994009 2994009 TS=37 
MRSTLETADVDAMFDSFDIEELDTMEIADGVALPEMAASSIPVTCCSSSSSSCCCC 
 




36_WP_079277171.1 Streptomyces sp. TSRI0261 218301 218301 TS=37 
MRSTLETADVDAMFDSFDIEELDTMEIADGVALPEMAASSLPATCCSSSSSSCCCC 
 
37_WP_104482524.1 Actinokineospora auranticolor 89137 89137 TS=36 
MNDHKGLASLADEILRLETETFEISDYADTNDVVLAACTSSSSTSTCSSTTSTTSCSA 
 
38_WP_151570259.1 Actinomadura rudentiformis 75901 75901 TS=36 
MNETDDSGTRSLLLEDLGLLEAETFEVRDHSDVAEELAGTCSCTSTTSSCSSSSGTSCCD 
 
39_WP_151570259.1 Actinomadura rudentiformis 76134 76134 TS=36 
MSDTDEDRGTHTVLQAELGLLEAETFEISDYVETIEEVAGTTSCTSTCSSCSSSSSTSCS 
 
40_WP_027346917.1 Hamadaea tsunoensis DSM 44101 222558 222558 TS=36 
MPTQDLELMDLDLDLEIVEISSVRDAVALPESGASSGTSSCGSSSCCGSCSCCCCL 
 
41_WP_033822905.1 Kitasatospora sp. MBT63 24103 24103 TS=36 
MEGFDDLVLDDGAFELVDLGEVVPASVTAGYGLTELSASGGASSCCCCCPCCSCT 
 
42_WP_033822905.1 Kitasatospora sp. MBT63 24328 24328 TS=36 
MEGFDDLVLDDGAFELVDLGEVVPASVTAGYGLTELSASGGASSCCCCCPCCSCT 
 






44_WP_145908795.1 Kitasatospora viridis 310781 310781 TS=36 
MEGFDDLVLDDSTFELVDLGVVVPASVTAGYGLTELAASSGGSSCCCCTPCCSCT 
 
45_WP_145908795.1 Kitasatospora viridis 311005 311005 TS=36 
MEGFNDDLVLDDSAFELVDLGAVVPASVTAGYGLTELSASKGTSSCCCCTPCCSCT 
 
46_WP_140008476.1 Nocardioides plantarum 1542643 1542643 TS=36 
MKNANAFAAFDIAELEVLETAQGMALPEMGASSGSIGTSSSSSSTCSAC 
 
47_WP_143802042.1 Paenibacillus thiaminolyticus 1669884 1669884 TS=36 
MEELKLENQEIELSLDDLELQDVKMEVLMTNSKGLPEMGATLGGITCCSCCCCST 
 
48_WP_152645972.1 Streptacidiphilus albus JL83 9685908 9685908 TS=36 
MEGFDDLVLDDSSFELVDLGAVVPESVTAGYGLTELSASGGASSCCCCCPCCSCT 
 
49_WP_152645972.1 Streptacidiphilus albus JL83 9686130 9686130 TS=36 
MEGFDDLVLDDSSFELVDLGAVVPESVTAGYGLTELSASGGQSSCCCCCPCCSCT 
 
50_WP_037604491.1 Streptacidiphilus rugosus AM-16 1514789 1514789 TS=36 
MEGFEDLVLDDGAFELVDLGEVVPASVTAGYGLTELSASGGQSSCCCCCPCCSCT 
 
51_WP_037604491.1 Streptacidiphilus rugosus AM-16 1515016 1515016 TS=36 
MEGFEDLVLDDGAFELVDLGEVVPASVTAGYGLTELSASGGASSCCCCCPCCSCT 
 
52_WP_020274901.1 Streptomyces afghaniensis 772 19644 19644 TS=36 
MHLSELDVDALEISEFLDDSRLEDSEVVAKVMSASCTTCECCCSCSS 
 












56_AQM75226.1 Streptomyces sp. 6618 6618 TS=36 
MDAELNGLDIDALEISEFLDENRLEDSEVVAKVMSASCTTCECCCSCSS 
 







58_WP_097239513.1 Streptomyces sp. 1331.2 7264638 7264638 TS=36 
MEDFDNLVLEDSAFELVDLGEVVPASVTAGYGLTELSASGGASSCCCCCPCCSCT 
 












62_WP_123493429.1 Streptomyces sp. 844.5 1163845 1163845 TS=36 
MEGFDNLVLDDSAFELVDLGEVVPASVTAGYGLTELSASGGASSCCCCCPCCSCT 
 
63_WP_123493429.1 Streptomyces sp. 844.5 1164062 1164062 TS=36 
VNDMEGFDNLVLDDSAFELVDLGEVVPASVTAGYGLTELSASGGQSSCCCCCPCCSCT 
 












67_WP_037764021.1 Streptomyces sp. VN1 3712729 3712729 TS=36 
MSTVAIDSADIEQVFDSFDVTELEVLEVSQGVALPEMGASGGTVGTSSSSSTCSSSTC 
 
68_WP_125824502.1 Streptomyces sp. W1SF4 192883 192883 TS=36 
MANTTAVADFDQLFTSFDIEELEVLDVADGVALPEMGASSGNALCCSSSSSSSSSCC 
 
69_WP_030891366.1 Streptomyces varsoviensis 52660 52660 TS=36 
MEGFDDLVLDDSAFELVDLGEVVPESVTAGYGLTELSASGGASSCCCCCPCCSCT 
 







71_WP_094236693.1 Tumebacillus algifaecis 2652905 2652905 TS=36 
MEIKALEVTGLEVMDLNDAMALPETAASSGSSSSSGCSTCGSSSCCGSC 
 
72_WP_094236693.1 Tumebacillus algifaecis 2653102 2653102 TS=36 
MEIKALEVTGLEVMDLNDAMALPETAASSGSSSSSGCSTCGSSSCCGSC 
 
73_WP_087458049.1 Tumebacillus avium 3770985 3770985 TS=36 
MEIKALEVTGLEVMDLNDAMALPETAASSGSSSSSGCSTCGSSSCCGSC 
 
74_WP_087458049.1 Tumebacillus avium 3771181 3771181 TS=36 
MEIKALEVTGLEVMDLNDAMALPETAASSGSSSSSGCSTCGSSSCCGSC 
 
75_WP_087458049.1 Tumebacillus avium 3771376 3771376 TS=36 
MEIKALEVTGLEVMDLNDAMALPETAASSGSSSSSGCSTCGSSSCCGSC 
 
76_WP_016697827.1 Actinoalloteichus spitiensis RMV-1378 45 45 TS=35 
MSADLPALNIESLEISEFLDDNRLEDGEVVAKVMSASCTTCECCCSCSS 
 
77_WP_173027111.1 Arthrobacter sp. NEB 688 749885 749885 TS=35 
MSKDTQDITFDSFDVQDVEVLEAADGTALPEMGASSGSIGTSSSSSSTCSAC 
 
78_WP_094181683.1 Cellulomonas sp. PSBB021 3338019 3338019 TS=35 
MTTNDIANLSGEITALESENFEISDYADAAEAILASCSSSSSTSTCSSTTSTTSCTA 
 
79_WP_141322329.1 Cellulomonas uda 30387 30387 TS=35 
MTTNDIANLSGEITALESENFEISDYADAAEAILASCSSSSSTSTCSSTTSTTSCTA 
 
80_WP_043588221.1 Clavibacter cf. michiganensis LMG 26808 41659 41659 TS=35 
MEKTMSMKISLPDLDFDSVEIMSVREAVAVPETGATSGSSSSNSSSCCGSSSCCSSS 
 
81_WP_147362287.1 Clavibacter michiganensis 24430 24430 TS=35 
MEKTMSMKISLPDLDFDSVEIMSVREAVAVPETGATSGSSSSNSSSCCGSSSCCSSS 
 
82_WP_051750259.1 Phycicoccus jejuensis 399039 399039 TS=35 
MSKDTQDITFDSFDVQDVEVLEAADGTALPEMGASSGSIGTSSSSSSTCSAC 
 
83_GAT69286.1 Planomonospora sphaerica 29424 29424 TS=35 
MSTATSQSIGVESLTGLDVDMLEISDYIDETLLDTADLTVTMVSSASCTTCICTCSCSS 
 
84_WP_131102100.1 Streptomonospora sp. M2 1433823 1433823 TS=35 
MDATNELDLNALEISDLIEDSSYNDETLSQVMAASCTTTGCTTSSSSSSSS 
 







86_WP_167745813.1 Streptomyces azureus 263530 263530 TS=35 
MSNASIGQDIGVEGLTGLDVDALEISDYMDEALLDSEDLTVTLVSSVSCTTCICSCSCSS 
 




88_WP_099198214.1 Streptomyces cinnamoneus 6082075 6082075 TS=35 
MNNDILEMDELDFQLEELSVLDIADARALPELGASNGSIGCSSSTCSSTCCC 
 
89_WP_099198214.1 Streptomyces cinnamoneus 6082271 6082271 TS=35 
MDELVFQLEELSVLDVSDAVALPEMGASSGWGCSSSTCSSCCC 
 
90_WP_121802851.1 Streptomyces griseocarneus 11806 11806 TS=35 
MTQKAELATLAQELLELESETFEISDYSDASEVVLAGSTSSSSTSTCSSTTSTTSCSA 
 
91_WP_120721641.1 Streptomyces hundungensis 3238693 3238693 TS=35 
MNNIEELDLNALEISDLIEDSGNNDESLSQIMAASCTTSGCACSSSSSSSS 
 








94_WP_073741099.1 Streptomyces sp. CB02115 809912 809912 TS=35 
MDVDAMFDSFDIEELETMELADGVALPEMAASTIPVACCSSSSSSCC 
 
95_WP_073741099.1 Streptomyces sp. CB02115 810474 810474 TS=35 
MSKILESVDADAMFDSFDIEELGTMELADGVALPEMGASKGDFTCCSSSSSSCC 
 
96_WP_073741099.1 Streptomyces sp. CB02115 810851 810851 TS=35 
MNADALFDSFDIEELDTMEVADGVALPEMGASTGNTMCCSSSSSSCC 
 
97_WP_073931449.1 Streptomyces sp. CB02400 57383 57383 TS=35 
MTAKDIKNDADNAFEGFDADELETLEVADGVALPEMGASSGSIGTSSSSSSTCSAC 
 
98_WP_073931449.1 Streptomyces sp. CB02400 57589 57589 TS=35 
MTAKDIKNDADNAFEGFDADELETLEVADGVALPEMGASSGSIGTSSSSSSTCSAC 
 







100_WP_047180975.1 Streptomyces sp. MNU77 2815736 2815736 TS=35 
MDVDAMFDSFDIEELDTMELADGVALPEMGASKGDFTCCSSSSSSCC 
 
101_WP_047180975.1 Streptomyces sp. MNU77 2816107 2816107 TS=35 
MNADALFDSFDIEELDTMEVADGVALPEMGASTGNTMCCSSSSSSCC 
 




103_WP_097963940.1 Streptomyces sp. or20 79468 79468 TS=35 
MDADAMFDSFDIEELGTMELADGVALPEMGASKGDFTCCSSSSSSCC 
 
104_WP_097963940.1 Streptomyces sp. or20 79842 79842 TS=35 
MNADALFDSFDIEELDTMEVADGVALPEMGASTGNTMCCSSSSSSCC 
 
105_WP_050360717.1 Streptomyces sp. or3 86854 86854 TS=35 
MNADALFDSFDIEELDTMEVADGVALPEMGASTGNTMCCSSSSSSCC 
 
106_WP_050360717.1 Streptomyces sp. or3 87231 87231 TS=35 
MSKILETVDADAMFDSFDIEELGTMELADGVALPEMGASKGDFTCCSSSSSSCC 
 
107_EHM28179.1 Streptomyces sp. W007 206 206 TS=35 
MSMAIEAMNADALFDSFDIEELDTMEVADGVALPEMGASTGNTMCCSSSSSSCC 
 
108_WP_052889351.1 Thermogemmatispora carboxidivorans 2855515




109_WP_052889351.1 Thermogemmatispora carboxidivorans 2855805




110_WP_165898146.1 Tumebacillus sp. BK434 341556 341556 TS=35 
MEIKALEVTGLEVMDLNDAMALPETAASSGSSSSSGCSTCGSSSCCGSC 
 
111_WP_165898146.1 Tumebacillus sp. BK434 341752 341752 TS=35 
MEIKALEVTGLEVMDLNDAMALPETAASSGSSSSSGCSTCGSSSCCGSC 
 







113_WP_015802628.1 Actinosynnema pretiosum subsp. pretiosum 4541473
 4541473 TS=34 
MDLTFDESELDLGDLAVTAMRDAVALPETGASTAACSCSSTSCCCCQQPPTPELPQV 
 
114_WP_066450536.1 Bacillus gottheilii 4313252 4313252 TS=34 
MKNELNLDLDFEVIELDDVTALPETAASSGSSGDNVYSTCGSSSCCSSCCT 
 
115_WP_066450536.1 Bacillus gottheilii 4313642 4313642 TS=34 
MKNELNLDLDFEVIELDDVTALPETAASSGSSGDNVYSTCGSSSCCSSCCT 
 
116_WP_151575809.1 Bacillus mesophilum 51812 51812 TS=34 
MNNDMNLDLDFEVIELDDVTALPETAASSGSSGDNVYSTCGSSSCCSSCCT 
 
117_WP_151575809.1 Bacillus mesophilum 52002 52002 TS=34 
MKVDVNLDLDFEVIELDDVTALPETAASSGSSGDNVYSTCGSSSCCSSCCT 
 
118_WP_151575809.1 Bacillus mesophilum 52201 52201 TS=34 
MKNEMNLDLDFEVIELDDVTALPETAASSGSSGDNVYSTCGSSSCCSSCCT 
 
119_WP_098212038.1 Bacillus sp. AFS075034 7326 7326 TS=34 
MNNNNDAKADLEKLNSGMGMTEVGASLLCSCSCPCSCCSSSSI 
 
120_WP_098212038.1 Bacillus sp. AFS075034 7547 7547 TS=34 
MNNNNDAKADLEKLNSGMGMTEVGASLLCSCSCPCSCCSSSSI 
 
121_WP_143406617.1 Exiguobacterium sp. AT1b 7220 7220 TS=34 
MENNLDVELELDFEVIELDDVTALPETAASSGSSGDNVYSTCGSSSCCSSCCT 
 
122_WP_143406617.1 Exiguobacterium sp. AT1b 7413 7413 TS=34 
MENNLDIELELDFEVIELDDVTALPETAASSGSSGDNVYSTCGSSSCCSSCCT 
 
123_WP_143406617.1 Exiguobacterium sp. AT1b 7608 7608 TS=34 
MENNLDIELELDFEVIELDDVTALPETAASSGSSGDNVYSTCGSSSCCSSCCT 
 
124_WP_106538471.1 Haloactinopolyspora alba 107149 107149 TS=34 
MAHTTLGMELLELEAVTFEVDEITDPSADMAASSSSCSCSSCSSCSTSSCCSCSTSTSSCG 
 












127_WP_120331704.1 Micromonospora globbae 32725 32725 TS=34 
MPITLNDELRELETETFEIEEVEDGGEALAASSSSCSCSSCCSCSTSSCCSTSTSTSSCG 
 
128_WP_120331704.1 Micromonospora globbae 33387 33387 TS=34 
MPELTEELRALESETFEIEDVDAIDAMVMDWSSSSCSCSSCCSCSTSSCCSSSTSTGCGGG 
 
129_WP_120688751.1 Micromonospora musae 112953 112953 TS=34 
MSIDETTAAQDDKTFDSFEIADLEVLEVAQGVALPELGASSGSIGTSSSSSTCSSSTC 
 
130_WP_120675210.1 Micromonospora musae 208089 208089 TS=34 
MSIDETTAAQDDKTFDSFEIADLEVLEVAQGVALPELGASSGSIGTSSSSSTCSSSTC 
 
131_WP_067140220.1 Microtetraspora malaysiensis 49059 49059 TS=34 
MNALSFDVEELALDELSVTTVRDGVALPDTGASACCFSWMTSSSCCCCTEIE 
 
132_WP_067140220.1 Microtetraspora malaysiensis 51434 51434 TS=34 
MSMTTTRFDLADLDLSGLQVTVMRDAVAVPEGGATSGSSSSDSSSTCGSSSCCSSVAQQ 
 
133_WP_167477798.1 Nocardia arthritidis 8632159 8632159 TS=34 
MENNLPALDINALEISEFLDDSRMDDRDVVAKVMSASCTTCECSCSCSS 
 
134_WP_067608788.1 Nocardiopsis listeri NBRC 13360 5300 5300 TS=34 
MRKSTGLSDLQGELELLESETFEVLDLVEAREEMLGSTTSTTSCCSSCSSSSCSSTSCAGG 
 
135_WP_087097343.1 Nocardiopsis sp. JB363 9265 9265 TS=34 
MSRTTALSNLQGELELLESETFEVLDLVEAREEMLGSTTSTTSCCSSCSSSSCSSTSCAGG 
 
136_WP_111153483.1 Paenibacillus dendritiformis 191 191 TS=34 
MEELKLENQEIELSLDDLELQDVKMEVLMTNSKGLPEMGATLGGITCCSCCCCST 
 
137_WP_111149723.1 Paenibacillus sambharensis 123808 123808 TS=34 
MEKNMTALVDEELSFEIIELEDITALPETAASSGSSSSDTCSTCGSCSCSSCCT 
 




139_KUJ37316.1 Streptomyces albus subsp. albus 45481 45481 TS=34 
MSVELKDELNALESATFEIEEMTDEAVELAWSSSSCSCSSCCSCSTSSCCSCSSSTS 
 
140_WP_157841653.1 Streptomyces atroolivaceus 434477 434477 TS=34 
MEQQIELDVLEISDLIAGAGENDDLAQVMAASCTTTSVSTSSSSSSS 
 






142_WP_031037067.1 Streptomyces olivaceus 349083 349083 TS=34 
MSTVAIDSADIEQVFDSFDVTELEVLEVSQGVALPEMGASGGTVGTSSSSSTCSSSTC 
 
143_WP_135337719.1 Streptomyces palmae 35357 35357 TS=34 
MSVELKNELNALESATFEIEEMTDEAVELAWSSSSCSCSSCCSCSTSSCCSCSSSTS 
 
144_WP_096213443.1 Streptomyces sp. 2323.1 4190685 4190685 TS=34 
MSTVAAVGQDVGVEGLTGLDAGALEISETRTRRCSTARAAVTLISSVSCTTCICSGRCSS 
 
145_WP_097223039.1 Streptomyces sp. Ag82_G6-1 3689019 3689019 TS=34 
MTAKDIKNQDADKAFEGFDADELETLEVTDGVALPEMGASSGSIGTSSSSSSTCSAC 
 
146_WP_097223039.1 Streptomyces sp. Ag82_G6-1 3689258 3689258 TS=34 
MTAKDIKNQDADKAFEGFDADELETLEVTDGVALPEMGASSGSIGTSSSSSSTCSAC 
 
147_WP_087767808.1 Streptomyces sp. CS057 2994943 2994943 TS=34 
MDVDAMFDSFDIEELGTMELADGVALPEMGASKGDFTCCSSSSSSCC 
 
148_WP_087767808.1 Streptomyces sp. CS057 2995314 2995314 TS=34 
MNADALFDSFDIEELDTMEVADGVALPEMGASTGNTMCCSSSSSSCC 
 
149_WP_127355247.1 Streptomyces sp. LAM7114 74848 74848 TS=34 
MNTVSVNSADIEQVFDSFDVTELEVLEVSQGVALPEMGASGGNGGTSSSSSTCSSSTC 
 
150_WP_030812058.1 Streptomyces sp. NRRL F-2799 40412 40412 TS=34 
MSVELRDELNALESATFEIEEMTDESVELAWSSSSCSCSSCCSCSTSSCCSCSSSTS 
 
151_WP_018560187.1 Streptomyces sp. SID8377 12175 12175 TS=34 
MSVELKDELSALESATFEIEEMTDESVELAWSSSSCSCSSCCSCSTSSCCSCSSSTS 
 
152_WP_019547680.1 Streptomyces sulphureus DSM 40104 63021 63021 TS=34 
MSNVTVDSIDIEQVFDSFDVTELEVLEVSQGVAQPEMGASGGTVGTSSSSSTCSSSTC 
 
153_WP_110669044.1 Streptomyces tateyamensis 30401 30401 TS=34 
MSAPTEIQNLGVVGLTGLDTDTLEISDYLDESLLDEHDLTVTMVASASCTTCICTCSCSS 
 
154_QJC58228.1 Streptomyces viridochromogenes 31046 31046 TS=34 
MFQVESAEQLDLNALEISDLIEDSSYSDETLSQVMAASCTTTGCTTSSSSSSSS 
 










157_WP_151570259.1 Actinomadura rudentiformis 76381 76381 TS=33 
MSADLVDLRNDLELLEAETFEILDYEEAPEVLADCCSTSSCSTSSSTTSCTSTASCA 
 
158_WP_014690724.1 Actinoplanes sp. SE50 4175479 4175479 TS=33 
MENIDEELDLNALEISDLIEDSGTEDETLSQIMAASCTTSGCACSSSSSSSS 
 
159_WP_098207202.1 Bacillus cereus 13832 13832 TS=33 
MEKMNKENVNFFDDLEITSLDITEVTDAISIPETGASSGSNGTYLCGSSSCCSSCCS 
 
160_WP_098207202.1 Bacillus cereus 14083 14083 TS=33 
MEKMNKENVNLFDDLEITGLDITEVTDAISIPETGASSGSNGTYLCGSSSCCSSCCS 
 
161_WP_098481582.1 Bacillus cereus 122446 122446 TS=33 
MEKMNKENVNLFDDLEITGLDITEVTDAISIPETGASSGSNGTYLCGSSSCCSSCCS 
 
162_WP_098481582.1 Bacillus cereus 122697 122697 TS=33 
MEKMNKENVNFFDDLEITGLDITEVTDAISIPETGASSGSNGTYLCGSSSCCSSCCS 
 




164_WP_002169253.1 Bacillus mycoides 4862089 4862089 TS=33 
MEKMNKENVNFFDDLEITGLDITEVTDAISIPETGASSGSNGTYLCGSSSCCSSCCS 
 
165_WP_002169253.1 Bacillus mycoides 4862335 4862335 TS=33 
MEKMNKENVNFFDDLEITGLDITEVTDAISIPETGASSGSNGTYLCGSSSCCSSCCS 
 
166_WP_044053021.1 Bacillus velezensis 13527 13527 TS=33 
MKKEKNDLLNNLEITGLDVTEITDSISIPETGATSGSGGHSTCGSSSCCSSCCS 
 





168_WP_128211777.1 Clostridium sp. CT4 1171657 1171657 TS=33 
MENKNNIFSEFDIEVSELEFIDVMPSTAASRAGIFPLSTSTCGSSSSSTCSSSCS 
 
169_WP_128211777.1 Clostridium sp. CT4 1171900 1171900 TS=33 
MEEKKAQEINNIIDDFDIEVIELDNVKAVPSTAASSGNGWSSTSTCGSSSSSTCSACCS 
 







171_WP_128211777.1 Clostridium sp. CT4 1172370 1172370 TS=33 
MNKENVKELNNILDDFDIEVIEMDNVQAVPSTAASGGNGSSTSTCGSSSSSTCSSSCA 
 
172_WP_128211777.1 Clostridium sp. CT4 1172600 1172600 TS=33 
MNKENVKELNNILDDFDIEVIEMDNVQAVPSTAASGGNGSSTSTCGSSSSSTCSSSCA 
 









175_WP_109243206.1 Kocuria rosea 3432150 3432150 TS=33 
MDRKPTDLVDLPMDVFELEDQGMDITSLTAGHGMTEVGASTNCFCYPCCSCSAPSSSA 
 
176_WP_172604317.1 Kocuria rosea 727572 727572 TS=33 
MDRKPTDLVDLPMDVFELEDQGMDITSLTAGHGMTEVGASTNCFCYPCCSCSAPSSSA 
 
177_WP_017833576.1 Kocuria sp. UCD-OTCP 60951 60951 TS=33 
MDRKPTDLVDLPMDVFELEDQGMDITSLTAGHGMTEVGASTNCFCYPCCSCSAPSSSA 
 




179_WP_110565432.1 Micromonospora arborensis 105583 105583 TS=33 
MTGLDIDTLEISDYLDESMLDTHDLTETMIASASCTTCICTCSCSS 
 
180_SCF23618.1 Micromonospora carbonacea 466536 466536 TS=33 
MSISVDPQTELGVEELTGLDIDTLEISDYLDESMLDTHDLTETMIASASCTTCICTCSCSS 
 




182_WP_120331704.1 Micromonospora globbae 33125 33125 TS=33 
MPDSVRSELRDLQAETFEVEDIADLTADLMDICSSSTSTSSCSSCSTSSCCSCTSSSCSSTS 
 








184_WP_123600439.1 Micromonospora sp. Llam0 379505 379505 TS=33 
MSDEIIDVEDLELDELSVSSIRDSAALPETGASSGSSSCSSSSCCGASSCCASCAEVEQSAL 
 




186_ADR01090.1 Nocardia sp. ATCC 202099 38581 38581 TS=33 
MSADLSALNIDSLEISEFLDDSRLEDSEVVAKVMSASCTTCECSCSCSS 
 
187_WP_111149723.1 Paenibacillus sambharensis 124018 124018 TS=33 
MENTKTVSVLDDLTFEIIELDDVTALPETAASSGSSSSDTCSTCGSSSCSSCSSCT 
 




189_WP_131102100.1 Streptomonospora sp. M2 1433577 1433577 TS=33 
MDATNELDLNALEISDLIEDLNHSEETLSQVMGASCVGCACTCSSTSSSS 
 
190_WP_078843712.1 Streptomyces albus subsp. albus 3810 3810 TS=33 
MDAKNELATLANDILELESETFEISDYSDAVEVVLAGSTSSSSTSTCSSTTSTTSCSA 
 
191_WP_167745813.1 Streptomyces azureus 263197 263197 TS=33 
MSNASIGQEIGVEGLTGLDVDALEISDYVDETLLDGEDLTVTMIASASCTTCICTCSCSS 
 
192_AGN11669.1 Streptomyces bernensis 10654 10654 TS=33 
MEQQIELDVLEISDLIAGAGENDDLAQVMAASCTTTSVSTSSSSSSS 
 
193_WP_037804196.1 Streptomyces caelestis 60329 60329 TS=33 
GFDADELETLEVADGVALPEMGASSGSIGTSSSSSSTCSAC 
 

















198_BAU84768.1 Streptomyces laurentii 4051564 4051564 TS=33 
MSNAALEIGVEGLTGLDVDTLEISDYMDETLLDGEDLTVTMIASASCTTCICTCSCSS 
 
199_ACN52295.1 Streptomyces laurentii 8076 8076 TS=33 
MSNAALEIGVEGLTGLDVDTLEISDYMDETLLDGEDLTVTMIASASCTTCICTCSCSS 
 
200_WP_069569928.1 Streptomyces lydicus 4027407 4027407 TS=33 
MQTELVLDLADLSADELEILPTSPGASLETVNVGHAMVEIGASNCTSTGTPASCCSCCCC 
 








203_WP_070390316.1 Streptomyces olivaceus 3660694 3660694 TS=33 
MSTVAIDSADIEQVFDSFDVTELEVLEVSQGVALPEMGASGGTVGTSSSSSTCSSSTC 
 








206_WP_125051547.1 Streptomyces rimosus subsp. paromomycinus 732273
 732273 TS=33 
MDANLVLDLDDLSVDQLDILPTAPGSTLESINVGHAMVEIGASNCTSKGSPASCCSCCCC 
 
207_QBP39279.1 Streptomyces sp. 13023 13023 TS=33 
MEQQIELDVLEISDLIAGAGENDDLAQVMAASCTTSSVSTSSSSSSS 
 
208_WP_116513357.1 Streptomyces sp. AcE210 2918363 2918363 TS=33 
MSINDIKNGDDAEKAFDSFDVDELETLEVAQGVALPEMGASSGSIGTSSSSSSTCSAC 
 
209_WP_116513357.1 Streptomyces sp. AcE210 2918608 2918608 TS=33 
MSINDIKNGDDAEKAFDSFDVDELETLEVAQGVALPEMGASSGSIGTSSSSSSTCSAC 
 








211_OKI60309.1 Streptomyces sp. CB00072 835883 835883 TS=33 
MSMAIEAMNADALFDSFDIEELDTMEVADGVALPEMGASTGNTMCCSSSSSSCC 
 
212_WP_100591758.1 Streptomyces sp. CB01635 193600 193600 TS=33 
MSINDIKNGDDAEKAFDSFDVDELETLEVAQGVALPEMGASSGSIGTSSSSSSTCSAC 
 
213_WP_100591758.1 Streptomyces sp. CB01635 193845 193845 TS=33 
MSINDIKNGDDAEKAFDSFDVDELETLEVAQGVALPEMGASSGSIGTSSSSSSTCSAC 
 
214_WP_073913239.1 Streptomyces sp. CB02009 398669 398669 TS=33 
MSIDDIKQGQDADKAFENFDVDELETLEVAQGVALPEMGASSGSIGTSSSSSSTCSAC 
 
215_WP_073913239.1 Streptomyces sp. CB02009 398876 398876 TS=33 
MSIDDIKNGDDAAFDNFDVAELETLEVAQGVALPEMGASSGSIGTSSSSSSTCSAC 
 
216_WP_071279171.1 Streptomyces sp. CC53 37175 37175 TS=33 
MAKSELATLADEILELESETFEISDYSDAVEVVLAGSCSSSSTSTCSSTTSTTSCSA 
 
217_WP_058043695.1 Streptomyces sp. MBT76 2287677 2287677 TS=33 
MAQQAELATLAQEILELESETFEISDYSDASEVVLAGSTSSSSTSTCSSTTSTTSCSA 
 




219_WP_065486866.1 Streptomyces sp. PTY087I2 139070 139070 TS=33 
MAPKTELATLADEILELESETFEISDYSDVAEVVLAGSTSSSSTSTCSATTSTTSCSA 
 
220_WP_153452235.1 Streptomyces sp. RB5 35851 35851 TS=33 
MMDQIKDVDVFEAFDIDELETLEVAQGVALPEMGASSGSIGTSSSSSSTCSAC 
 
221_WP_018515651.1 Streptomyces sp. SID5594 132742 132742 TS=33 
MAPKTELATLADEILELESETFEISDYSDAVEVVLAGSTSSSSTSTCSSTTSTTSCSA 
 
222_WP_149184555.1 Streptomyces sp. TRM49041 37595 37595 TS=33 
MAKTELATLADEILELESETFEISDYSDAVEVVLAGSCSSSSTSTCSSTTSTTSCSA 
 
223_WP_159694946.1 Streptomyces sp. Tu 2975 2049893 2049893 TS=33 
MSIDDIKNNGDDAAKAFESFDVDELETLEVAQGVALPEMGASSGSIGTSSSSSSTCSAC 
 
224_WP_159694946.1 Streptomyces sp. Tu 2975 2050108 2050108 TS=33 
MSINDIKNDDADKAFESFDVDELETLEVAQGVALPEMGASSGSIGTSSSSSSTCSAC 
 










227_APE26458.1 Streptomyces venezuelae 5537821 5537821 TS=33 
MSIDDIKNGDDAAFDNFDVAELETLEVAQGVALPEMGASSGSIGTSSSSSSTCSAC 
 
228_WP_150508245.1 Streptomyces venezuelae 2510362 2510362 TS=33 
MSIDDIKNGDDAAFDNFDVAELETLEVAQGVALPEMGASSGSIGTSSSSSSTCSAC 
 
229_WP_150508245.1 Streptomyces venezuelae 2510569 2510569 TS=33 
MSDDIKQGQDADKAFENFDVDELETLEVAQGVALPEMGASSGSIGTSSSSSSTCSAC 
 
230_PWW57157.1 Streptomyces venezuelae 109058 109058 TS=33 
MSIDDIKNGDDAAFDNFDVAELETLEVAQGVALPEMGASSGSIGTSSSSSSTCSAC 
 
231_PWW57157.1 Streptomyces venezuelae 109265 109265 TS=33 
MSDDIKQGQDADKAFENFDVDELETLEVAQGVALPEMGASSGSIGTSSSSSSTCSAC 
 








234_WP_093656411.1 Streptomyces wuyuanensis 176289 176289 TS=33 
MEQQIELDVLEISDLIAGAGENDDLAQVMAASCTTSSVSTSSSSSSS 
 
235_WP_043471952.1 Streptomyces xinghaiensis 286787 286787 TS=33 
MDAKTELATLANDILELESETFEISDYSDAVEVVLAGSTSSSSTSTCSSTTSTTSCSA 
 
236_WP_084012656.1 Thermobifida halotolerans 79874 79874 TS=33 
MSTQSLGMELMELEAVTFEVDEIADLSDQLAACSSSCSCSSCCSCSTSSCCSTSTSTSSCG 
 
237_WP_084012656.1 Thermobifida halotolerans 80199 80199 TS=33 
MSTQSLGMELMELEAVTFEVDEIADLSDQLAACSSSCSCSSCCSCSTSSCCSTSTSTSSCG 
 



















241_WP_052889351.1 Thermogemmatispora carboxidivorans 2855170
















245_WP_129626314.1 Yimella sp. RIT 621 45714 45714 TS=33 
MNKLNLTAELAELEAETFEIADYADDAEMVLAGCTSSSSTSTCSSTTSTTSCSA 
 
246_WP_129626314.1 Yimella sp. RIT 621 45926 45926 TS=33 
MNKLNLTAELAELEAETFEIADYADDAEMVLAGCTSSSSTSTCSSTTSTTSCTA 
 
247_WP_129626314.1 Yimella sp. RIT 621 46138 46138 TS=33 
MNKLNLTAELAELEAETFEIADYADDAEMVLAGCTSSSSTSTCSSTTSTTSCTA 
 
248_WP_151570259.1 Actinomadura rudentiformis 76613 76613 TS=32 
MAMLEAETFEIHDHVEATEDLLGWTSCDCSTSTGSSTSSTSTSSSTTSCTSTASCA 
 
249_OLO56992.1 Actinomyces oris 389 389 TS=32 
VKYVNNVIDFAAIEISDLVEDAVEGGELPSQVMAASTTTCGCACSSCSSTCS 
 







251_ATE55167.1 Actinosynnema pretiosum 4512414 4512414 TS=32 
MDLTFDESELDLGDLAVTAMRDAVALPETGASTAACSCSSTSCCCCQQPPMPELPQV 
 
252_PET35443.1 Bacillus anthracis 17458 17458 TS=32 
MKEQKELKNEEFELDVEFLDLDEVSAIPETTASSGTSSCSASSTCGSSSCCGSC 
 
253_PET35443.1 Bacillus anthracis 17658 17658 TS=32 
MKEQKELKELKNEEFELDVEFLDLDEVSAIPETTASSGSSGCSASSTCGSSSCCGSC 
 
254_PET35443.1 Bacillus anthracis 17858 17858 TS=32 
MKEQKELKELKNEEFELDVEFLDLDEVSAIPETTASSGTSSCSASSTCGSSSCCGSC 
 
255_PET35443.1 Bacillus anthracis 18058 18058 TS=32 
MKEQKELKELKNEEFELDVEFLDLDEVSAIPETTASSGTSSCSASSTCGSSSCCGSC 
 




257_WP_066417934.1 Bacillus cohnii 4131041 4131041 TS=32 
MEKNLNLELDFEVIELDDVTALPETAASSGSSGDNVYSTCGSSSCCSSCCT 
 
258_WP_062352644.1 Bacillus kwashiorkori 33888 33888 TS=32 
MENALNLDLDFEVIELDDVTALPETAASSGSSGDKVYSTCGSSSCCSSCCT 
 
259_WP_062352644.1 Bacillus kwashiorkori 34098 34098 TS=32 
MENTLNLDLDFEVIELDDVTALPETAASSGSSGDKVYSTCGSSSCCSSCCT 
 
260_WP_113938616.1 Bacillus mycoides 19804 19804 TS=32 
MKNNFEPKKEKLDLEEMLAAANLEIIELDQAEALPSTAASSGSSSGNTCSTCGSSSSSTI 
 
261_WP_113938616.1 Bacillus mycoides 20277 20277 TS=32 
MKNNFEPKKEKLDLEEMLAAANLEIIELDQAEALPSTAASSGSSSGNTCSTCGSSSSSTI 
 















265_WP_071803305.1 Couchioplanes caeruleus 3433567 3433567 TS=32 
MEDLKLDLEDLEVESLAFGGETDADLQSLGMGHGMTEVGASAGCCCCTCSCCCCPCG 
 
266_WP_002518053.1 Cutibacterium acnes 1500 1500 TS=32 
MENETLDLDVMELADIIGSASDQDDMAQVMAASCTTTSVSTSSSSSS 
 
267_WP_115884642.1 Cutibacterium acnes 574732 574732 TS=32 
MENETLDLDVMELADIIGSASDQDDMAQVMAASCTTTSVSTSSSSSS 
 
268_AEH29193.1 Cutibacterium acnes 6609 945694 945694 TS=32 
MENETLDLDVMELADIIGSASDQDDMAQVMAASCTTTSVSTSSSSSS 
 
269_EFT77539.1 Cutibacterium acnes HL030PA1 583847 583847 TS=32 
MENETLDLDVMELADIIGSASDQDDMAQVMAASCTTTSVSTSSSSSS 
 




271_WP_069647476.1 Enterococcus ureasiticus 63661 63661 TS=32 
MDTEIEELDELFGEVELIEIDETITLSETAASSGISSCNSCSCCASTSCCSSSSVSFT 
 
272_WP_154775326.1 Erwinia sp. CPCC 100877 37208 37208 TS=32 
MEQEKELQNLLEELEIETIEMDNIQAIPTAAASSGSGKGTLCGSSSSSTCSSCCS 
 
273_WP_116950971.1 Jiangella sp. KE2-3 80982 80982 TS=32 
VTALTTELLALETATFEVEEISDVAQDAAGWCSSSTSTSSCSSCSTSSCCGCSSCSCSSTS 
 
274_WP_073810225.1 Kitasatospora sp. CB01950 385477 385477 TS=32 
MADTSLASLAQEILNLESETFEISDYSDTSEVMLGSSTSCSSTSTCSSTTSTTSCTA 
 
275_WP_090047425.1 Lechevalieria fradiae 364393 364393 TS=32 
MKDLSFDLDDLELGELAVTSMRDSVALPESGASGAPSSCSCGSSSCSSCTQPQLPPA 
 
276_WP_056374170.1 Microbacterium sp. Leaf161 667587 667587 TS=32 
MSFHVDSSRASSLPTRDRDAVAQASTSCTTTSSSTGTMM 
 
277_WP_089022234.1 Micromonospora coriariae 6769318 6769318 TS=32 
MPITLNDELRELETETFEIEEVEDGGEALAATSSSCSCSSCCSCSTSSCCSTSTSTSSCG 
 


























283_WP_123604194.1 Micromonospora sp. Llam0 5994064 5994064 TS=32 
MENELSTLDIDDLEISEFLDESRLEDSEVVAKVMSASCTTCECSCSCSS 
 




285_WP_026125251.1 Nocardiopsis alba DSM 43377 57923 57923 TS=32 
MNKDIDLSAIEISDLISETEQSDDALSQVMAASCTTTGCACSSSSSST 
 
286_ADO67771.1 Nocardiopsis sp. TFS65-07 14551 14551 TS=32 
MNKDIDLSAIEISDLISETEQSDDALSQVMAASCTTTGCACSSSSSST 
 
287_EGL44723.1 Propionibacterium sp. 434-HC2 10496 10496 TS=32 
MENETLDLDVMELADIIGSASDQDDMAQVMAASCTTTSVSTSSSSSS 
 
288_KOX20424.1 Saccharothrix sp. NRRL B-16348 23605 23605 TS=32 
MDLTFDDSELDLGDLAVTAMRDAVALPETGASAAACSCSSTSCCCCQQPQLPTLPV 
 












291_WP_124728414.1 Staphylospora marina 2497352 2497352 TS=32 
MEIRDLEITGLEVLDLSDAAALPETGASSGSTSCSASSTCGSSSCCASC 
 
292_WP_124728414.1 Staphylospora marina 2497541 2497541 TS=32 
MEIRDLEITGLEVLDLSDAAALPETGASSGSSSCSASSTCGSSSCCGSC 
 




294_WP_129806648.1 Streptomyces albidoflavus 35368 35368 TS=32 
MTPKTELATLADEILELESETFEISDYSDAAEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
295_WP_128826424.1 Streptomyces albidoflavus 137209 137209 TS=32 
MTPKTELATLADEILELESETFEISDYSDAAEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
296_WP_071337239.1 Streptomyces albidoflavus 155064 155064 TS=32 
MTPKTELATLADEILELESETFEISDYSDAAEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
297_WP_010643005.1 Streptomyces albidoflavus 138167 138167 TS=32 
MTPKTELATLADEILELESETFEISDYSDAAEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
298_WP_129809367.1 Streptomyces albidoflavus 143068 143068 TS=32 
MTPKTELATLADEILELESETFEISDYSDAAEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
299_WP_129814060.1 Streptomyces albidoflavus 131410 131410 TS=32 
MTPKTELATLADEILELESETFEISDYSDAAEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
300_WP_040246700.1 Streptomyces albus 1272677 1272677 TS=32 
MEKTPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
301_WP_030578091.1 Streptomyces globisporus subsp. globisporus 151316
 151316 TS=32 
MNSSEELDLNALEISDLIDELGRDNETLSQVMAASCVGTACACSSTSSSS 
 
302_WP_137310449.1 Streptomyces lasalocidi 7721055 7721055 TS=32 
MSVDLKDELSALESATFEIEEMTDESVELAWSSSSCSCSSCCSCSTSSCCSCSSSTS 
 
303_WP_123498760.1 Streptomyces sp. 844.5 4774965 4774965 TS=32 
MENRKSDALATLTQEILELESETFEITDYADASEVMNGTCSSTTSSCCSKVT 
 
304_WP_037796980.1 Streptomyces sp. ADI91-18 1298906 1298906 TS=32 
MEKSPLASLAEEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 





306_WP_100582969.1 Streptomyces sp. CB02120-2 57948 57948 TS=32 
MEKSPLASLAEEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
307_WP_073794041.1 Streptomyces sp. CB03578 172641 172641 TS=32 
MEKSPLASLAEEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
308_WP_087767808.1 Streptomyces sp. CS057 2994390 2994390 TS=32 
MDVDAMFASFDIEELDTLEIADGVALPEMGASYLNAPLCCSSSSSCC 
 
309_WP_075986497.1 Streptomyces sp. FR-008 757852 757852 TS=32 
MTPKTELATLADEILELESETFEISDYSDAAEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
310_WP_159312970.1 Streptomyces sp. GF20 4571275 4571275 TS=32 
MTPKTELATLADEILELESETFEISDYSDAAEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 




312_WP_168542416.1 Streptomyces sp. LD120 108164 108164 TS=32 
MEKTPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
313_WP_073775987.1 Streptomyces sp. MJM1172 56069 56069 TS=32 
MEKSPLASLAEEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
314_WP_069813260.1 Streptomyces sp. TP-A0874 138483 138483 TS=32 
MPTTLKEELHALESATFEIEEMNDSAAVELAWSSSSCSTSSCCSCSTSSCCSTSTSTS 
 
315_OKJ11516.1 Streptomyces sp. TSRI0261 216643 216643 TS=32 
MSMAIEAMNADSLFDSFDIEELDTMEVADGVALPEMGASTGNTMCCSSSSSSCC 
 































322_WP_151570259.1 Actinomadura rudentiformis 73230 73230 TS=31 
MVSKMCVPDSGMMSSSPIPVTASFSVTATTDSSCMGAPHTVSPRCWPHI 
 
323_WP_173391936.1 Actinomadura sp. DSM 109109 20674 20674 TS=31 
MSDMALPDLGDLEIEDLEFSTDQEGGLDALRMGHDVSEVGASCCCSTSSCSCST 
 
324_WP_098207032.1 Bacillus cereus 43346 43346 TS=31 
MNKEIQNQANAIDFLELGDVEVLDVEGSLGMPETGASSAPVSWLCCSSSSSCCS 
 
325_WP_098207032.1 Bacillus cereus 43571 43571 TS=31 
MQNQANAIDFLELGDVEVLDVEGSLGMPETGASSAPVSWLCCSSSSSCCS 
 
326_WP_113938616.1 Bacillus mycoides 19118 19118 TS=31 
MKNKFEPKKEKLDLEEMLAAANLEIIELDQAEALPSTAASSGSSSGNTCSTCGSS 
 
327_WP_119908502.1 Carnobacterium divergens 2438529 2438529 TS=31 
MEKELSTKDFDLEVELLDLDEVSAIPETTASSGSTSCSASSTCGSTSCCGSC 
 
328_WP_119908502.1 Carnobacterium divergens 2438746 2438746 TS=31 
MERELSVNETTTEDFDLEVELLDLDEVSAIPETTASSGSTSCSASSTCGSTSCCGSC 
 
329_WP_135025206.1 Carnobacterium divergens 79190 79190 TS=31 
MEKELSTKDFDLEVELLDLDEVSAIPETTASSGSTSCSASSTCGSTSCCGSC 
 
330_WP_135025206.1 Carnobacterium divergens 79407 79407 TS=31 
MERELSVNETTTEDFDLEVELLDSDEVSAIPETTASSGSTSCSASSTCGSTSCCGSC 
 
331_WP_135081547.1 Carnobacterium divergens 79186 79186 TS=31 
MEKELSTKDFDLEVELLDLDEVSAIPETTASSGSTSCSASSTCGSTSCCGSC 
 










334_WP_123701223.1 Curtobacterium sp. PhB130 874603 874603 TS=31 
MERNSIIDLPDLDFSGLEVLSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSSGSCG 
 
335_WP_132046886.1 Curtobacterium sp. PhB136 310908 310908 TS=31 
MERNSIIDLPDLDFSGLEVLSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSSGSCG 
 
336_KFC17662.1 Cutibacterium acnes HL201PA1 1258 1258 TS=31 
MENETLDLDVMELADIIGSASDQDDMAQVMAASCTTTSVSTSSSSSS 
 
337_GAE70556.1 Cutibacterium acnes JCM 18909 10240 10240 TS=31 
VNRMENETLDLDVMELADIIGSASDQDDMAQVMAASCTTTSVSTSSSSSS 
 
338_ESS85761.1 Cutibacterium acnes P6 10263 10263 TS=31 
MENETLDLDVMELADIIGSASDQDDMAQVMAASCTTTSVSTSSSSSS 
 

















343_WP_154775326.1 Erwinia sp. CPCC 100877 37395 37395 TS=31 
MEQEKELQNLLEELEIETIEMDNIQAIPTAAASSGSGKGTLCGSSSSSTCSSCCG 
 













346_WP_116950971.1 Jiangella sp. KE2-3 80198 80198 TS=31 
MSNETLGLELLELEAVTFEIGEISDPSLEMAATSSSCSCSSCSSCSTSSCCSTSTSTSSCG 
 
347_WP_116950971.1 Jiangella sp. KE2-3 80474 80474 TS=31 
MSNATLGLELLELEAVTFEIDELTDPSVELAATSSSCSCSSCSSCSTSSCCSCSTSTSSCG 
 
348_WP_116950971.1 Jiangella sp. KE2-3 80855 80855 TS=31 
VDADLACGQRISRRRSPCWCSSSSSSTCCRRSSSSRSSSSCTSRRRPARRR 
 




350_WP_056374170.1 Microbacterium sp. Leaf161 678286 678286 TS=31 
MSETMELADIDVMFDEIEIIELDETVTLSETAASSVSSSCNSCSCCASTSCCSVNVFVGL 
 





352_WP_111214312.1 Micromonospora craterilacus 8830 8830 TS=31 
MPELTDELRTLETETFEIEDVDAIDSMVMAWSSSSCSCSSCCSCSTSSCCSSSTSTGCGGG 
 

























358_WP_091639110.1 Micromonospora pallida 640971 640971 TS=31 
MPITLNHELRELETETFEIEEVEDGAEALAATSSSCSCSSCCSCSTSSCCSTSTSTSSCG 
 




360_WP_073835304.1 Micromonospora sp. CB01531 77059 77059 TS=31 
MPELTEELRALETETFEIEDVDAIDAMVMDWSSSSCSCSSCCSCSTSSCCSSSTSTGCGGG 
 












364_WP_046564724.1 Micromonospora sp. HK10 74413 74413 TS=31 
MPELTEELRALETETFEIEDVDAIDAMVMDWSSSSCSCSSCCSCSTSSCCSSSTSTGCGGG 
 




366_WP_148799196.1 Micromonospora sp. MP36 43526 43526 TS=31 
MPELTEELRALETETFEIEDVDAIDAMVMDWSSSSCSCSSCCSCSTSSCCSSSTSTGCGGG 
 
367_WP_165521730.1 Micromonospora zingiberis 473342 473342 TS=31 
MPELSEELRTLETETFEIEDVDAIDAMVMDWSSSSCSCSSCCSCSTSSCCSSSTSTGCGGG 
 
368_WP_165521730.1 Micromonospora zingiberis 474003 474003 TS=31 
MPITLNDELRELETETFEIEEVTDGGETLAASSSSCSCSSCCSCSTSSCCSTSTSTSSCG 
 






370_WP_017606430.1 Nocardiopsis alkaliphila YIM 80379 349 349 TS=31 
MTTKEIPTIELPALDFDDMEVMSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSSGSCG 
 
371_WP_073380611.1 Nocardiopsis flavescens 140959 140959 TS=31 
MQDSPSIELPDLDFSDMEVMSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSSGSCG 
 
372_WP_067608788.1 Nocardiopsis listeri NBRC 13360 4896 4896 TS=31 
MSNTFTSLRHELEQLESETFEVLDFADSPEEMLSGTTSTSSTSCCSSCTSCTSTASSCA 
 
373_WP_017544320.1 Nocardiopsis prasina DSM 43845 325 325 TS=31 
MALQETPTIDLPDLNFDDMEVMSVREAVAVPETGATSGSSSCTSPSCCGSSSCCSSGSCG 
 












377_WP_110052479.1 Nocardiopsis sp. L17-MgMaSL7 30664 30664 TS=31 
MALQETPTIDLPDLNFDDMEVMSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSSGSCG 
 


























383_SEM92144.1 Nonomuraea pusilla 31086 31086 TS=31 
MSVSKGLDFDLANLPMDVFELADSGLGLESLTAGHGLTETGASTSALCSCSVACSSSS 
 
384_WP_165977801.1 Nonomuraea sp. KC712 16169 16169 TS=31 
MDVFDLTDSGLTIESLTAGHGMTENGASTTCVCSSGCSS 
 









387_WP_131104644.1 Ornithinimicrobium sp. HY008 14872 14872 TS=31 
MSAPTLTTTIELPDLDFDGLEVMSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSSGSCG 
 
388_WP_036732400.1 Paenibacillus sp. FSL R7-277 176317 176317 TS=31 
MKDLNKELEALDLELIELDQVEAIPSTAASSGSGSSSTCGSSSCSSCSSSCA 
 
389_WP_036732400.1 Paenibacillus sp. FSL R7-277 176531 176531 TS=31 
MKDLNKELEDLDLELIELEQVEAIPSTAATSGSGSSSTCGSSSCSSCSSSCA 
 
390_WP_036732400.1 Paenibacillus sp. FSL R7-277 176748 176748 TS=31 
MKSFDKELEDLDLELIELDQVEAIPSTAATSGSGSSSTCGSSSCSSCSSSCA 
 
391_WP_160499259.1 Paenibacillus sp. HJL G12 149025 149025 TS=31 
MSQTLNKELNKELENLDLELIELDQAEAIPSTAASSGSGSSSTCGSSSCSSCSSSCA 
 
392_WP_160499259.1 Paenibacillus sp. HJL G12 149253 149253 TS=31 
MSQSLNKELNKDLENLDLELIELDQVEAIPSTAASSGSGSSSTCGSSSCSSCSSSCA 
 
393_WP_160499259.1 Paenibacillus sp. HJL G12 149483 149483 TS=31 
MSNLNKELNKELENLDLELIELDQVEAIPSTAATSGSGSSSTCGSSSCSSCSSSCA 
 
394_WP_036707317.1 Paenibacillus sp. P1XP2 14921 14921 TS=31 
MSDLNMELNKELENLDLELIELDQAEAIPSTAASSGSGSSSTCGSSSCSSCSSSCA 
 














398_WP_143802042.1 Paenibacillus thiaminolyticus 1669713 1669713 TS=31 
MKEEEIRIMLDDLELDQVEIRGLIVEDGKAIPDMGATIGAISCCSCCST 
 
399_WP_143802042.1 Paenibacillus thiaminolyticus 1670089 1670089 TS=31 
LHLDDLELDDVNIIALTQDDAKGLPDMGATMMWVGCCSCCST 
 




401_WP_165968252.1 Saccharopolyspora sp. 7K502 77049 77049 TS=31 
MEDLKLDLESLQVESLAFGADADHDLQSLGMGHGMTEVGASAGCCCCTCSCCCCPCG 
 








404_WP_142043611.1 Stackebrandtia endophytica 4635036 4635036 TS=31 
MSELNDQIALLEAETFEVIDSTPSEDFAGSSSTSSSTSSTTCSCSTSSTCSTSSSSCSSTSSCG 
 
405_WP_124728414.1 Staphylospora marina 2496897 2496897 TS=31 
MDLSDAAALPETGASSGESSCSVASSTCGSSSCCSSCW 
 
406_WP_016397512.1 Streptococcus pneumoniae 14110 14110 TS=31 
MDKQRDLDISFLDDFEFEVIELDDVSVLPETAASSGSSGNNVHSTCGSCSCCSSCCT 
 
407_WP_149561037.1 Streptococcus salivarius 45881 45881 TS=31 
MKNEKNLLEELEIDILELDDVEGIPATAASSGSGGSSTCGSTSCSSCSSSCA 
 
408_WP_149561037.1 Streptococcus salivarius 46089 46089 TS=31 
MKDEKNLLEELEIDILELDDVEGIPATAASSGSGGSSTCGSTSCSSCSSSCA 
 





410_WP_149561037.1 Streptococcus salivarius 46507 46507 TS=31 
MKDEKNLLEELEIDILELDDVEGIPATAASSGSGGSSTCGSTSCSSCSSSCA 
 
411_WP_149561037.1 Streptococcus salivarius 46716 46716 TS=31 
MKDEKNLLEELEIDILELDDVEGIPATAASSGSGGSSTCGSTSCSSCSSSCA 
 
412_WP_149561037.1 Streptococcus salivarius 46925 46925 TS=31 
MKDEKNLLEELEIDILELDDVEGIPATAASSGSGGSSTCGSTSCSSCSSSCA 
 
413_WP_149561037.1 Streptococcus salivarius 47134 47134 TS=31 
MKDEKNLLEELEIDILELDDVEGIPATAASSGSGGSSTCGSTSCSSCSSSCA 
 
















418_WP_044375373.1 Streptomyces badius 4532734 4532734 TS=31 
MTPKTELATLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
419_WP_114931476.1 Streptomyces cavourensis 2845046 2845046 TS=31 
MAPKTELTTLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
420_WP_142229169.1 Streptomyces cavourensis 2850763 2850763 TS=31 
MAPKTELTTLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 











423_WP_030589129.1 Streptomyces globisporus subsp. globisporus 250464
 250464 TS=31 
MTPKTELATLADEIMELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
424_WP_014677376.1 Streptomyces hygroscopicus subsp. jinggangensis TL01
















428_WP_030803226.1 Streptomyces mediolani 118583 118583 TS=31 
MTPKTELATLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 




430_WP_046505522.1 Streptomyces odonnellii 27349 27349 TS=31 
MADKSTLASLADEIMELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 




432_WP_136228001.1 Streptomyces sp. A0592 75269 75269 TS=31 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
433_WP_037796980.1 Streptomyces sp. ADI91-18 1315523 1315523 TS=31 
LDRERTATTRSSSSSRSACRSRSPCWCSSSSSRPRTSCTPARCWWRRPRWRP 
 




















438_WP_053630189.1 Streptomyces sp. MMG1064 92673 92673 TS=31 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
439_WP_045322258.1 Streptomyces sp. NRRL F-4428 39374 39374 TS=31 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 




441_EYU71052.1 Streptomyces sp. PCS3-D2 1213911 1213911 TS=31 
MQKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
442_WP_065486866.1 Streptomyces sp. PTY087I2 138728 138728 TS=31 
MAPKTELATLADEILELESETFEISDYSDVAEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
443_WP_018492813.1 Streptomyces sp. SID8356 164062 164062 TS=31 
MAPKTELTTLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
444_WP_028417601.1 Streptomyces sp. SID8359 376777 376777 TS=31 
MAPKTELTTLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
445_WP_079273369.1 Streptomyces sp. TN58 6865695 6865695 TS=31 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 




447_WP_030899367.1 Streptomyces virginiae 306816 306816 TS=31 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 





449_WP_031152038.1 Streptomyces xanthophaeus 322083 322083 TS=31 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
450_WP_016906219.1 Streptomyces xiaopingdaonensis 6646 6646 TS=31 
MSNVTVDSMDIEQVFDSFDVTELEVLEVSQGVAQPEMGASGGTVGTSSSSSTCSSSTC 
 
451_WP_046775770.1 Streptomyces yangpuensis 205357 205357 TS=31 
MDKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 









454_WP_102658257.1 Verrucosispora sp. ts21 8803 8803 TS=31 
MPELTEELRALETETFEIEDVDAIDAMVMDWSSSSCSCSSCCSCSTSSCCSTSTSTGCGGG 
 








457_WP_124934044.1 Actinomyces bowdenii 1620 1620 TS=30 
MNNVIDFAAIEISDLIEDAVDGGELPSQVMAASTTTSGCACSSCSSTCS 
 
458_WP_126382269.1 Actinomyces howellii 2257 2257 TS=30 
MNTFDIPMDVFELEDSGMDVEPLTAGHGMTEVGASTNCFCYPCCSCSAPSSSSA 
 




460_WP_098481569.1 Bacillus cereus 18661 18661 TS=30 
MQNQANAIDFLELGDVEVLDVEGSLGMPETGASSAPVSWLCCSSSSSCCS 
 







462_WP_000438834.1 Bacillus cereus ATCC 14579 5000697 5000697 TS=30 
MSEIKKALNTLEIEDFDAIEMVDVDAMPENEALEIMGASCTTCVCTCSCCTT 
 
463_WP_000438834.1 Bacillus cereus ATCC 14579 5000901 5000901 TS=30 
MSEIKKALNTLEIEDFDAIEMVDVDAMPENEALEIMGASCTTCVCTCSCCTT 
 
464_WP_000438834.1 Bacillus cereus ATCC 14579 5001105 5001105 TS=30 
MSEIKKALNTLEIEDFDAIEMVDVDAMPENEALEIMGASCTTCVCTCSCCTT 
 
465_WP_000438834.1 Bacillus cereus ATCC 14579 5001309 5001309 TS=30 
MSEIKKALNTLEIEDFDAIEMVDVDAMPENEALEIMGASCTTCVCTCSCCTT 
 
466_WP_159145314.1 Bacillus sp. 9J 1612729 1612729 TS=30 
MTNLKKALNSIEIEELDVTEMVDAEAMSEEDATQIMGASCTTCVCTCSCCTT 
 





468_WP_123701223.1 Curtobacterium sp. PhB130 887874 887874 TS=30 
MSGSMLELPDLDFDGLEVLSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSAGSCG 
 
469_WP_132046886.1 Curtobacterium sp. PhB136 297637 297637 TS=30 
MSGSMLELPDLDFDGLEVLSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSAGSCG 
 




471_WP_049761140.1 Frankia sp. B2 6065 6065 TS=30 
MDDKLFAGFDIEELEVLEVSDSVALPEMGASSGSGILCCSSSSSSSSCC 
 








474_WP_100586424.1 Kitasatospora sp. CB02891 32685 32685 TS=30 
MADTSLASLAQEILNLESETFEISDYSDTSEVMLGSSTSCSSTSTCSSTTSTTSCTA 
 





476_WP_132283874.1 Kribbella sp. VKM Ac-2568 58548 58548 TS=30 
MTDLTTELLSLETATFEVDEIADVGQDAADWCSSSTSTSSCSSCSTSSCCGCSSCSCSSTS 
 




478_WP_093590332.1 Lentzea waywayandensis 1164236 1164236 TS=30 
MKDLSFDPDDLELGDLAVTSLRDSVALPESGASGGASSCSCGSSSCSSCTQPPVQNA 
 




















484_WP_151488655.1 Micromonospora sp. ALFpr18c 19240 19240 TS=30 
MSDSVRGELRDLQTETFEVEDIADLSADHMDICSSSTSTSSCSSCSTSSCCSCTSSSCSSTS 
 
485_WP_073835304.1 Micromonospora sp. CB01531 76798 76798 TS=30 
MPDSVRSELRDLQTETFEVEDIAELSADLMDICSSSTSTSSCSSCSTSSCCSCTSSSCSSTS 
 





487_WP_046564724.1 Micromonospora sp. HK10 74151 74151 TS=30 
MSDSVRSELRDLQTETFEVEDIADLSADLMDICSSSTSTSSCSSCSTSSCCSCTSSSCSSTS 
 













491_WP_067138951.1 Microtetraspora malaysiensis 273569 273569 TS=30 
MSELARELVALETVTFEVEDIPDLGRDAVDWCSSSTSTSSCSSCSTSSCCSCTSSSCGSTS 
 
492_WP_073380611.1 Nocardiopsis flavescens 140484 140484 TS=30 
MPETTALDIDLPELNFDDMEVMSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSGGSCG 
 
493_WP_067608788.1 Nocardiopsis listeri NBRC 13360 5107 5107 TS=30 
MTIGNIQGLRHELEQLESETFEVLDFVDSPEEMLAGTTSTSSTSTCSSCTSCTSCASF 
 
494_WP_150240357.1 Nocardiopsis quinghaiensis 131359 131359 TS=30 
MPHSTAPDIDLPELDFDNMEVMSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSGGSCG 
 
495_WP_077692331.1 Nocardiopsis sinuspersici 175814 175814 TS=30 
MPHSTAPDIDLPELDFDSMEVMSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSGGSCG 
 




497_WP_087097343.1 Nocardiopsis sp. JB363 9019 9019 TS=30 
MNNTFTSLRHELEQLESETFEVLDFADSPEEMLSGTTSTSSTSTCSSCTSCTSTASSCA 
 
498_WP_110052479.1 Nocardiopsis sp. L17-MgMaSL7 30354 30354 TS=30 
MPHSTAPEIDLPELNFDDMEVMSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSGGSCG 
 
499_WP_073704895.1 Nocardiopsis sp. TSRI0078 219136 219136 TS=30 
MPHSTAPDIDLPELDFDNMEVMSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSGGSCG 
 

















503_WP_131104644.1 Ornithinimicrobium sp. HY008 34403 34403 TS=30 
MTLRRTLRVRVISSSSGSSCLCSSTNRWTRIASGRSSLECTISSAMSS 
 












507_WP_158847633.1 Saccharothrix deserti 82460 82460 TS=30 
MDLTFDVEELALDDLAVVAMRDAVALPETGASGGSCSGGSSCCCCPSPQLPD 
 
508_WP_156077241.1 Saccharothrix sp. NRRL B-16314 1639 1639 TS=30 
MDLTFDDSELDLGDLAVTAMRDAVALPETGASAQACSCSSTSCCCCQVPQLPA 
 
509_WP_170184966.1 Saccharothrix texasensis 1633738 1633738 TS=30 
MDLTFDDSELDLGDLAVTAMRDAVALPETGASAAACSCSSTSCCCCQQPQLPTLPTQG 
 




511_WP_124728414.1 Staphylospora marina 2497100 2497100 TS=30 
MDMEIRHLEVTGLEVMELSDAAALPETGASSGITPCTYCSTCGSSSCCASCQ 
 













515_WP_002998788.1 Streptococcus downei MFe28 173531 173531 TS=30 
MKDENKLLEELEIDILELDDVEGAPATAASSGSGGSSTCGSTSCSSCSSSCA 
 




517_WP_115267823.1 Streptococcus hyointestinalis 106414 106414 TS=30 
MKDEKNLLEELEIDILELDDVEGVPATAATSGSGGHSTCGSTSCSSCSSSCA 
 
518_WP_115267823.1 Streptococcus hyointestinalis 106620 106620 TS=30 
MKDEKNLLEELEIDILELDDVEGVPATAATSGSGGHSTCGSTSCSSCSSSCA 
 
519_WP_115267823.1 Streptococcus hyointestinalis 106826 106826 TS=30 
MKDEKNLLEELEIDILELDDVEGVPATAATSGSGGHSTCGSTSCSSCSSSCA 
 
520_WP_138068656.1 Streptococcus porcinus 1302514 1302514 TS=30 
MFDNDINLLDAAIENLDVSEFEVLSNDVLSEANEKTVIGASCTTCVCTCSSCCSA 
 
521_WP_102210137.1 Streptococcus sp. UMB0029 58021 58021 TS=30 
MKDEKKLFEDLEIDILELDDVEGVPATAASSGSGGFSTCGSTSCSSCSSSCA 
 
522_WP_102210137.1 Streptococcus sp. UMB0029 58212 58212 TS=30 
MKDEKKLLEELEIDILELDDVEGVPATAATSGSGGYSTCGSTSCSSCSSSCA 
 
523_WP_070012657.1 Streptomyces abyssalis 130664 130664 TS=30 
MADKSSLDSLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
524_WP_008409260.1 Streptomyces albidoflavus 139180 139180 TS=30 
MTPKTELATLADEILELESETFEISDYSDAAEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 




526_WP_093786373.1 Streptomyces guanduensis 135754 135754 TS=30 
MADISKLDAPLASLAQEILELESETFEITDYSDASEVMLGSSTSCSSTSTCSSTTSTTSCTA 
 
527_WP_055593610.1 Streptomyces hirsutus 11408 11408 TS=30 
MNKDLSTLADEILELEAETFEISDYSDASEVVLAGCTSTSSTSTSSSTCSTTSCSA 
 











530_WP_127152319.1 Streptomyces lydicus 3419629 3419629 TS=30 
LATIWWPLTGSMPSSKSPLGLASSSSAYSTVSSSGARSSGTSARWCPSASFSPRSTYGP 
 
531_WP_004943480.1 Streptomyces mobaraensis NBRC 13819 = DSM 40847 39195




532_WP_023541200.1 Streptomyces niveus 3558 3558 TS=30 
MAPKTGLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
533_WP_070195834.1 Streptomyces oceani 56745 56745 TS=30 
MNDKTQLASLADEILELESETFEISDYSDAAEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
534_WP_055471433.1 Streptomyces pathocidini 10908 10908 TS=30 
MAADLVLDLADLSVDELDILPTSPGASLESINVGHAMVEIGASNCTSTGTPASCCSCCCC 
 
535_WP_028801239.1 Streptomyces sp. 142MFCol3.1 25970 25970 TS=30 
MADSPLASLAQEILDLESETFEITDYSDASEVMLGSSTSCSSTSTCSSTTSTTSCTA 
 
536_WP_084994964.1 Streptomyces sp. 196(2019) 25659 25659 TS=30 
MAPKTELTTLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
537_WP_069628351.1 Streptomyces sp. 4R-3d 204148 204148 TS=30 
MAPKTGLATLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 




539_WP_097215169.1 Streptomyces sp. Ag82_G6-1 922656 922656 TS=30 
MAPKSELASLAQEILELESETFEISDYSDESEVLLAGSTSCSSTSTTSSTTSTTSCSA 
 
540_KOV59016.1 Streptomyces sp. AS58 36004 36004 TS=30 
MADKSTLAALADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
541_AEM00619.1 Streptomyces sp. ATCC 55365 7407 7407 TS=30 
MGNNEEYFIDVNDLSIDVFDVVEQGGAVTALTADHGMPEVGASTNCFCYICCSCSSN 
 






543_WP_073771703.1 Streptomyces sp. CB02366 111651 111651 TS=30 
MAPKTELTTLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 




545_OKJ76123.1 Streptomyces sp. CB02460 145965 145965 TS=30 
MEKNLSTLADEILELEAETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCTA 
 
546_WP_067398575.1 Streptomyces sp. F-3 8965 8965 TS=30 
MNKDLSTLADEILELEAETFEISDYSDASEVVLAGCTSTSSTSTSSSTCSTTSCSA 
 
547_WP_053673516.1 Streptomyces sp. H036 59225 59225 TS=30 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
548_WP_053686323.1 Streptomyces sp. IGB124 14779 14779 TS=30 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
549_WP_129766430.1 Streptomyces sp. L-9-10 233439 233439 TS=30 
MADKSPLASLADEIMELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 




551_WP_063345887.1 Streptomyces sp. MJM8645 100940 100940 TS=30 
MSDHFEDVLALDDLDLGELTVTALRDTVALPETGASGAPSSSSCGSSSCAAPHPPTQTF 
 








554_WP_030822034.1 Streptomyces sp. NRRL S-104 23504 23504 TS=30 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 









557_WP_109378529.1 Streptomyces sp. NWU339 69135 69135 TS=30 
MNKDLSTLADEILELEAETFEISDYSDASEVVLAGCTSTSSTSTSSSTCSTTSCSA 
 
558_SCK09537.1 Streptomyces sp. SceaMP-e96 736171 736171 TS=30 
MEDTEFDFNLEDIPSDVFELADRGLTVESLTSGHGLVENGASSPSCGSSCSSLP 
 
559_WP_161271514.1 Streptomyces sp. SID10115 34892 34892 TS=30 
MSIDTMNSGDVEQIFEGFDIDELEVLEVSQGVALPEMGASGGNSGTSSSSSTCSSCTC 
 
560_WP_164601129.1 Streptomyces sp. SID13031 131471 131471 TS=30 
MTDLTAELLSLETATFEVEEIADVGMDAASWCSSSTSTSSCSSCSTSSCCGCSSCSCSSTS 
 
561_WP_164616055.1 Streptomyces sp. SID14515 41819 41819 TS=30 
MAPKTELATLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
562_WP_093589027.1 Streptomyces sp. SID4917 9688 9688 TS=30 
MADKSTLASLADEIMELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
563_WP_093636282.1 Streptomyces sp. SID4951 736171 736171 TS=30 
MEDTEFDFNLEDIPSDVFELADRGLTVESLTSGHGLVENGASSPSCGSSCSSLP 
 
564_WP_103507787.1 Streptomyces sp. SM13 9436 9436 TS=30 
MAPKTELATLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
565_WP_051265163.1 Streptomyces sp. TAA204 244623 244623 TS=30 
MAEKSSLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
566_WP_028435937.1 Streptomyces sp. TAA486 167189 167189 TS=30 
MAEKSSLDSLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 




568_WP_167933484.1 Streptomyces sp. ventii 2135 2135 TS=30 
MTQKPELATLADEILELESETFEISDYSDTAEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
569_WP_148587905.1 Streptomyces sp. WAC01526 37221 37221 TS=30 
MEDNEFDFNLEDIPSDVFELADRGLTVESLTSGHGLVENGASSPSCGSSCSSLP 
 
570_WP_125815636.1 Streptomyces sp. WAC07149 207544 207544 TS=30 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 






572_WP_053706163.1 Streptomyces sp. XY413 14680 14680 TS=30 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
573_WP_053627034.1 Streptomyces sp. XY593 88182 88182 TS=30 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
574_WP_053679289.1 Streptomyces sp. XY66 14707 14707 TS=30 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
575_WP_053760581.1 Streptomyces sp. ZFG47 1590886 1590886 TS=30 
MADKSTLAALADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
576_WP_069922943.1 Streptomyces subrutilus 6493249 6493249 TS=30 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 




578_APE26458.1 Streptomyces venezuelae 5566907 5566907 TS=30 
MICSAPMSSTPWTSSASSSSPSPAPCWPSARTSTSSASPSSPRSPRWAAVSSVT 
 
579_PWW57157.1 Streptomyces venezuelae 79972 79972 TS=30 
MICSAPMSSTPWTSSASSSSPSPAPCWPSARTSTSSASPSSPRSPRWAAVSSVT 
 
580_WP_150205637.1 Streptomyces venezuelae 336768 336768 TS=30 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 

































588_WP_148872464.1 [Eubacterium] rectale 14082 14082 TS=29 
MEDKKVLDDVFEGIEIVELDETTTLSETAASSGISSCNSCSCCLSTSCCSIHFGA 
 




590_WP_132119980.1 Actinocrispum wychmicini 46786 46786 TS=29 
MKELTFDVEDLRLDDIAVTSMRDAVALPESAASSSCNSCSCGSSSCCCCQQELPPQLA 
 
591_WP_169735453.1 Actinokineospora inagensis DSM 44258 10441 10441 TS=29 
MAPENTPQGLESLDFDFSALEISDFIDESRLEDGETISTVMAASCTSCECCCSTS 
 
592_ABC02780.1 Actinomadura melliaura 11777 11777 TS=29 
VSSNTLLALDDLDIEAIHVVEIPGIADSLAAGHSMPETGASACCSIVCSSCCCSC 
 








595_WP_147680663.1 Actinomyces ruminicola 2150 2150 TS=29 
MDVFELEDGSVDVEPLTAGHGMSEVGASTNCFCYPCCSCSAPSSSSSSSA 
 
596_WP_044856426.1 Amycolatopsis orientalis 4923074 4923074 TS=29 
MNLNLDDLNLDELDVTSLRDTVALPETAASSSNNGSGTNTGSCTDPA 
 






598_WP_002151253.1 Bacillus cereus HuA4-10 37518 37518 TS=29 
MRNNKDVNDNLLDELDIEILELDDVESIPSSAATSGSGGSSTCGSSSCSSCSSSCA 
 
599_WP_142325983.1 Bacillus thuringiensis 47413 47413 TS=29 
MRNNKDVNDNLLDELDIEILELDDVESIPSSAATSGSGGSSTCGSSSCSSCSSSCA 
 
600_WP_142325983.1 Bacillus thuringiensis 47608 47608 TS=29 
MLDNKESKLNLVDELDIEILELDDVESIPSSAASSGSGGSSTCGSSSCSSCSSSCA 
 
601_WP_104129685.1 Cryobacterium sp. N21 28794 28794 TS=29 
MADSIKGLPIDVFELMDEGLNVNSLTAGHGMDEVGASTNCFCYPCCSCSAPSSSA 
 
602_PZA02665.1 Cutibacterium acnes 1906450 1906450 TS=29 
MENETLDLDVMELADIIGSASDQDDMAQVMAASCTTTSVSTSSSSSS 
 
603_KPG63735.1 Cutibacterium acnes 10289 10289 TS=29 
VNRMENETLDLDVMELADIIGSASDQDDMAQVMAASCTTTSVSTSSSSSS 
 
604_KPG65283.1 Cutibacterium acnes 1271 1271 TS=29 
VNRMENETLDLDVMELADIIGSASDQDDMAQVMAASCTTTSVSTSSSSSS 
 
















609_WP_148872464.1 Eubacterium rectale 14082 14082 TS=29 
MEDKKVLDDVFEGIEIVELDETTTLSETAASSGISSCNSCSCCLSTSCCSIHFGA 
 
610_ABD13543.1 Frankia casuarinae 5019309 5019309 TS=29 
MPEPDDAPISGSATLSETSSTSSSSMSKPANSLSSMGFSLARALIVLSFIMDCVSL 
 











613_WP_058858331.1 Kocuria flava 1670162 1670162 TS=29 
MDRTPHDIVDLPMDVFELEDQGMDVTSLTAGHGMTEVGASTNCFCYPCCSCSAPSSSA 
 
614_WP_077018665.1 Kribbella sp. ALI-6-A 1658851 1658851 TS=29 
MALREELLVLETATFEIEDIIDLGQDAAGWCSSSCSCSSCSSCSTSSCCSTSTSTGCGGG 
 
615_WP_077018665.1 Kribbella sp. ALI-6-A 1659152 1659152 TS=29 
MSTQSLGLELLDLEAVTFEVDEITDPSLDLAATSSSCSCSSCCSCSTSSCCSTSTSTSSCG 
 




617_WP_132283874.1 Kribbella sp. VKM Ac-2568 59106 59106 TS=29 
MSTQTLGLELLDLEAATFEVDEITDPSLDLAATSSSCSCSSCCSCSTSSCCSTSTSTSSCG 
 








620_WP_111214312.1 Micromonospora craterilacus 9492 9492 TS=29 
MLITLNDELRELETETFEIEDVEDGAEALAATSSSCSCSSCCSCSTSSCCSCSTSCSSCG 
 




622_WP_151488655.1 Micromonospora sp. ALFpr18c 18831 18831 TS=29 
MPITLNDELRELETETFEIEEVEDGGEALAATSSSCSCSSCCSCSTSSCCSTSTSTSSCG 
 
623_WP_073835304.1 Micromonospora sp. CB01531 76394 76394 TS=29 
MPITLNDELRELETETFEIEEVEDGGEALAATSSSCSCSSCCSCSTSSCCSTSTSTSSCG 
 







625_WP_148799196.1 Micromonospora sp. MP36 42859 42859 TS=29 
MPITLNDELRELETETFEIEEVEDGGEALAATSSSCSCSSCCSCSTSSCCSTSTSTSSCG 
 
626_WP_171023219.1 Micromonosporaceae bacterium KJ-029 73326 73326 TS=29 
MPITLNDELRELETETFEIEEIEDGAEALAATSSSCSCSSCCSCSTSSCCSCSTSCSSCG 
 




628_WP_067138951.1 Microtetraspora malaysiensis 274022 274022 TS=29 
MSKTLGLELLELEAATFEVVDNIDPSMDMAATSSSCSCSSCCSCSTSSCCSTSTSTSSCG 
 
















633_WP_017590583.1 Nocardiopsis ganjiahuensis DSM 45031 5569 5569 TS=29 
MAIQESPTIELPDLNFDDMEVMSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSSGSCG 
 
634_WP_165977801.1 Nonomuraea sp. KC712 16774 16774 TS=29 
MDVFDLADSGLTVESLTAGHGMAENGASWLCSCVCSSSASSS 
 
635_WP_077720345.1 Novibacillus thermophilus 2607694 2607694 TS=29 
MSDLKHSLNELEIEELDVSEMMDSDSLSEQEATQVMGASCTTCVCTCSCCTT 
 
636_WP_111153483.1 Paenibacillus dendritiformis 362 362 TS=29 
MDLKEEEIRIMLDDLELDQVEIRGLIVEDGKAIPDMGATIGAISCCSCCST 
 
637_WP_163743638.1 Phytoactinopolyspora halotolerans 30486 30486 TS=29 
MALHEELLDLETTTFEVEEITDLGQDAAGWCSSSCSCSSCSSCSTSSCCSTSTSTGCGGG 
 









640_WP_106620269.1 Saccharothrix carnea 30430 30430 TS=29 
MDLTFDDSELDLGDLAVTAMRDAVALPETGASAAACSCSGTSCCCCQQPQLPTTLG 
 
641_WP_106620217.1 Saccharothrix carnea 54473 54473 TS=29 
MELSFEVDDLVVDDLSVTVMRDAVALPEAGASGGSCCGGSSCCCCPNPM 
 
642_WP_106620217.1 Saccharothrix carnea 54659 54659 TS=29 
MELNFEVDDLVLDDLSVTAMRDAVALPEAGASGGSCSGGSSCCCSVQPPDPTF 
 
643_WP_015102784.1 Saccharothrix espanaensis DSM 44229 6068085
 6068085 TS=29 
MDNDHVLLDLSDLDVETLDFASNTAGLESLRMGHGLTEVGASCCCSTSACSCST 
 
644_WP_170231938.1 Saccharothrix saharensis 1279763 1279763 TS=29 
MDLTFDDSELDLGDLAVTAMRDAVALPETGASAAACSCSGTSCCCCQQPELPAQG 
 
645_WP_123741114.1 Saccharothrix texasensis 99953 99953 TS=29 
MNEFDLTFDAEDLVLDDLAVTTMRDTVALPESGASIGASCGSSCCCQPQLPQPTF 
 








648_WP_114033190.1 Sphaerisporangium album 138817 138817 TS=29 
MSKTLGLELMELEAATFEVVDNVDPSMDMAATSSSCSCSSCCSCSTSSCCSTSTSTSSCG 
 
649_WP_114033190.1 Sphaerisporangium album 139043 139043 TS=29 
MALSQELLALETATFEIADISDLGQDAAGWCSSSCSCSSCSSCSTSSCCSCSTSTGCGGG 
 











652_WP_143935226.1 Streptococcus dysgalactiae subsp. equisimilis 126151
 126151 TS=29 
MDKQRDLDISFLDDFEFEVIELDDVSVLPETAASSGSSGDNVYSTCGSCSCCSSCCT 
 
653_WP_111692612.1 Streptococcus equi subsp. zooepidemicus 1476993
 1476993 TS=29 
MDKQRDLDISFLDDFDFEVIELDDVSVLPETAASSGSSGDNVFSTCGSCSCCSSCCT 
 
654_WP_061411505.1 Streptococcus gordonii 246488 246488 TS=29 
MKHLDEEQVAALEEISQLDLSILDLDESDLVSSAAASSGSSSCKVTSTCGSSSCCA 
 












658_WP_121798699.1 Streptomyces griseocarneus 133441 133441 TS=29 
MNNEDYFVDVSDLSIDVFEVVEQGGAVTALTADHGMPEVGSSTNCFCYICCSCSSN 
 
659_WP_055552665.1 Streptomyces kanamyceticus 2636 2636 TS=29 
MSIDTMNSGDVEQIFEGFDIDELEVLEVSQGVALPEMGASGGNSGTSSSSSTCSSCTC 
 




661_WP_097239702.1 Streptomyces sp. 1331.2 7559497 7559497 TS=29 
MLALDGLDLGELTVTALRDTVALPETGASGAPSSSSCGSSSCATPYPPVYPY 
 
662_WP_030086229.1 Streptomyces sp. B226SN101 35539 35539 TS=29 
MAPKTELATLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 










665_WP_073863645.1 Streptomyces sp. CB01249 727012 727012 TS=29 
MSGSPRSSLLGGSSSVRTGSGPGAGAVPCSSTGTLSCPSVAVSLPDAFSVT 
 
666_WP_100591758.1 Streptomyces sp. CB01635 171674 171674 TS=29 
VRSTRPRAASTGRRRPCSSSSETASSGVKASSAPRSSVSSPAAR 
 
667_OKJ76123.1 Streptomyces sp. CB02460 139559 139559 TS=29 
MSGSPGGSLRGGSSSRTGSGPGAGAVPCSSTGTLSCPSVAVSLPDALSVT 
 












671_WP_172629511.1 Streptomyces sp. NL15-2K 57954 57954 TS=29 
MGNNEEYFVEIDDLSIDVFDVVEQGGAVTALTADHGMPEVGASTNCFCYICCSCSSN 
 
672_WP_164601129.1 Streptomyces sp. SID13031 131687 131687 TS=29 
VITMALCEELLVLETATFEVEDISDLGQDALGWCSSSCACSSCTSCSTSGCCSSSTSTSSS 
 
673_WP_164601129.1 Streptomyces sp. SID13031 130908 130908 TS=29 
MSTQSLGLELLDLEAVTFEVDEITDPSLDLAATSSSCSCSSCCSCSTSSCCSTSTSTSSCG 
 
674_OKJ88320.1 Streptomyces sp. TSRI0107 18161 18161 TS=29 
MSDTSSTPGLDLADLDLGDLTVTSMRDTVALPEGGASNGASSCSCSSSSCAQPQLPVPL 
 
675_WP_125823540.1 Streptomyces sp. W1SF4 6944096 6944096 TS=29 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 
676_WP_125595288.1 Streptomyces sp. WAC07061 6957 6957 TS=29 
MEKSPLASLADEILELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 















680_WP_102658257.1 Verrucosispora sp. ts21 9466 9466 TS=29 
MPITLHDELRELETETFEIEEVADGEEMLAATSSSCSCSSCCSCSTSSCCSTSTSTSSCG 
 









683_WP_037311645.1 Amycolatopsis orientalis DSM 40040 = KCTC 9412 45509
 45509 TS=28 
MNLNLDDLNLDELDVTSLRDTVALPETAASSGTNSGSCGNTGSCTDPV 
 
684_WP_173027111.1 Arthrobacter sp. NEB 688 728099 728099 TS=28 
VRCSAGSPGPGRSTASRPPSTSSAAASSACCARSSCRWSSSRSSSASPGCAR 
 
685_WP_098223293.1 Bacillus thuringiensis 36167 36167 TS=28 
MLDNKESKLNLVDELDIEILELDDVESIPSSAASSGSGGSSTCGSSSCSSCSSSCA 
 
686_WP_098223293.1 Bacillus thuringiensis 36362 36362 TS=28 
MRNNKDVNDNLLDELDIEILELDDVESIPSSAATSGSGGSSTCGSSSCSSCSSSCA 
 












































696_ALS37682.1 Enterococcus rotai 2405418 2405418 TS=28 
MEVLNSQVELNDLDEMFGEVELIEIDETITLSETAASSGLSSCDSCSCCLSTSCCALT 
 
697_WP_069647476.1 Enterococcus ureasiticus 63443 63443 TS=28 
MEELDELFGEVELIEIDETITLSETAASSGISSCNSCSCCASTSCCSNSSISIT 
 
698_KFB02771.1 Frankia sp. Allo2 3422 3422 TS=28 
MSALASEKPMDDKLFAGFDIEELEVLEVSDSVALPEMGASSGSGILCCSSSSSSSSSCC 
 














702_WP_089952438.1 Lechevalieria xinjiangensis 164750 164750 TS=28 
MKDLSFDLDDLELGDLAVTTMRDSVALPESGASGAPSSCSCGSSSCSSCHQPQLPTLPA 
 
703_WP_030478671.1 Lentzea albidocapillata 513449 513449 TS=28 
MKDLSFDPDDLELGDLAVTSLRDSVALPESGASGGASSCSCGSSSCSSCTQPPQLPAQNA 
 
704_WP_090064780.1 Lentzea flaviverrucosa 148747 148747 TS=28 
MKDLSFDPDDLELGDLAVTSLRDSVALPESGASGGASSCSCGSSSCSSCTQPPVQNA 
 
705_WP_090003615.1 Lentzea violacea 56214 56214 TS=28 
MKDLSFDPDDLELGDLAVTSLRDSVALPESGASGGASSCSCGSSSCSSCTQPPVQTA 
 




707_WP_115858067.1 Lysobacter sp. zong2l5 1283977 1283977 TS=28 
LPMRWLRRTMSAAARKPSPRGTTMSTTPMRCSSSTGYTRASSIIRSACTGVTRRVRKV 
 









710_WP_132401450.1 Micromonospora sp. KC207 12669 12669 TS=28 
MATGNAPQTTAPDSLESMDFDFSSLEISDFIDESRLEDGETISNVMAASCTSCECCCSTS 
 


























717_WP_042284370.1 Nocardiopsis alba 2300103 2300103 TS=28 
MPHSTAPAIDLPELDFDDMEVMSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSGGSCG 
 








720_WP_017590583.1 Nocardiopsis ganjiahuensis DSM 45031 5191 5191 TS=28 
MPHSTAPEIDLPELNFDDMEVMSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSGGSCG 
 








723_WP_159944718.1 Nocardiopsis sp. FR26 46370 46370 TS=28 
LALPASMSLRTFSGVGPCSSMVRTSSAPSWRRCQLVCSRVLSSSCTAESSS 
 





































732_WP_165968252.1 Saccharopolyspora sp. 7K502 72327 72327 TS=28 
LIGGSGRAPGRSSLTPGTSVGSPLGGASVRCSSSAVCCCAGQGRVA 
 




734_WP_147133977.1 Stackebrandtia albiflava 992768 992768 TS=28 
MNSLIKDIAELEAQTFEIVDVAELSQDEALTWSSCSTSSCCGTTSTSCGSTSSCA 
 




736_WP_019777477.1 Streptococcus sobrinus 491401 491401 TS=28 
MVSLTENEQNTLDELTQLDLTVLDLDESELVSAAAASSGSSSSCSISTCGSSSCCA 
 
737_WP_002963036.1 Streptococcus sobrinus 510977 510977 TS=28 
MVSLTENEQNTLDELTQLDLTVLDLDESELVSAAAASSGSSSSCSISTCGSSSCCA 
 











740_WP_061921828.1 Streptomyces bungoensis 42185 42185 TS=28 
MGNNEEYFVDVNDLSIDVFDVVEQGGAVTALTADHGMPEVGASTNCFCYICCSCSSN 
 
741_WP_043497397.1 Streptomyces glaucescens 163923 163923 TS=28 
MSDTGVTPDLDLADLDLGDLTVTSMRDTVALPEGGASNGASSCSCSSSSCAQPQLPVPL 
 




743_WP_014677376.1 Streptomyces hygroscopicus subsp. jinggangensis TL01
 9769932 9769932 TS=28 
MSPPEPASGSSPRPGVCCTRPSSTTPWPPQALTHTSGTRSTTGCS 
 
744_WP_052713429.1 Streptomyces katrae 9723 9723 TS=28 
MDNLTAEDFASFELEDLEILDVVDGVALPEMGASNLGSWLCCSSSSSGSSCC 
 
745_WP_052713429.1 Streptomyces katrae 10006 10006 TS=28 
MDKNLGTEDFASFELEEIEVLDVAEGAALPEVGASSGGWLCCSSSSSSSCC 
 
746_WP_127149161.1 Streptomyces lydicus 8083624 8083624 TS=28 
MEDTEFDFNLEDIPSDVFELADRGLTVESLTSGHGLVENGASSPSCGSSCSSLP 
 
747_WP_125051547.1 Streptomyces rimosus subsp. paromomycinus 759211
 759211 TS=28 
VSTGTATAPALAMPRSTVTSSAVRGSSTATRSPGPTPCACRWCAYWLARASSSR 
 
748_WP_121176943.1 Streptomyces sp. 1114.5 5179019 5179019 TS=28 
MLALDGLDLGELTVTALRDTVALPETGASGAPSSSSCGSSSCATPYPPVYPY 
 




750_WP_123498760.1 Streptomyces sp. 844.5 4774758 4774758 TS=28 
MSKNTTDSIATLNQEILELESETFEITDYADASEVLNGSTCSSTTSSCCAGAKK 
 
751_WP_123502812.1 Streptomyces sp. 844.5 400664 400664 TS=28 
MNDNNALASLTQEILELESDTFEITDYADAAEVLNGTCSSTCSSCCSKLN 
 





753_WP_099879114.1 Streptomyces sp. CNZ279 1461704 1461704 TS=28 
VLAMTCGGSSISSISKVSASSASSSSTSMCQLPCQIRELRGHPPLW 
 




755_QCW77982.1 Streptomyces sp. S6 2932986 2932986 TS=28 
MAPKTELTTLADEILELESETFEISDYSDAVEVVLAGSTSSSSTSTCSSTTSTTSCSA 
 





757_WP_093847691.1 Streptomyces sp. SID4934 8603 8603 TS=28 
MTPKTELATLADEILELESETFEISDYSDAAEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 































765_WP_030891366.1 Streptomyces varsoviensis 24450 24450 TS=28 
VRRPGATRAICTSPGVCCAPTPSCAATACCRSSPPSSAR 
 












769_GES11969.1 Acrocarpospora macrocephala 12277 12277 TS=27 
MINPRIELAALEIETFEIAEIADLDSAFASAEMPVDSSFSCSVPTWCSTSSSCSIVTSCGPGS 
 




771_WP_146884718.1 Deinococcus cellulosilyticus NBRC 106333 = KACC 11606
 109305 109305 TS=27 
VAMICPVFLAGQWAFTPRSRTFLTTTGSSSSKSSCSMTVR 
 























777_WP_082267664.1 Lactobacillus sakei 18926 18926 TS=27 
VRVVEELNKAQQESLETLNDLDLSLLDLDESDLVSSAAASSGSSSCKVTSTCGSSSCCA 
 
778_WP_109636348.1 Lechevalieria deserti 560338 560338 TS=27 
MKDLSFDLDDLELGDLAVTSMRDSVALPESGASGGPSSCSCSSGSCSSCHQPQLPALTA 
 
779_WP_167748232.1 Microbispora bryophytorum 311868 311868 TS=27 
MSNESLKLDLRGLDVDSIDVLSADSIVAEGHGAVETGASSAAGYCSSYLSATSCWAPEA 
 
780_WP_169947016.1 Microbispora sp. H11081 907547 907547 TS=27 
MSNDSLKLDLRGLDVDSIDVLSADSIVAEGHGAVETGASSAAGYCSSYLSATSCWTPEA 
 








783_WP_117665680.1 Micromonospora sp. MW-13 4312 4312 TS=27 
MENELLTLDIDDLEISEFLDESRLEDSDVVAKVMSASCTTCECSCSCSS 
 
784_WP_157320809.1 Nesterenkonia alkaliphila 53342 53342 TS=27 
MERTDNFDLPMDVFELEDQGMDVKSLTAGHGMTEVGASTNCFCYPCCSCSAPSSSA 
 
785_WP_147287926.1 Nocardia pseudobrasiliensis 196295 196295 TS=27 
MSAQGKDPNEIRRRFEELPMEVFQLDGSGLPIESLTDGHGMTEVGASCTSCVCICSCCT 
 
786_WP_123201682.1 Nocardiopsaceae bacterium YIM 96095 51969 51969 TS=27 
MPEKFNLELDDLQVDGLELPTGDGASLETMTTGQGLTEMGASDCGCWCCSCC 
 





788_AFR06332.1 Nocardiopsis alba ATCC BAA-2165 2818836 2818836 TS=27 
MNHEIDLSAIEISDLVHEVEQGEDAFSQVMAASCVGTACTCSSTSSST 
 
789_WP_026125251.1 Nocardiopsis alba DSM 43377 45865 45865 TS=27 
MNHEIDLSAIEISDLVHEVEQGEDTFSQVMAASCVGTACTCSSTSSST 
 






791_ADO67771.1 Nocardiopsis sp. TFS65-07 26609 26609 TS=27 
MNHEIDLSAIEISDLVHEVEQGEDTFSQVMAASCVGTACTCSSTSSST 
 




793_ACS83784.1 Nonomuraea sp. Bp3714-39 4826 4826 TS=27 
MDLSDLPMDVFELADDGVAVESLTAGHGMTEVGASCNCFCYICCSCSSA 
 
794_WP_131104644.1 Ornithinimicrobium sp. HY008 34745 34745 TS=27 
VRTSLARSITTRCPSSSRYPASPVCSHPCSSTAFAVSSGWRW 
 
795_WP_125229216.1 Pseudopropionibacterium propionicum 4472 4472 TS=27 
MSDDTVASNLQEIEAETFEIQDVSDADLLLAPSSCTSTASTSCCSTTSCALCSCMNPWK 
 
796_WP_132489383.1 Saccharopolyspora sp. 7K502 59770 59770 TS=27 
VIELHNGPRSMAGMSPASSARSRSNSSARLPMSSQCSSTQSRHLASRSCAKPGWG 
 









799_KOX21547.1 Saccharothrix sp. NRRL B-16348 44815 44815 TS=27 
MPDIAFDARELHLDDLSVTAMRDAVALPEAGASGASCSCNSSCCCQQEPIPTFG 
 








802_WP_125367351.1 Streptococcus gordonii 251954 251954 TS=27 
MKHLDKEQAAALEEISQLDLSILDLDESDLVSSAAASSGSSSCKVTSTCGSSSCCA 
 







804_WP_125375864.1 Streptococcus gordonii 252100 252100 TS=27 
MKHLDKEQAAALEEISQLDLSILDLDESDLVSSAAASSGSSSCKVTSTCGSSSCCA 
 
805_WP_071519546.1 Streptococcus parauberis 415936 415936 TS=27 
MKHLDKEQAAALEEISQLDLSILDLDESDLVSSAAASSGSSSCKVTSTCGSSSCCA 
 
806_KWT63928.1 Streptomyces albus subsp. albus 203921 203921 TS=27 
VSSCPGPGGRRTRWCPGSGTPSSRAWPGGGTSCSSSPTPCCARKDRSSPRST 
 
















811_WP_121025185.1 Streptomyces sp. 3212.4 6074033 6074033 TS=27 
MPDHREDLLAFEDLDLGELTVTALRDTVALPETGASGGASSCSCGSSSCAVPRLPDLPY 
 




813_WP_116150976.1 Streptomyces sp. 3212.5 6077626 6077626 TS=27 
MPDHREDLLAFEDLDLGELTVTALRDTVALPETGASGGASSCSCGSSSCAVPRLPDLPY 
 




815_WP_168093022.1 Streptomyces sp. AA8 7248 7248 TS=27 
MAQQAELATLAQEILELESETFEISDYSDASEVVLAGSTSSSSTSTCSSTTSTTSCSA 
 











818_WP_089510236.1 Streptomyces sp. NBS 14/10 294273 294273 TS=27 
MENTSLLDLEQLGDEMFEVVESDTTEDNGGAGSAWAYACCHSASSSCALS 
 
819_ADZ45316.1 Streptomyces sp. NRRL 30471 3283 3283 TS=27 
MEETEFDFDLEDIPSDVFELADRGLTVESLTSGHGLVENGASSPSCGSSCSSLP 
 
820_WP_111002325.1 Streptomyces sp. NTH33 17387 17387 TS=27 
VEQEQQLLVEQLLLDQASSTSAGSVISSISNVALSRESSSSFSSMGISNPPFV 
 





822_KIF07648.1 Streptomyces sp. RSD-27 20670 20670 TS=27 
MDQNLGTEDFASFELEEVEVLDVADGVALPEVGASSGGWLCCSSSSSSSCC 
 































830_WP_108074040.1 Vitiosangium sp. GDMCC 1.1324 85769 85769 TS=27 
LSARSFVRVKMSAVSSSCANNVSSSADFSSGFTTYSRCSARSAGVPLRVTSTRTGR 
 
831_WP_155357449.1 Acrocarpospora macrocephala 16260 16260 TS=26 
MSKIRNELAALESEVFEIDEIPDLMEALASAEMPIASSTDGLSCTSTNSCTSSASTNSCCSG 
 
832_WP_124934044.1 Actinomyces bowdenii 27770 27770 TS=26 
VSAPRRAASASSSRPTSTSWATAPCPCTTTSRSPSSCTRR 
 












836_PZA02665.1 Cutibacterium acnes 1906061 1906061 TS=26 
MMEFSDMIGDATERDDVTQMMAASCVETSVSSSSTSSS 
 




























843_WP_082267664.1 Lactobacillus sakei 18733 18733 TS=26 
LHELLPLLAAAEETKSDSSRSKSDKSKSFNVSKDSCCALFNSSTTLTSNY 
 
844_WP_090064780.1 Lentzea flaviverrucosa 130060 130060 TS=26 
VPGVSASCCHRVGVTASPPSSTSAGLCSAPSSPSATSCCA 
 








847_SCL44848.1 Micromonospora citrea 448174 448174 TS=26 
MAASAGRGRAARAGCRRTTTSCTACGSSMAATRWATTSCGASSAPASPRRPPWPY 
 








850_WP_049566838.1 Nocardiopsis sp. SBT366 102666 102666 TS=26 
MPHSTAPEIDLPELNFDDMEVMSVREAVAVPETGATSGSSSCTSTSCCGSSSCCSGGSCG 
 
851_AQZ61457.1 Nonomuraea sp. ATCC 55076 1833806 1833806 TS=26 
MSAENLKLDLRGLEIDSIDVVSADSIVAEGHGTIETGASSSPGYCSSYLTAMSCWAPEL 
 
852_WP_168006649.1 Nonomuraea sp. FMUSA5-5 110856 110856 TS=26 
MSAENLKLDLRGLEIDSIDVVSADSIVAEGHGTIETGASSSPGYCSSYLTAMSCWAPEL 
 







854_WP_084779544.1 Planobispora rosea 800510 800510 TS=26 
MNLNDLPMDVFEMADSGMEVESLTAGHGMPEVGASCNCVCGFCCSCSPSA 
 
855_PZS18042.1 Pseudonocardiales bacterium 12032 12032 TS=26 
MIDQAIDLGFDLGDLDLTAVSVTVMTDAAALPETGASSGSSSCDSHSTCGSSSCCILL 
 
856_WP_158847633.1 Saccharothrix deserti 82727 82727 TS=26 
MYELSFEVEDLVLDDLAVTAMRDGVALPETGASNSCSCGSCCCCQQDPGLPPAMG 
 












860_WP_050956578.1 Staphylococcus aureus 26219 26219 TS=26 
MSEFNTDVLDNIDLDSLELASEEISEKEEKEIMGASCTTCVCTCSCCTT 
 




862_WP_034090612.1 Streptacidiphilus albus 53454 53454 TS=26 
VTRASTCGRSAVTTPSRTTTSTTPASTTPATARGSTSARPTATGASTAAACRTPPTTT 
 
863_WP_086573078.1 Streptomyces alboverticillatus 20236 20236 TS=26 
MSDTTGALGFELEDLDLGELTVTSMRDTIALPEGGASNGGSSCSCGSSSCATPQLPHLPQ 
 




865_GFE19186.1 Streptomyces glebosus 8044601 8044601 TS=26 
MEDTEFDFDLADIPSDVFELADRGLTVESLTSGHGLVENGTSSPSCGSSCSSLP 
 
















869_GFE29173.1 Streptomyces libani subsp. rufus 1575119 1575119 TS=26 
MEDTEFDFDLADIPSDVFELADRGLTVESLTSGHGLVENGTSSPSCGSSCSSLP 
 
870_WP_066952401.1 Streptomyces lushanensis 8147 8147 TS=26 
MADKSILASLADEIMELESETFEISDYSDASEVVLAGSTSCSSTSTCSSTTSTTSCSA 
 












874_WP_085923094.1 Streptomyces platensis 492510 492510 TS=26 
MEDTDFDFDLADIPSDVFELADRGLTVESLTSGHGLVENGTSSPSCGSSCSSLP 
 








































884_WP_147972293.1 Streptomyces sp. col6 132914 132914 TS=26 
MEDLGDLEFNLDDIPADVFELADSGLTVESLTSGHGLAENGASAPSCGSSCSSLP 
 





























891_WP_093858544.1 Streptomyces sp. TLI_053 813766 813766 TS=26 
MSDMSSDFGLDLQDLDLSELTVTALRDTVALPENGASHGSCSCQASSSCVQPNLSATELI 
 




893_WP_125650645.1 Streptomyces sp. WAC06614 8636 8636 TS=26 
MANTTAVADFDQLFTSFDIEELEVLDVADGVALPEMGASSGNALCCSSSSSSSSSCC 
 
894_WP_125600994.1 Streptomyces sp. WAC07061 10731 10731 TS=26 
MANTTAVADFDQLFTSFDIEELEVLDVADGVALPEMGASSGNALCCSSSSSSSSSCC 
 
















899_WP_091295323.1 Amycolatopsis xylanica 91349 91349 TS=25 
MSDFELDSLDLGELTVTSLRDTVALPETGASWGSCSCQGSSSCSQQPVEQ 
 
900_WP_119908502.1 Carnobacterium divergens 2418348 2418348 TS=25 
VRISLRSSVENVCSCSSNSTSNSSCTLSCPPTVTKALIL 
 
901_WP_135025206.1 Carnobacterium divergens 59010 59010 TS=25 
VRISLRSSVENVCSCSSNSTSNSSCTLSCPPTVTKALIL 
 
































909_WP_156858452.1 Klebsiella pneumoniae subsp. pneumoniae 20582 20582 TS=25 
MNLNDLPMDVFEMADSGMEVESLTAGHGMPEVGASCNCVCGFCCSCSPSA 
 

























915_WP_172686362.1 Macrococcus caseolyticus 13329 13329 TS=25 
MSEFQTNNIEGLDVTDLEFISEEVTEKDEKEIMGASCTTCVCTCSCCTT 
 




917_WP_169982732.1 Microbispora sp. H10836 280451 280451 TS=25 
MSNDSLKLDLRGLDVDSIDVLSADSIVAEGHGAVETGASSAAGYCSSYLSATSCWTPEA 
 








920_WP_017607927.1 Nocardiopsis xinjiangensis YIM 90004 92550 92550 TS=25 
MSEESTDFNLDDIPADVFELSDKGLTVESLTSGHGLVENGASSPSCGCSCSSLP 
 
921_SEL93819.1 Nonomuraea pusilla 101434 101434 TS=25 
MESKLDLSDLPMDVFEMADSGMEVESLTAGHGMPEVGASCNCVCGFCCSCSPSA 
 
922_WP_166427735.1 Nonomuraea sp. 6K102 963 963 TS=25 
MSENLKLDLRGLDVDSIDVVSADSIVAEGHGTVETGASSSPGYCSSYLTAMSCWAPEV 
 




924_WP_111178107.1 Nonomuraea sp. KC333 40836 40836 TS=25 
MDLNDLPMDVFEMADSGMEVESLTAGHGMPEVGASCNCVCGFCCSCSPSA 
 
925_WP_165977389.1 Nonomuraea sp. KC712 49587 49587 TS=25 
MSENLKLDLRGLDVDSIDVVSADSIVAEGHGTIETGASSSPGYCSSYLTAMSCWAPEL 
 
926_ACS83769.1 Nonomuraea sp. WU8817 9635 9635 TS=25 
MSELESKLNLSDLPMDVFEMADSGMEVESLTAGHGMPEVGASCNCVCGFCCSCSPSA 
 





928_WP_111156021.1 Paenibacillus dendritiformis 11847 11847 TS=25 
VKDLELLLEDLDVHLFQLKIEGATSKDEKALPEMGASGCWSCCCPLNT 
 
929_KOX21547.1 Saccharothrix sp. NRRL B-16348 57953 57953 TS=25 
MTSAGSSRGGRSSAPPTTTSPPTSPWCPAGTASRSSTAASPT 
 




931_WP_096560225.1 Staphylococcus felis 7985 7985 TS=25 
MSEFNTDILDNVDLDSLELASEEISEKEEKEIMGASCTTCVCTCSCCTT 
 
932_WP_125444147.1 Streptococcus gordonii 7537 7537 TS=25 
MKHLDKEQAAALEEISQLDLSILDLDESDLVSSAAASSGSSSCKVTSTCGSSSCCA 
 
933_WP_125366556.1 Streptococcus gordonii 6847 6847 TS=25 
MKHLDKEQAAALEEISQLDLSILDLDESDLVSSAAASSGSSSCKVTSTCGSSSCCA 
 




935_WP_067007690.1 Streptomyces cellostaticus 29073 29073 TS=25 
VIVVLLAVDAMTPTACCTGSSRSTWPTPVSICAVPPADASPWMS 
 




937_WP_014677376.1 Streptomyces hygroscopicus subsp. jinggangensis TL01
 9800790 9800790 TS=25 
VRNARASPDTRAMVASSAIPTSRRGPPAIPTPDCSPAARSSSCLTTATSSLTGPTP 
 




939_WP_100661070.1 Streptomyces lavendulae subsp. lavendulae 7025552


















942_QBP39279.1 Streptomyces sp. 24439 24439 TS=25 
VPPTRTTCCGSSASAPSRSTWSARSRRSTTRRVCRSTTSTSRSSSGRCCAV 
 









































952_WP_093642064.1 Streptomyces sp. SID4951 333868 333868 TS=25 
MENTLLDLEQLGDEMFEVVGSESAQGEGDANSAWAYACCQSASSSCALS 
 
953_WP_093858544.1 Streptomyces sp. TLI_053 825826 825826 TS=25 
MAILDLQTMELPETEAAPIDDTLASTSSLSVLNCGTSTVSTLICL 
 
954_WP_099897193.1 Streptomyces sp. TLI_171 414087 414087 TS=25 
MSDLSRSVETETVLDLQDLDLSELTVTSLRDTVALPENGASWGSCSCQGSSSCAQPQQL 
 




956_WP_148588519.1 Streptomyces sp. WAC01526 41416 41416 TS=25 
MENTLLDLEQLGDEMFEVVGSESAQGEGDANSAWAYACCQSASSSCALS 
 












960_WP_110669416.1 Streptomyces tateyamensis 33171 33171 TS=25 
MSDTADRPHFELEDLDLSDLTVSSLRDSAALPEGGASWGSSSCQGSSSCAVQQHLLPA 
 
961_WP_170198917.1 Thermopolyspora flexuosa 5011691 5011691 TS=25 
MAENLFDLDGLKVDSIEVLSADSIVAEGHGLIETGASSYSPYCSSYMQACSCWAPEQ 
 
962_GES11969.1 Acrocarpospora macrocephala 12926 12926 TS=24 
MNRTKAELAALETETFEIEVIADMDSTLASVEMPIDPGYSSCTYCSTSCSCWTSTSTSCS 
 














966_WP_126890039.1 Curtobacterium sp. HSID17257 98924 98924 TS=24 
MATDSNFDFDLNDLAAEVFDLSDEGLTVESLTAGHGLVETGASFPSCGSSCSSLP 
 
967_WP_146884718.1 Deinococcus cellulosilyticus NBRC 106333 = KACC 11606




968_WP_083529318.1 Kocuria flava 5085 5085 TS=24 
MDRTPHDIVDLPMDVFELEDQGMDVTSLTAGHGMTEVGASTNCFCYPCCSCSAPSSSA 
 
969_WP_134385526.1 Massilia plicata 3211847 3211847 TS=24 
MQNVDTAVDFDFEILETNEATAMEEMGASSTICAGSTCSKQDSSLVAAC 
 





971_WP_123200200.1 Nocardiopsaceae bacterium YIM 96095 9314 9314 TS=24 
MDKNEPAFEVDDLPVDVFSLSGESLTVESLTSGHGTPENGASCFEDDPTGSLSCTS 
 





973_WP_111156021.1 Paenibacillus dendritiformis 38 38 TS=24 
LHLDDLELDDVNIIALTQDDAKGLPDMGATMMWVGCCSCCST 
 
974_PZS18042.1 Pseudonocardiales bacterium 9726 9726 TS=24 
MDELRLDDISVIRMHDAIALPETGASPASSMASSWACHSCGSCCCQE 
 
975_WP_160487251.1 Rathayibacter iranicus NCPPB 2253 = VKM Ac-1602 12656































982_WP_170184969.1 Saccharothrix texasensis 1659585 1659585 TS=24 
VVTACSVSRPAMTAGSVTWPGCSTHAAPCRSGPNSSSANASHETGEHCNHTSSAVNST 
 











































993_WP_138053671.1 Streptomyces sp. ICN19 3375966 3375966 TS=24 
MRTSRSVWTRPRRTTAASSASSTCSAAARCCRSRSSRSASCRTSRRASSCNC 
 




995_WP_138048765.1 Streptomyces sp. NEAU-C151 26795 26795 TS=24 
MELEFDLDDIPADVFDLADSGLTVESLTAGHGLVENGASFPSCGSSCSSLP 
 


















































1008_WP_133205963.1 Arthrobacter sp. JH1-1 42751 42751 TS=23 
LTESSEEYRFVSWWAGGASSPVALSRTLRNCATRSSSSTRGTCPVGSSRGFGSRSHCLKR 
 
1009_WP_066415890.1 Bacillus cohnii 1461934 1461934 TS=23 
MIDEQQPSFPMDAPISSITVASSTSNISNSTSSMFCSIFIFHSSFNSLLLH 
 
1010_WP_066415890.1 Bacillus cohnii 1462124 1462124 TS=23 
MDEQQPSFPIDAPISSITVASSTSKISNSTSSMLCSTFIFYSSFDSL 
 
1011_WP_112225817.1 Lechevalieria atacamensis 1261940 1261940 TS=23 
MKDLSFDLDDLELGDLAVTSMRDSVALPESGASGGPSSCSCSSGSCSSCHQPQLPALTA 
 





1013_EGL44723.1 Propionibacterium sp. 434-HC2 19792 19792 TS=23 
MTRLSSDGSISCSLSSWRRTSYCSQEMSSGFTRERSATSSH 
 
1014_WP_104263765.1 Rathayibacter iranicus 12625 12625 TS=23 
MNEKESFQKIDAQVFDLSDDGLTVESLTAGHGLVETGASWPSCGCSCSSLP 
 












1018_BAO57436.1 Streptomyces lactacystinaeus 3149 3149 TS=23 
MSDITASRVESLDLQDLDLSELTVTSLRDTVALPENGASWGSCSCQASSSCAQPQDM 
 

































1026_WP_151570259.1 Actinomadura rudentiformis 41637 41637 TS=22 
LTAPASSVATTEWSSSFQASPSVCTLSGLPFISSWWRPL 
 




1028_WP_066415890.1 Bacillus cohnii 1461795 1461795 TS=22 
MHNYLIMIDEQQPSFPMDAPISSITVASSTSKISNSTSSTFVS 
 
1029_PZA02665.1 Cutibacterium acnes 1918159 1918159 TS=22 
VLEVPAAGQDVNSSWPASAISTNSSVWRQRSQESSPAGCCS 
 
1030_WP_088248048.1 Deinococcus indicus 115677 115677 TS=22 
MNEPTTTAIPEALELNDLHLEDVSVAVEEDAYDLPEAGASLSPRFSCSIVIDLS 
 
1031_WP_099749137.1 Deinococcus sp. UR1 75067 75067 TS=22 
MNEQTKAAIPEALELNDLHLEDVSVAVEEDAYDLPEAGASVSPRFSCSIIIDLS 
 
1032_WP_061289420.1 Herbidospora cretacea 457091 457091 TS=22 
MEKLPLDLSGLEVEAIDVLSADSIVMEGHGAVETGASSAMGYCSSYMQANSCWAPEA 
 












1036_WP_148443734.1 Nonomuraea sp. PA05 966 966 TS=22 
MSSENLKLDLRGLEIDSIDVVSADSIVAEGHGTIETGASSSPGYCSSYLTAMSCWAPEL 
 























1042_WP_173260350.1 Streptomyces sp. CWH03 54324 54324 TS=22 
MDRMLDTDVLELVLEGERPELEVLPAGYAPGSSVGSAGSISCASCPAASISSASTASSH 
 




1044_WP_146884718.1 Deinococcus cellulosilyticus NBRC 106333 = KACC 11606
 79082 79082 TS=21 
MHQDRPLDDLDLRDLDLSEVEVESEDDTYALPEAGASVSWNSCSSIRPK 
 
1045_WP_146884718.1 Deinococcus cellulosilyticus NBRC 106333 = KACC 11606
 79265 79265 TS=21 
MSHDKKQEELNIQDLDLNEVEVTTEDDSYALPEAGASIGYNSCSSVKVSK 
 
1046_WP_066368573.1 Herbidospora mongoliensis 394279 394279 TS=21 
MATNEPFHLDLDSLDVMTVELPGEDLVKALGMGLGNTEVGASGYMRTSWVV 
 













































1057_WP_170231932.1 Saccharothrix saharensis 1241693 1241693 TS=21 
MSSSTARHRRSPSSLPVSSHSPHTAPSCGTCSTCAPTTWR 
 








1060_WP_129806648.1 Streptomyces albidoflavus 69044 69044 TS=21 
LATVSSSGGLPASRSRNASKSSPQGSSSRSTRSCTDQPSWSRASS 
 





















1066_WP_075986497.1 Streptomyces sp. FR-008 723962 723962 TS=21 
LATVSSSGGLPASRSRNASKSSPQGSSSRSTRSCTDQPSWSRASS 
 
1067_WP_167151757.1 Streptomyces sp. MBT27 624219 624219 TS=21 
VPRSRDMAIQPPSVTSHPYSGRCPMTVTTTDRARSSSSQTPRPAITRSKKT 
 













1071_AUS77075.1 Actinoalloteichus sp. AHMU CJ021 115457 115457 TS=20 
VPGREERGWSPHPDMRTGAAMRPCQDCRSASSNHAHATRSSPIGASSSR 
 



















1076_WP_173027111.1 Arthrobacter sp. NEB 688 749713 749713 TS=20 
VLRSPGWSGERSWCPPWPSPRDGRGRWSVVPPACPDSSPTGARAAVCTTTTAR 
 
1077_WP_066415890.1 Bacillus cohnii 1461750 1461750 TS=20 
VIHDFGEGGEKMEIEKVMDFELEIFEVEEATVMEEMGASIFIIACCSSIEIKPY 
 




1079_WP_106538471.1 Haloactinopolyspora alba 124215 124215 TS=20 
VPVSLLAAITVTSTVSSVRAAASCEGSTTPSVSTGRYVTRTPCRRSRDRQVSSTAGCSVT 
 
1080_WP_027344871.1 Hamadaea tsunoensis DSM 44101 38999 38999 TS=20 
MRRVRLGGRAASFTSDNCGDALGGAVRSRWSSRPSSSSSSPSPSPSPR 
 









1083_WP_158515427.1 Kitasatospora sp. MBT63 4348 4348 TS=20 
MSDTTAQHAFDLEDLDLSDLTVSSLRDTAALPETGASWGSCSCQGSSSCAQPEVDTLAF 
 

























1089_WP_167477798.1 Nocardia arthritidis 8606460 8606460 TS=20 
MAWQRLFPQLTTSSCSRTPTTGIPFEGIPVTSFAATLIG 
 











































1099_WP_040246700.1 Streptomyces albus 1271860 1271860 TS=20 
MPPPARRRTAAATTCTSARPPGPRCSSPGPGSPGGAPSSSSASPPRRPWRAPGPC 
 
1100_WP_120757588.1 Streptomyces klenkii 93377 93377 TS=20 
VDQRSSEFEPCRACGRTTLVWVAWSDESSGMQHGTVEEHSSQAGQQGEK 
 
1101_WP_037796980.1 Streptomyces sp. ADI91-18 1315959 1315959 TS=20 
LMTSMYGPSGIWATSAVTKPSRTASSPPTMPVTTASRRNAAPQWRMTSTRSSS 
 
1102_WP_148643628.1 Streptomyces sp. CB01881 1892339 1892339 TS=20 
MTSPPPSATATGSGTPVPDARRRSGFVALGMVGTLALALSGCSSSSSSPPSAASTPPR 
 



































1111_WP_116178934.1 Kutzneria buriramensis 158169 158169 TS=19 
MFMYSKGPVSTRRATTVRAARSSSRSDTQLHTRPCSSGCMVSRNLT 
 




1113_WP_048778129.1 Streptococcus gordonii 1236 1236 TS=19 
MKHLDKEQAAALEEISQLDLSILDLDESDLVSSAAASSGSSSCKVTSTCGSSSCCA 
 
1114_WP_125400247.1 Streptococcus gordonii 265 265 TS=19 
MKHLDKEQAAALEEISQLDLSILDLDESDLVSSAAASSGSSSCKVTSTCGSSSCCA 
 
1115_WP_103344440.1 Streptococcus parauberis 577 577 TS=19 
MKHLDKEQAAALEEISQLDLSILDLDESDLVSSAAASSGSSSCKVTSTCGSSSCCA 
 








1118_WP_037873311.1 Streptomyces sp. NRRL S-37 33184 33184 TS=18 
VPPRSLPTATGGRTGPRRPTAGSRAVRSPAATERRTTTRCCT 
 






















1124_WP_018090006.1 Streptomyces sp. SID8375 259491 259491 TS=17 
LPLGVSGQLSTTTNAEGVMYDGSSAAVSSRTAAGLNGGPSGACWT 
 
1125_WP_089317077.1 Actinomadura mexicana 1715 1715 TS=16 
VAPRSAPLEPSAQGSSMTNSSSIPTARCGASVGSRRGVDC 
 
1126_WP_122195758.1 Actinomadura sp. NEAU-Ht49 4910 4910 TS=16 
MTAGSLLVREGHSGTCGTWDAGGRTRDTERQKRLPSSRGLGFS 
 
1127_WP_156046005.1 Herbidospora cretacea 197191 197191 TS=16 
VRRSPAAFPVSGPTPCSPERHSPSPDSTSPSWARNTISTTPTCLRSTTSASSSTARSSIPATR 
 
1128_WP_156046005.1 Herbidospora cretacea 226789 226789 TS=16 
LSPLVARPPADPLRRRCAHRSGREVTTTTARPRLGGAMPAAITSHSRFVNC 
 
1129_WP_062436515.1 Herbidospora daliensis 157084 157084 TS=16 
VCGLPCTVTSTSCSTTTTSGSPPWCRETRRTRTTSAGEDPQLRPYPARISSRPV 
 























1135_WP_125815392.1 Streptomyces sp. WAC07149 132625 132625 TS=16 
MPGGDRPPGRVRCCTGERMPCFATTSRGGEECESPIRVSASHTTPA 
 




1137_WP_003649851.1 Lactobacillus paragasseri JV-V03 6157 6157 TS=15 
MKDLFDIDEKSLENLDLGDFKILDSEDLSEKDEKSILGASCTTCTCCCSCCA 
 




1139_WP_148033048.1 Nonomuraea sp. C10 5232706 5232706 TS=15 
MSAENLKLDLRGLDVDSIEVVSADSLVVEGHGAIETGASSALGYCSSYLTATSCWAPEA 
 
1140_AXI76532.1 Streptacidiphilus bronchialis 563785 563785 TS=15 
VPPTGSRAWDRTPAARRSCCGCPTATTTAWCCPRTHGSGRPTM 
 








1143_WP_114024659.1 Candidatus Streptomyces philanthi 72894 72894 TS=14 
VGAPGVEWSARASQVGTRPSWAFLPSRGVSSSSTDLYCVTKPGGSQT 
 
1144_WP_049161721.1 Lactobacillus gasseri 3701 3701 TS=14 
MKDLFDIDEKSLENLDLGDFKILDSEDLSEKDEKSILGASCTTCTCCCSCCA 
 
1145_AFR07166.1 Nocardiopsis alba ATCC BAA-2165 1704912 1704912 TS=14 
MTRLLSWPVSCSEERPRVIVVRDSDVIAKPSIRGCSSSLDSCSSKERTRKAAR 
 












1148_KOT43230.1 Streptomyces caelestis 37519 37519 TS=14 
LPAAPGGTEERCAPDSCEERSSGVTGPGPLHDRHWPSVT 
 
1149_KJY39143.1 Streptomyces katrae 4093 4093 TS=14 
VVTTGRAASPPRAATRESSSAPSSSSGTHTSATRNSAAGPRTTNEVPSAPK 
 
1150_BAU81447.1 Streptomyces laurentii 554629 554629 TS=14 
MLTHANLIANICQNEQVLPQTTAETVPAVLPFFHDSGSQGHH 
 




























1157_WP_094862908.1 Amycolatopsis antarctica 325770 325770 TS=13 
MARAGEGHTNAGALLGPCLPVRPGSATTPADRGLVPAPAGTRRPSPADRPQGT 
 
1158_WP_034336238.1 Deinococcus misasensis DSM 22328 90312 90312 TS=13 
MLTEAIIPVQSNPTPQMLRALSSLNETEVLSEVKTVKKPTKLGDSLISCWANPC 
 










1161_WP_026928618.1 Glycomyces tenuis 311897 311897 TS=13 
LDLSSARPRGAERSSAPRTRRPPRLRPGAAPRCGRLLHRLHHPRESHR 
 




1163_WP_063494187.1 Lactobacillus plantarum 7305 7305 TS=13 
VQSGLPFSMIYSTTKIKKLLVMRIANGQRKLCEKLIRLYTAMPKQEKLWHS 
 




1165_WP_040691311.1 Nocardiopsis lucentensis DSM 44048 7330 7330 TS=13 
VSVHADLPTSNKSMLLPSSTVRQWGKAHLAYGRVMCGAVAGQEREIDRRGG 
 




1167_WP_070437603.1 Streptococcus sp. HMSC10E12 15670 15670 TS=13 
LSNFWGAVQKLFAHGEDNIILVTNFYDYSLFISMKSSMYPFINSSSVV 
 
1168_WP_125051747.1 Streptomyces rimosus subsp. paromomycinus 951775








1170_WP_138054944.1 Streptomyces sp. ICN19 5272952 5272952 TS=13 
LRHMVYEIIAASSTRFPCFDSRCRNRSSPCCFFKTRPLGEGRSHRT 
 
1171_WP_109293928.1 Streptomyces spongiicola 1931785 1931785 TS=13 
MNDITPATGLALDLRLDQEAPELEVLPTSHSPGSTVGCAATGSSISTPSGCFSSAGTASSA 
 










1174_WP_109293928.1 Streptomyces spongiicola 1958314 1958314 TS=13 
MQVGGAAPVGRRARSGLTGARGRWIRVGTDPFRRYGESRTDRRRNATVSSSRVCCWT 
 


















1179_WP_028414789.1 Bacillus sp. 278922_107 416169 416169 TS=12 
VKETEKSILAQVKNEPLINIFDSWFVFLLFNYVFTCPLFPSIPSMCETVS 
 
1180_WP_028414789.1 Bacillus sp. 278922_107 443549 443549 TS=12 
MELKLDFNVLENLEENISFDEVKALDIEGSIGATEGASSAGSSLPFPPYFWFTCSA 
 
1181_WP_009582377.1 Fulvivirga imtechensis AK7 38911 38911 TS=12 
VLARTPSGFKKRSSSRLVKYRKAESPGDEHLWGKHSADIGACFRDTT 
 
1182_WP_090945800.1 Nonomuraea jiangxiensis 12225 12225 TS=12 
MSAENFTLDLRGLDVDSIDVVSADSIVVEGHGAIETGASSALGYCSSYLTATSCWAPEE 
 
1183_WP_027734140.1 Streptomyces sp. CNR698 45136 45136 TS=12 
MNDITPVSGPALDLRLDQEAPELEVLPASHSPGSTVGTAATGSSISTPSGCFSSAGTASSA 
 
1184_WP_027734140.1 Streptomyces sp. CNR698 45463 45463 TS=12 
MDRLPDTDVLELVLEGEPPELEVLPAGHAPSSTLGSAGSISCASCPAASASSASTASSH 
 






1186_WP_018891562.1 Streptomyces sp. CNT302 64272 64272 TS=12 
MNDITPVPGPALDLRLDQEAPELEVLPASHSPGSTVGTAATGSSISTPSGCFSSAGTASSA 
 
1187_WP_170812553.1 Streptomyces sp. PKU-MA01144 10589 10589 TS=12 
MDRLPDTDVLELVLEGEPPELEVLPAGHAPSSTLGSAGSISCASCPAASASSASTASSH 
 
1188_WP_170812553.1 Streptomyces sp. PKU-MA01144 10916 10916 TS=12 
MNDITPVPGPALDLRLDQEAPELEVLPASHSPGSTVGTAATGSSISTPSGCFSSAGTASSA 
 
1189_WP_129842995.1 Streptomyces sp. RFCAC02 5132401 5132401 TS=12 
MTEGVVIVAPRERQESSSAGSPATCRPAGFTRHCTGLDRQSCAFAGNPPFRPD 
 












1193_WP_119313826.1 Meiothermus terrae 14190 14190 TS=11 
VEVSITRGAAGPVVAVGREPVARSPPEALRCCRAARRRSPRDPANVGDFT 
 








1196_WP_151462301.1 Micromonospora sp. AMSO31t 32525 32525 TS=11 
MACTCAGPSVGCSSCPPPHRSSSRVRVVRAPRGSPTSSVNIR 
 
1197_WP_117665659.1 Micromonospora sp. MW-13 14251 14251 TS=11 
VRGQYGEHCAGLGCCRRDGSVVMSGGERAKDCDTQRSSPY 
 
















1201_WP_162824113.1 Streptacidiphilus bronchialis 592495 592495 TS=11 
MSIDFGAFDVNELEVLDVTDSVALPDMGASAIIIFPTVTPDGEEILGEADLGISGSLSTSCC 
 




1203_WP_167515856.1 Streptomyces huasconensis 25346 25346 TS=11 
MRAARSSRSRTSSSPSTTARSPSWAPPPCAAPRRRSSSPAAPTSCAAPSSRSA 
 




1205_PIG63282.1 Streptomyces sp. CNZ279 1456744 1456744 TS=11 
LFSDHFWPLRLKTQGCEPNSRHLPGEFTPRSPSPFAFVTPCG 
 
1206_PIG63282.1 Streptomyces sp. CNZ279 1475724 1475724 TS=11 
LYNVGNGDSWHDSTHAGPCPGTRRRQPNRARSGQRAGGVGHG 
 








1209_WP_025028233.1 Bacillus mannanilyticus JCM 10596 35897 35897 TS=10 
LHSIAEETRRTLSRAELKDECKNHLREGELMKKVLNVVFKKSGTTVVPGDKMSW 
 













1212_WP_028594895.1 Paenibacillus assamensis DSM 18201 26155 26155 TS=10 
VTYPPREWPSSTNLSSSSLSANAIISSAICSIVYAPFGAVDFP 
 








1215_WP_033226294.1 Streptomyces virginiae 5190 5190 TS=10 
VGGGGPGGGGGGGGGGSGCELRPDKGPGGGPVGCSEEGGREFTTLAPRHRAVGKPW 
 




1217_KIC48916.1 Tateyamaria sp. ANG-S1 679855 679855 TS=10 
MWLTQIGKSREGTTPAIALSSSWLSRYDCATKGRIAAPIGRDVNGT 
 












1221_WP_147012481.1 Luteibaculum oceani 270507 270507 TS=9 
MGFNPEVRIALFPFLERMGNKKAPRCGVGLSEVHMWSHLGSNQGPLDYESSALTS 
 

























1227_WP_167972679.1 Streptomyces lonarensis 11278 11278 TS=9 
MTAVTSDTAPAPAAVPTTAGPFAAARDRLERLLAERHAREGRPPLLGA 
 
1228_WP_030019170.1 Streptomyces monomycini 164156 164156 TS=9 
VAIAPAAAAASAMPEFRPRAPKGAKRCPASPASSTRPCRSVKSSATTCWKR 
 








1231_WP_159036914.1 Streptomyces sp. Ag109_G2-1 26323 26323 TS=9 
VGSLVPGPMEPRTQRGLPSSAVKASADSRAMRAPASESS 
 




1233_WP_051779832.1 Streptomyces sp. NRRL S-241 24271 24271 TS=9 
LQSWTSRSHVDGKMTDNLGRPSSSRVQAGSRVNFSNIPGVNSDKGKCLW 
 
























1239_WP_062351038.1 Herbidospora yilanensis 176204 176204 TS=8 
VLLSRIEADRSTTITTSSAVTLPVEPCDSMDAHALAGDDGTGADVH 
 
1240_WP_082527048.1 Kitasatospora sp. MBT63 462 462 TS=8 
MPFGLAGDQDQQAAEVHPPRHGKLRGFAAMCQGRARGWAS 
 
1241_WP_027890929.1 Meiothermus chliarophilus DSM 9957 6064 6064 TS=8 
LDGGVLAIASSWSGLEPAHVGPEERICPSPEPESRTGTD 
 
1242_WP_027890929.1 Meiothermus chliarophilus DSM 9957 6082 6082 TS=8 
MDNTKNTPKPEDIQADFNLEDLDLNDVKVLAESDSYALPEAGASIGKFSCTIVITK 
 
1243_WP_132402251.1 Micromonospora sp. KC207 12591 12591 TS=8 
VAAPAAAPAGSARFRSTTSRSPTWKSAGGPSCGSWRRRCRRWDSSA 
 
1244_WP_028559081.1 Paenibacillus pinihumi DSM 23905 = JCM 16419 548961
 548961 TS=8 
MSSLASSRARTKSRNTSSSSVGICTAVNSPPGITGLIFTRLICLFLSGLLHVLAGQLPSAR 
 




























1251_WP_069755267.1 Streptomyces sp. EN16 22553 22553 TS=8 
VPDSFSGCGSRWDRHSKCSSSRFVSPGGRRTTASVRADGSRSHHSRRG 
 




1253_WP_125542282.1 Streptomyces sp. WAC05292 4845 4845 TS=8 
LLSASMAHPFLPAGCPAAASGLASHAPPVVRAAHEWLGGPNGPTLEG 
 
1254_OBZ08797.1 Bacillus sp. FJAT-27264 44139 44139 TS=7 
LHILDLNQIPYSTCPLADISSQSVSLSSMKSRDLRVLPTS 
 


























1260_WP_109900069.1 Micromonospora sp. S4605 25267 25267 TS=7 
VARAGEPPPLRCTDARCPARVGACCGQPAGRSRSERIRRKPPCPPPHPTPQLRRFPVFAM 
 
1261_WP_017625650.1 Nocardiopsis chromatogenes YIM 90109 24198 24198 TS=7 
VPSMSTLLPTDGPHGTMSLPLTGRSRRVGPEISPSGVRCGGSGRN 
 
1262_WP_017625650.1 Nocardiopsis chromatogenes YIM 90109 26592 26592 TS=7 
MPTTGSSSVERAVPGGCGRSPKTRTAGGVPTGAPTGAASAWPSP 
 













1266_WP_161027165.1 Pseudoduganella sp. DS3 88741 88741 TS=7 
MTDKIKSEEVVKAELEISGAIKDLESQKEGFLARLSDDLLEDVNGGSVHLNGHGNVVVT 
 
1267_WP_161027165.1 Pseudoduganella sp. DS3 119409 119409 TS=7 
VPSKWRAPSEADLSRRTAQLLRTCFPAQATTLDLMSAIWIIGA 
 
1268_WP_161027165.1 Pseudoduganella sp. DS3 132816 132816 TS=7 
VRSGMRDKLTDSKAKCATQKQHLHFCRSSPYNLAPKRTSCSVCEISK 
 
1269_WP_061377893.1 Streptococcus pneumoniae 6632 6632 TS=7 
MKLLFFFTILCYYTKFPSSKQCSSDGNNGSSGLNNRSEFCFSIVLDI 
 
1270_WP_061377893.1 Streptococcus pneumoniae 24581 24581 TS=7 
MSIQGFMWIDIRRIVIDDFSVLNHDNSHLDNFSLTTCASCL 
 
















1274_WP_136290219.1 Streptococcus pyogenes 13128 13128 TS=7 
MLIYNKLTSFCPGLVTRQTNEENFVFRNLFFIELNIILS 
 
1275_WP_030019169.1 Streptomyces monomycini 93240 93240 TS=7 
VPRCWSPGCRWSRWSCSDRRRRCCGCGCSGSSSGRCWRPSRGRPCARPRCSRW 
 
















1280_WP_171433399.1 Corallococcus exercitus 22474 22474 TS=6 
MAVFLEIGWASVRRRPVQRCGGQEHGACHAPHALLEETSSRNCSRAG 
 
















1284_WP_154116038.1 Paenibacillus sp. LC-T2 88986 88986 TS=6 
MIESFFFIITISYLLLVIFTTIQLYSNSSSLLRSFIGYSKISPANVTPNRASNIRLR 
 
























1291_VFH36036.1 Streptococcus pneumoniae 320479 320479 TS=6 
MNIKKRVLSAGLTFASVLLLAACGQSGSDTKTYSSTFSGNPTTFNYLLDYYTDNIVN 
 




1293_WP_097867410.1 Streptomyces sp. rh34 10403 10403 TS=6 
LRPSTNSEASLHPSMSGLQRSMCSSRNRSGSSSLLANADRH 
 












1296_WP_014174828.1 Streptomyces milbemycinicus 3537 3537 TS=5 
VDRGGAQQASGEGPAFWPGTGRPPWCVEPGSALDTALRRLEGATDG 
 








1299_WP_057090276.1 Enterococcus faecalis 8062 8062 TS=4 
MDEVESNCTHLLFLKKGKVVECGKLSDILSKYDTNMNEFYLEKNKGAY 
 
1300_SBO97612.1 Nonomuraea gerenzanensis 7664584 7664584 TS=4 
VHVPAVPVCPVGKCARIHRVVLLVSNGGGPAEFGCGVSRDGCGWWTVG 
 
1301_SBO97612.1 Nonomuraea gerenzanensis 7708541 7708541 TS=4 
LLDGQVPGAVGRVEAGVAGQQNGASDGGAQGVHSVHGVHGPNATVGKDPI 
 
1302_WP_036835402.1 Pontibacillus litoralis JSM 072002 25452 25452 TS=4 
MLPTMFITSATFGRGRRLSIIAIGAFKRSAILRALVTPPWSGDTITTSSKFFSSK 
 




1304_RME10422.1 Bacteroidetes bacterium 1064 1064 TS=3 
LLPSFYKYPANADARAILHDIFFAIVVPCLSMYQNLDVRKKKKPSRRYTSERL 
 
1305_WP_155203238.1 Cytophagales bacterium RKSG123 1009 1009 TS=3 
MIGKAPASIKIEEMTPSSKELLSFNGEDLVSEFVVQWSC 
 
1306_WP_155169938.1 Fulvivirga kasyanovii 7650 7650 TS=3 
MGQKIKQYEACRRKSVNLTCYYCIPVCNCFCRLLLTTVVCISPEIPPDH 
 





















1312_WP_097910655.1 Streptomyces sp. wa1071 3319 3319 TS=1 
MSGSAHCSLSGARRGGIVSPAGPRHTTSGGRHLPQRLPIMNGYAA 
 
1313_WP_097910655.1 Streptomyces sp. wa1071 3460 3460 TS=1 
MLRPLRGGLGELSAGAKVLSSRRPGPEASKPPGTAASAGLRSSTVRGPRHGGRSGGT 
 
1314_WP_168090536.1 Streptomyces bohaiensis 1654 1654 TS=0 
VAAGSPAAPAQAAARTAGGTPRDGGAPAAVRHDAPRSASPARWRDRSTRS 
 




1316_KJY27547.1 Streptomyces katrae 1465 1465 TS=0 
VLVGTHARRAPLFGPLRRPSSVGRRPSSVRRPVAPSSHGRRPVR 
 

























1323_WP_089317077.1 Actinomadura mexicana 10573 10573 TS=10 
MDKLDLDGLKVESIEVVSLEGLESGHGMTEIDASCGAFCICATISCQAPVAE 
 
1324_WP_089317077.1 Actinomadura mexicana 1389 1389 TS=8 
MEFARCLALLGRCLRRLTSGPGRSSGLLSVSPAPMGTSWGSLIKRCSCTS 
 




1326_WP_156046005.1 Herbidospora cretacea 221841 221841 TS=14 
MDKLPLDLSGLEVEAIDVLSADSIVMEGHGAIETGASSAMGYCSSYMQANSCWAPEA 
 








1329_WP_071967152.1 Streptomyces cinnamoneus 232120 232120 TS=8 
MHTGGNAMLPQLDFDALDITNIELPEDEQVFDSLADGSAHSEIGASCFRFCYHCSYVI 
 
1330_WP_051879301.1 Streptomyces sp. NRRL B-24720 9616 9616 TS=11 
MAASTPYRLQLVVSTWSHLANGGDPGPIYDHGLGALSGSVGGTFAGSSIRTPVWIC 
 
1331_AFR07166.1 Nocardiopsis alba ATCC BAA-2165 1721193 1721193 TS=11 
MADTDKEVLMPHSTAPAIDLPELDFDDMEVMSVRDGGSCG 
 
1332_WP_127937127.1 Nonomuraea polychroma 8873330 8873330 TS=13 
MSNDILPLDLSGLEVASIDVLSADSIVVEGHGAIETGASSYSPYCSSYMQACSCWVPEQ 
 








1335_BAU81447.1 Streptomyces laurentii 524649 524649 TS=11 
VVFTGGCPPCSWTCSRTGCRPAWRRRAVRVAPGGERGAGRGASPPGFSYSNP 
 










1338_WP_094862908.1 Amycolatopsis antarctica 309976 309976 TS=12 
MLSDELGALEAEAFEVIDIEEPARMLAGTTVTSPSTCAVPTGGSNTENR 
 












1342_WP_026928618.1 Glycomyces tenuis 308895 308895 TS=12 
MKKSSSPVSMHIPFGSGVNRWLPPLLSCASSMSQRTSYSSPS 
 
1343_WP_067368384.1 Micromonospora rosaria 11581 11581 TS=6 
MDNVVTEAAEFADLDIVDLDLAVDEELAALSVGGLGNTEVGASGWLGSWVI 
 
1344_WP_067368384.1 Micromonospora rosaria 11870 11870 TS=6 
MDNAATEATEFADLDIVNLDLPIDEELAAVSVGGLGNTEVGASGFFGRSWLI 
 




1346_WP_125051747.1 Streptomyces rimosus subsp. paromomycinus 953410
 953410 TS=7 
MFVLTDPSPQAARPVAPSLRNAVCRARTSTGSPSAVPVPCASM 
 
1347_WP_125051747.1 Streptomyces rimosus subsp. paromomycinus 953932
 953932 TS=6 
MASTARWTATSELEQAVSTGSLGPRRSSTYEMRLASIEWALPVEVNASGSTPYVVSSVA 
 
1348_WP_138054944.1 Streptomyces sp. ICN19 5266269 5266269 TS=12 
MNDITPASGPVLDLRLDQEAPELEVLPAAHSPGSTVGCAGTGSSISTPSGCFSSAGTASSV 
 





1350_WP_138054944.1 Streptomyces sp. ICN19 5265674 5265674 TS=10 
MNDLDLRLDQEMPELEVLPEEYSAGNVSCAATVGSGSCPAMTWGTASTLSSK 
 
1351_WP_138054944.1 Streptomyces sp. ICN19 5265953 5265953 TS=10 
MDRLPDTDVLELVLERELPELEVLPAGYAPGSTLGSAGSISCASCPAASISSASTASSH 
 
1352_WP_109293928.1 Streptomyces spongiicola 1932652 1932652 TS=12 
MNELDLRIEQESLEIEVLPDTQSAGNCAGTASTAGSFSCPAGSIGSAGSASST 
 
1353_WP_109293928.1 Streptomyces spongiicola 1932405 1932405 TS=11 
MNELDLRLDQEMPELEVLPEEYSAGNVSSAATVGSGSCPAMTWGTASTLSSK 
 
















1358_WP_009582377.1 Fulvivirga imtechensis AK7 37092 37092 TS=7 
VSIRKTYGDPSLRTNDKFSLHADSQMTASYCSVCNFCVYCDFS 
 
1359_WP_027734140.1 Streptomyces sp. CNR698 46020 46020 TS=11 
MNELDLRIEQENPEVEVLPDTQSAGSCAGSAGTAGSLSCPGGSIGTVGTASSSG 
 
1360_WP_027734140.1 Streptomyces sp. CNR698 45761 45761 TS=10 
MNDLDLRLDQEMPELEVLPEEYSAGNVSCAATVGSGSCPAMTWGCASTLSSK 
 




1362_WP_018891562.1 Streptomyces sp. CNT302 63388 63388 TS=11 
MNELDLRIEQESPEVEVLPDTQSAGSCAGSAGTAGSLSCPGGSIGTVGTASSSG 
 









1365_WP_170812553.1 Streptomyces sp. PKU-MA01144 10032 10032 TS=11 
MNELDLRIEQESPEVEVLPDTQSAGSCAGSAGTAGSLSCPGGSIGTVGTASSSG 
 
1366_WP_170812553.1 Streptomyces sp. PKU-MA01144 10291 10291 TS=10 
MNDLDLRLDQEMPELEVLPEEYSAGNVSCAATVGSGSCPAMTWGCASTLSSK 
 




1368_WP_129842995.1 Streptomyces sp. RFCAC02 5116202 5116202 TS=11 
MSDHEFTLDLDGLDVDTIDVLPADSVMTEGHGAIETGASCSPGYCSCYSTAMSCFVPEEI 
 
1369_WP_119313826.1 Meiothermus terrae 6888 6888 TS=10 
MDNTKNTPKPEDIQADFNLEDLDLNDVKVLAESDSYALPEAGASIGKFSCTIVITK 
 
1370_SCL48150.1 Micromonospora yangpuensis 811256 811256 TS=5 
MEDMAVEATEFADLDIVDLDLPIDEELAAVSIGGLGNTEVGASGFWGRSWLI 
 
1371_WP_149666213.1 Pseudonocardia sp. EV170527-09 304 304 TS=6 
VLVACCQAASSVLRVSMSVMRRSGHWRARVESSISAMLSQEPCRA 
 




1373_WP_161371729.1 Streptomyces sp. SID5770 9893 9893 TS=8 
MGITRILSVKVGKIRPEVQKSRSTGTNAPARRLREETRGRARGAGSPPVPAPDLAISLA 
 




1375_WP_121832244.1 Streptomyces sp. S1 9925 9925 TS=8 
MGITRILSVKVGKIRPEVQKSRSTGTNAPARRLREETRGRARGAGSPPVPAPDLAISLA 
 
1376_KIC48916.1 Tateyamaria sp. ANG-S1 703427 703427 TS=7 
VFVFLNAAAFVENLPQPTRGENSKTDAKSHPGCWSVARWRVTSCPKT 
 






1378_WP_122194823.1 Actinomadura sp. NEAU-Ht49 40673 40673 TS=5 
MGMLYSATATSANAPCPPDTGPAPPAAARGEPQEPAHRCTGRFRATGHSRTTAGHSSA 
 








1381_WP_066415890.1 Bacillus cohnii 1461919 1461919 TS=19 
MLINYLKGGDHMAQLTNVEEVELEIFEVEEATVMEEMGASIGKLGCCSSIIIR 
 
1382_WP_066415890.1 Bacillus cohnii 1462100 1462100 TS=19 
MNMEQNMEEVELEIFEVEEATVMEEMGASIGKLGCCSSIIIR 
 
1383_WP_066415890.1 Bacillus cohnii 1462281 1462281 TS=19 
MNVEQSMEEVELEIFEVEEATVMEEMGASIGKLGCCSSIIIR 
 
1384_WP_088248048.1 Deinococcus indicus 115228 115228 TS=10 
MNEQTTTATAEVIELNDLHLEDVSVAVEEDAYALPEAGASVSPKYSCTVVIER 
 
1385_WP_088248048.1 Deinococcus indicus 115445 115445 TS=10 
MNEQNTTATSEVIELNDLHLEDVSVAVEEDAYALPEAGASASPKYSCTVVIKPN 
 
1386_WP_088248048.1 Deinococcus indicus 115888 115888 TS=9 
MNEPTTTAIPEVIELNDLHLEDVSVAVEEDAYDLPEAGASASPRFSCSIIIEL 
 
1387_WP_088248048.1 Deinococcus indicus 116105 116105 TS=8 
MNEPTTTAIPEALELNDLHLEDVSVAVEEDAYDLPEAGASLSPRFSCSIIIARE 
 
1388_WP_099749137.1 Deinococcus sp. UR1 74633 74633 TS=19 
MNEQTTTAIPEALELNDLHLEDVSVAVEEDAYDLPEAGASASPRFSCSIIIQL 
 
1389_WP_099749137.1 Deinococcus sp. UR1 75301 75301 TS=10 
MNEQTTTATAEALELNDLHLEDVSVAVEEDAYALPEAGASVSPKYSCTVVIEK 
 
1390_WP_099749137.1 Deinococcus sp. UR1 74847 74847 TS=8 
MNEQTKAAIPEALELNDLHLEDVSVAVEEDAYDLPEAGASVSPRFSCSIVIAKE 
 
1391_WP_146884718.1 Deinococcus cellulosilyticus NBRC 106333 = KACC 11606






1392_WP_146884718.1 Deinococcus cellulosilyticus NBRC 106333 = KACC 11606
 79630 79630 TS=19 
MSHEKKQEELNIQDLDLNEVEVTTEDDSYALPEAGASIGYNSCSSVKLK 
 
1393_WP_146884718.1 Deinococcus cellulosilyticus NBRC 106333 = KACC 11606
 79807 79807 TS=19 
MSHEKKQEELNIQDLDLNEVEVTTEDDSYALPEAGASIGYNSCSSVKPK 
 
 
 
 
 
 
 
